mitomycin has been researched along with Cancer of Liver in 895 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of transcatheter arterial chemoembolization (TACE) using multiple anticancer drugs (epirubicin, cisplatin, mitomycin C, and 5-furuorouracil: Multi group) with TACE using epirubicin (EP group) for hepatocellular carcinoma (HCC)." | 9.16 | Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. ( Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T, 2012) |
| "We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with extensively pretreated metastatic colorectal cancer (mCRC)." | 9.16 | Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. ( Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D, 2012) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 9.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "It is unknown whether sorafenib can be combined with transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma." | 9.14 | Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. ( Borner, M; Candinas, D; Dufour, JF; Heim, MH; Helbling, B; Hoppe, H; Kickuth, R; Maurhofer, O; Saar, B; Szucs-Farkas, Z, 2010) |
| "This study was designed to assess the safety and efficacy of capecitabine and mitomycin C (MMC) in previously untreated patients with advanced colorectal cancer (CRC)." | 9.11 | Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer. ( Cunningham, D; Hill, ME; Norman, AR; Oates, J; Price, T; Rao, S; Ross, PJ; Shellito, P; Tebbutt, N, 2004) |
| "To observe the effect of postoperative transcatheter hepatic arterial chemoembolization (TACE) and thymosin alpha(1) (T(alpha1)) treatment on recurrence of hepatocellular carcinoma (HCC)." | 9.11 | [Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma]. ( Chen, H; Cheng, SQ; Cong, WM; Shen, F; Wang, PJ; Wu, MC; Yang, JH; Zhao, YX, 2004) |
| "A multicenter randomized study comparing high dose of mitomycin and epirubicin given as hepatic intra-arterial chemotherapy (HIAC) combined with caval chemofiltration (CF) versus low doses of the same drugs in unresectable liver metastases from colorectal cancer showed a significant improvement in the survival rate of the 20 patients treated with high dose compared to the 22 patients treated with low doses with a 1 year survival of 69% vs 39%." | 9.11 | Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study. ( Bernardeschi, P; Cantore, M; De Simone, M; Dentico, P; Fiorentini, G; Guadagni, S; Poddie, DB; Rossi, G; Rossi, S; Tumolo, S; Valori, VM, 2004) |
| "The aim of this phase II study was to investigate the therapeutic value of second-line treatment with oxaliplatin, irinotecan (CPT-11) and mitomycin C (MMC) in patients with metastatic colorectal cancer pretreated with 5-fluorouracil (5-FU)-based chemotherapy." | 9.09 | Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer. ( Brodowicz, T; Hejna, M; Köstler, WJ; Raderer, M; Scheithauer, W; Tomek, S; Wiltschke, C; Zielinski, CC, 2000) |
| "We evaluated the technical feasibility of isolated liver perfusion (ILP) in the treatment of patients with colorectal cancer metastases confined to the liver, and investigated whether ILP allows exposure of the tumor to high concentrations of mitomycin C (MMC)." | 9.08 | Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver. ( Beerman, H; de Brauw, LM; Keizer, HJ; Marinelli, A; Tjaden, UR; van Bockel, JH; van de Velde, CJ, 1996) |
| "Mitomycin C has been found clinically useful in the treatment of colorectal cancer when administered via the hepatic artery." | 9.08 | Superselective intra-arterial chemotherapy with mitomycin C in hepatic metastases from colorectal cancer. ( Kairaluoma, M; Kantola, R; Kiviniemi, H; Laitinen, S; Leinonen, S; Mäkelä, J; Siniluoto, T; Tikkakoski, T, 1997) |
| "Mitomycin C (MMC)-vinblastine (VBL) is a regimen that has commonly been used as salvage therapy for advanced breast cancer for many years." | 9.08 | Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC). ( Awada, A; Geurs, F; Habboubi, N; Kerger, J; Kusenda, Z; Piccart, MJ; Van Vreckem, A, 1997) |
| "Effectiveness, toxicity and complications of 5-fluorouracil (FU) and mitomycin-C (MMC) treatment were analyzed in 30 patients with metastatic colorectal cancer confined to the liver." | 9.07 | Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer. ( Largiadèr, F; Metzger, U; Röthlin, M; Weder, W, 1991) |
| "Background The aim of the study was to evaluate the safety and feasibility of intra-arterial mitomycin C (MMC) infusion after selective internal radiation therapy (SIRT) using Yttrium-90 (90Y) resin microspheres in liver metastatic breast cancer (LMBC) patients." | 7.96 | Sequential intra-arterial infusion of 90Y-resin microspheres and mitomycin C in chemo refractory liver metastatic breast cancer patients: a single centre pilot study. ( Aarts, BM; Beets-Tan, RGH; Deroose, CMALO; Dresen, RC; Klompenhouwer, EG; Maleux, G; Neven, P; Punie, K; Wildiers, H, 2020) |
| "The aim of this study was to determine the safety and efficacy of Mitomycin C (MMC) infusion in a large cohort of advanced liver metastatic breast cancer patients (LMBC) and to determine factors influencing overall survival (OS)." | 7.91 | Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival. ( Aarts, BM; Beets-Tan, RGH; Dresen, RC; Klompenhouwer, EG; Laenen, A; Maleux, G; Neven, P; Punie, K; Wildiers, H, 2019) |
| "To compare local control effects of superselective transcatheter arterial chemoembolization (TACE) using epirubicin (EPI) plus mitomycin C (M) and miriplatin (MPT) for hepatocellular carcinoma (HCC)." | 7.78 | Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. ( Hashimoto, M; Matsui, O; Miyayama, S; Shibata, Y; Toshima, F; Tsuji, K; Yamashiro, M; Yoshida, M, 2012) |
| "The purpose of our study was to retrospectively evaluate the feasibility, toxicity and impact on overall (OS) and disease-free (DFS) survival of intra-arterial liver perfusion with mitomycin-C (MMC) [hypoxic liver perfusion with MMC (HLPM)] in patients with multifocal liver metastases or with unresectable primary liver tumours." | 7.77 | Hypoxic liver perfusion with mitomycin-C for treating multifocal metastases and unresectable primary tumours: a single-centre series of 42 patients. ( Baggiani, A; Bagliani, A; Belli, L; Belloni, P; Bregni, M; Campagnoli, E; Caspani, B; Crocchiolo, R; Ierardi, AM; Motta, F; Setola, E; Tempini, S; Toniolo, D, 2011) |
| "In the treatment of extensive liver metastasis of breast cancer (LMBC), locally administered Mitomycin C (MMC) to the liver might be an effective approach with limited toxicity." | 7.74 | Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer. ( Demey, W; Heye, S; Maes, T; Maleux, G; Neven, P; Paridaens, R; Van Oosterom, AT; Wildiers, H, 2008) |
| "We histologically examined the effect of hepatic arterial infusion of degradable starch microspheres mixed with adriamycin and mitomycin C (DSM therapy) for liver metastases of colorectal cancer." | 7.72 | [Histological examination of the effect of hepatic arterial infusion of degradable starch microspheres mixed with adriamycin and mitomycin C for liver metastases of colorectal cancer--second report]. ( Hashimoto, D; Hoshino, T; Ishida, H; Mastumoto, Y; Miura, T; Ohsawa, T; Osada, H; Takeuchi, I; Yokoyama, M, 2004) |
| "Combined infusion of 5-FU and mitomycin C by hepatic artery catheter port is an effective treatment for liver metastases from colorectal cancer." | 7.71 | Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer. ( Jiang, HC; Liu, LX; Piao, DX; Qi, SY; Wu, LF; Zhang, WH; Zhu, AL, 2002) |
| "mitomycin C (MMC) on aged patients with liver metastases of colorectal cancer." | 7.71 | [Audit of the safety of hepatic arterial infusion of degradable starch microspheres (DSM). Adriamycin (ADM).mitomycin C (MMC) on aged patients with liver metastases of colorectal cancer]. ( Hashimoto, D; Ishida, H; Kashimada, A; Kuwabara, K; Matumoto, Y; Miura, T; Osada, H; Takeuchi, I, 2002) |
| "Measurement of serum pancreastatin levels is an easy and useful method to predict success in patients who undergo HACE plus somatostatin therapy for metastatic neuroendocrine tumors to the liver." | 7.71 | Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. ( Desai, DC; Jung, SS; Khabiri, H; Martin, EW; O'Dorisio, TM; Schirmer, WJ; Villanueva, V, 2001) |
| "The aim of this study is to clarify whether the expression of metallothionein (MT) is related with the malignant potential in primary colorectal cancer and/or synchronous liver metastasis." | 7.71 | Expression of metallothionein in colorectal cancers and synchronous liver metastases. ( Dhar, DK; Hishikawa, Y; Kimoto, T; Kohno, H; Koji, T; Kubota, H; Nagasue, N; Tachibana, M; Ueda, S, 2001) |
| "Little is known about the histological effect of hepatic arterial infusion with degradable starch microspheres (DSM), adriamycin (ADM), and mitomycin C (MMC) on liver metastasis of colorectal cancer." | 7.71 | [Histological evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin/mitomycin C]. ( Hashimoto, D; Hoshino, T; Inokuma, S; Ishida, H; Matsumoto, Y; Miura, T; Murata, N; Nakada, H; Ohsawa, T; Takeuchi, I, 2001) |
| "To determine the incidence of nausea and vomiting and the antiemetic effect of ondansetron hydrochloride (OND) in patients with hepatocellular carcinoma treated with arterial chemo-embolization, we studied 59 patients with hepatocellular carcinoma who were treated with transcatheter arterial embolization (TAE) or lipiodolized transcatheter arterial infusion (L-TAI)." | 7.70 | Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride. ( Abe, T; Hashimoto, Y; Kojima, A; Mori, M; Nagamine, T; Sohara, N; Takagi, H; Takahashi, H, 1999) |
| "In order to assess the efficacy of repeated hepatic arterial infusion (HAI) therapy for advanced hepatocellular carcinoma, we administered HAI therapy using 5-fluorouracil, epirubicin and mitomycin C, with an implanted drug delivery system." | 7.70 | Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C. ( Chiba, T; Ito, K; Kojima, K; Nakajima, N; Seno, H, 1999) |
| "The efficacy of transcatheter arterial Lipiodol chemoembolization (TALCE) using epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma (HCC) was assessed retrospectively." | 7.69 | Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. ( Kanematsu, M, 1995) |
| "Seventy five patients with nodular type of hepatocellular carcinoma (HCC) non-occluding the main portal vein were divided into the following groups and were compared for the prognosis: (I) administered intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate (DBcAMP) and mitomycin C (MMC) (n = 13); (II) treated with transcatheter arterial embolization (TAE) (n = 62)." | 7.69 | [Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for nodular type of hepatocellular carcinoma non-occluding the main portal vein--in comparison with transcatheter arterial embolization]. ( Sugimoto, M, 1994) |
| "One hundred thirty-five patients with hepatocellular carcinoma (HCC) were treated by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone (59 cases) and ADMOS plus cis-diaminodichloroplatinum (CDDP) (76 cases)." | 7.68 | [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum]. ( Fukukura, Y; Hokotate, H; Hori, A; Ida, K; Ikeda, K; Inoue, H; Kanetsuki, I; Miyazono, N; Tanaka, D; Tsuchimochi, S, 1993) |
| "We evaluated the effects of intraarterial injection of Adriamycin/Mitomycin C oil (Lipiodol) suspension (ADMOS) alone and ADMOS+cis-diaminodichloroplatinum (CDDP) in 135 patients with hepatocellular carcinoma (HCC)." | 7.68 | Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP). ( Hori, A; Ikeda, K; Inoue, H; Kanetsuki, I; Miyake, S; Miyazono, N; Nakajo, M; Nishida, H; Satake, M, 1993) |
| "Of 210 patients with hepatocellular carcinoma (n = 135), metastatic liver cancer (n = 71) and cholangiocarcinoma (n = 4) who underwent intra-arterial infusion of adriamycin and/or mitomycin C oil suspension (ADMOS) and cisplatin, and both regimens, pyogenic liver abscess occurred in seven (3." | 7.68 | [Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS)]. ( Hori, A; Ikeda, K; Inoue, H; Kanetsuki, I; Kobayashi, H; Nakajo, M; Nishida, H; Satake, M; Ueno, K, 1992) |
| "An advanced breast cancer patient refractory to CAF (Cyclophosphamide, Adriamycin, 5-fluorouracil), 5-FU-Methotrexate sequential therapy and Tamoxifen was treated with the combination 5' DFUR, MMC, Etoposide and MPA." | 7.68 | [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]. ( Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K, 1991) |
| "1-Hexylcarbamoyl-5-fluorouracil (HCFU) was orally administered at doses of 300-600 mg daily for 7-360 days to 27 inoperable cirrhotics with hepatocellular carcinoma." | 7.67 | [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma]. ( Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y, 1984) |
| "A regimen combining hepatic irradiation and intravenous dacarbazine and mitomycin C for treating colorectal adenocarcinoma with liver metastases offers no advance in the management of patients with this disease." | 7.67 | Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract. ( Evans, M; Hellmann, K; Jones, R; Newton, K; Peters, N; Phillips, RH; Smith, BJ, 1984) |
| "Intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate and mitomycin C was administered to 8 patients with hepatocellular carcinoma occluding the main portal vein." | 7.67 | Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for hepatocellular carcinoma occluding main portal vein: case studies. ( Ishii, K; Karube, H; Okabe, H; Okudaira, M; Shibata, H; Tsuchiya, M, 1989) |
| "A 46-year-old male (performance status 1) with hepatocellular carcinoma (HCC), which diffusely involved the anterior segment of the right lobe, occluded the second portal branch and metastased to the left lobe (stage IV-A), was on combined therapy with TAE of lipiodol (LPD), mitomycin C (MMC) 10 mg and gelatin sponge at the time of angiography on March 16, 1987." | 7.67 | [Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report]. ( Inagaki, Y; Miyairi, M; Miyamoto, K, 1989) |
| "Of 66 patients with hepatocellular carcinoma, 32 were treated by intraarterial injection of mitomycin C microcapsules (group A) and 34 patients by intraarterial injection of mitomycin C microcapsules followed by transcatheter hepatic artery embolization (group B)." | 7.67 | Arterial chemoembolization with mitomycin C microcapsules followed by transcatheter hepatic artery embolization for hepatocellular carcinoma. ( Iida, S; Nomura, F; Ohnishi, K; Sugita, S; Tanabe, Y, 1987) |
| "An intra-arterial injection of an Adriamycin-Lipiodol emulsion and a Mitomycin C microcapsule has been given to two patients of hepatocellular carcinoma (HCC) complicated with a tumor thrombosis of the portal trunk." | 7.67 | [Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis]. ( Abe, T; Iizuka, H; Katakai, S; Nagamine, T; Ojima, T; Saitoh, S; Takagi, H; Takayama, H; Takezawa, J; Uehara, M, 1988) |
| "An analysis is done of 40 evaluable patients treated with a combination of 5-Fluorouracil, adriamycin and mitomycin-C for primary hepatocellular carcinoma in Saudi Arabia." | 7.67 | Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C. ( Abdel Satir, A; Al-Idrissi, HY; Al-Kasem, S; Al-Qurain, A; Ibrahim, EM; Satti, MB, 1985) |
| "Four patients with advanced hepatocellular carcinoma, but with stage I functional disease, were treated with intrahepatic arterial lipoidal mixed with small doses of Adriamycin (20 mg) and Mitomycin C (10 mg)." | 7.67 | Treatment of irresectible hepatocellular carcinoma with intrahepatic arterial lipoidal mixed with adriamycin and mitomycin C. ( Chin, JH; Oon, CJ; Tan, L; Yong, YM, 1986) |
| "Forty-nine patients with liver metastases of breast cancer were treated with arterial infusion involving simultaneous use of adriamycin: 30-50 mg and mitomycin C: 10-20 mg through the hepatic artery by Seldinger catheter." | 7.67 | [Arterial infusion of combination chemotherapy consisting of adriamycin and mitomycin C for liver metastases of breast cancer]. ( Horikoshi, N; Inagaki, J; Inoue, K; Ito, Y; Mukaiyama, T; Nakamura, T; Ogawa, M; Tada, A; Ueno, K; Yamazaki, H, 1986) |
| "Survival period of 28 cases with unresectable hepatocellular carcinoma treated with transhepatic arterial one-shot infusion of 30 mg mitomycin C (MMC) were retrospectively reviewed from the standpoint of hepatic angiographic findings, scintigraphic existence of liver cirrhosis and changes of AFP value." | 7.66 | [Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C]. ( Kobayashi, H, 1982) |
| "Twenty elderly patients with hepatocellular carcinoma were treated with 5-fluorouracil (5-FU) at a daily dose of 200-300 mg per os, and with a combination of 0." | 7.66 | [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil]. ( Asano, K; Ejiri, T; Fujii, M; Matsuka, Y; Murakami, N, 1982) |
| "This phase II prospective study investigates possible benefits of radiofrequency ablation (RFA) combined with hepatic arterial chemoembolization using degradable starch microsphere (DSM) mixed with mitomycin C (MMC) in non-surgical candidates with colorectal liver metastases." | 6.84 | Radiofrequency Ablation Combined with Hepatic Arterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Liver Metastasis from Colorectal Cancer: A Prospective Multicenter Study. ( Hayashi, S; Inaba, Y; Nakatsuka, A; Nobata, K; Sato, Y; Takaki, H; Yamakado, K; Yamanaka, T; Yasumoto, T, 2017) |
| "The MTDs were determined as 5FU 800 mg/m(2) on RT days 1-4 and 29-32 and MMC 8 mg/m(2) on days 1 and 29 when combined with IMRT/VMAT with SIB and cetuximab in locally advanced anal cancer." | 6.80 | Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer. ( Gunnlaugsson, A; Guren, MG; Johnsson, A; Leon, O; Radu, C, 2015) |
| "Treatment with mitomycin-C only showed median and mean survival times of 13." | 6.75 | Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. ( Eichler, K; Gruber-Rouh, T; Naguib, NN; Nour-Eldin, NE; Vogl, TJ; Zangos, S, 2010) |
| " The aim was to investigate the therapeutic efficacy and tolerance of mitomycin C (MMC) in combination with gemcitabine (GEM) or capecitabine (CAPE) in previously untreated patients with advanced biliary tract cancer." | 6.71 | Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. ( Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B, 2004) |
| " However, BW12C in combination with MMC for 5-FU-resistant colorectal cancer is not an effective regimen." | 6.69 | Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer. ( Braybrooke, JP; Dixon, RM; Ganesan, TS; Harris, AL; Levitt, NC; Littlewood, TJ; O'Byrne, K; Propper, DJ; Rajagopalan, B; Talbot, DC; Thompson, CH, 2000) |
| "In an attempt to improve tumor response and survival among patients with colorectal cancer metastases confined to the liver, we developed an experimental (rats and pigs) and clinical isolated hepatic perfusion (IHP) technique to exploit maximally the steep dose-response relation of may anticancer drugs." | 6.40 | Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases. ( Marinelli, A; Vahrmeijer, AL; van de Velde, CJ, 1998) |
| "20 patients had Barcelona Clinic Liver Cancer (BCLC) stage B, while 8 patients obtained chemoembolization for bridging purposes (BCLC stage A)." | 5.48 | Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients. ( Beeres, M; Eichler, K; Gruber-Rouh, T; Kamal, A; Langenbach, M; Naguib, NN; Vogl, TJ, 2018) |
| "Unresectable intrahepatic cholangiocarcinoma has a poor prognosis, with a median survival of 5 to 8 months without treatment." | 5.37 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. ( Albert, M; Christians, K; Fraker, D; Kiefer, MV; McNally, M; Olthoff, K; Pappas, S; Rilling, W; Robertson, M; Soulen, MC; Sun, W, 2011) |
| "We report on a 45-year-old breast cancer patient with disseminated hepatic metastases." | 5.36 | Successful remission of extensive liver metastases in a breast cancer patient with acute liver failure using a combined chemotherapy regimen with mitomycin, folinate, and 5-fluorouracil (Mi/Fo/FU). ( Eichbaum, MH; Hauser, N; Hohl, MK; Sohn, C; Stoiber, B; Stoiber, N, 2010) |
| "Prognosis of advanced hepatocellular carcinoma (HCC) treated by conventional therapies has been considered to be poor." | 5.33 | [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C]. ( Ahn, SH; Cho, KB; Choi, JS; Chung, WJ; Hwang, JS; Hwang, JY; Jang, BK; Kim, GC; Kim, YH; Kwon, JH; Kwon, KM; Park, KS, 2005) |
| "A 64-year-old male was admitted for treatment of hepatocellular carcinoma." | 5.28 | [A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C]. ( Eto, T; Ishinoda, Y; Iwaki, Y; Kawano, T; Kitamura, M; Kitamura, T; Komura, K; Maruyama, T; Shimada, Y; Tamaki, N, 1992) |
| "Chemotherapy for liver metastasis of breast cancer has rarely been found effective." | 5.28 | [Clinical efficacy of ifosfamide for liver metastasis of breast cancer]. ( Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y, 1990) |
| "From 1986 to 1988, 35 patients with a hepatoma judged either inoperable or unresectable because of coexistent cirrhosis were treated with hepatic arterial embolization of mitomycin C microcapsules." | 5.28 | Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. ( Audisio, RA; Bellegotti, L; Damascelli, B; DeFazio, C; Doci, R; Marchianò, A; Mazzaferro, V; Montalto, F; Piva, A; Tommasini, M, 1990) |
| "Hepatocellular carcinoma is the most common cause of cancer death in Thai males." | 5.28 | High-dose mitomycin C: activity in hepatocellular carcinoma. ( Auethaveekiat, V; Cheirsilpa, A; Kangsumrit, N; Leelasethakul, S; Maoleekulpriroj, S; Phanthumjida, P; Thanakaravit, P, 1989) |
| "Of 20 patients with inoperable hepatocellular carcinoma (HCC) treated with one or more courses via a hepatic arterial catheter, a change in tumor size could be measured in 16." | 5.27 | Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules. ( Goto, N; Hiyama, Y; Iwama, S; Kono, K; Nakajima, Y; Nakayama, T; Ohnishi, K; Ohtsuki, T; Takashi, M; Tsuchiya, S, 1984) |
| " Because previous studies showed that long-term telbivudine treatment improved renal function in chronic hepatitis B virus (HBV) infected patients, we conducted a case-control study to evaluate the clinical outcome of telbivudine preemptive therapy in HBV-related advanced HCC patients treated by combination chemotherapy comprising 5-fluorouracil, mitoxantrone and cisplatin (FMP)." | 5.19 | Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study. ( Chang, ML; Chen, YC; Chien, RN; Hsu, CW; Lin, CL; Yeh, C; Yeh, CT, 2014) |
| "To compare the efficacy of transcatheter arterial chemoembolization (TACE) using multiple anticancer drugs (epirubicin, cisplatin, mitomycin C, and 5-furuorouracil: Multi group) with TACE using epirubicin (EP group) for hepatocellular carcinoma (HCC)." | 5.16 | Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. ( Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T, 2012) |
| "We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with extensively pretreated metastatic colorectal cancer (mCRC)." | 5.16 | Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. ( Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D, 2012) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 5.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "It is unknown whether sorafenib can be combined with transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma." | 5.14 | Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. ( Borner, M; Candinas, D; Dufour, JF; Heim, MH; Helbling, B; Hoppe, H; Kickuth, R; Maurhofer, O; Saar, B; Szucs-Farkas, Z, 2010) |
| "Stages I-III colorectal cancer patients (n = 753) were randomized to receive either surgery alone (control arm), surgery plus postoperative portal venous infusion of 5-FU 500 mg/m(2) plus heparin given for 24 hours for seven consecutive days plus mitomycin C 10 mg/m(2) given on the first day (arm 2), or surgery and the same chemotherapy regimen administered by peripheral venous route (arm 3)." | 5.13 | Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial. ( Aeberhard, P; Harder, F; Herrmann, R; Laffer, U; Lorenz, M; Maibach, R; Metzger, U; Zuber, M, 2008) |
| "This study was designed to assess the safety and efficacy of capecitabine and mitomycin C (MMC) in previously untreated patients with advanced colorectal cancer (CRC)." | 5.11 | Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer. ( Cunningham, D; Hill, ME; Norman, AR; Oates, J; Price, T; Rao, S; Ross, PJ; Shellito, P; Tebbutt, N, 2004) |
| "To observe the effect of postoperative transcatheter hepatic arterial chemoembolization (TACE) and thymosin alpha(1) (T(alpha1)) treatment on recurrence of hepatocellular carcinoma (HCC)." | 5.11 | [Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma]. ( Chen, H; Cheng, SQ; Cong, WM; Shen, F; Wang, PJ; Wu, MC; Yang, JH; Zhao, YX, 2004) |
| "A multicenter randomized study comparing high dose of mitomycin and epirubicin given as hepatic intra-arterial chemotherapy (HIAC) combined with caval chemofiltration (CF) versus low doses of the same drugs in unresectable liver metastases from colorectal cancer showed a significant improvement in the survival rate of the 20 patients treated with high dose compared to the 22 patients treated with low doses with a 1 year survival of 69% vs 39%." | 5.11 | Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study. ( Bernardeschi, P; Cantore, M; De Simone, M; Dentico, P; Fiorentini, G; Guadagni, S; Poddie, DB; Rossi, G; Rossi, S; Tumolo, S; Valori, VM, 2004) |
| "The aim of this study was to evaluate the activity and toxicity of a combination regimen of CPT-11 and mitomycin-c as second-line chemotherapy for pretreated patients with advanced, metastatic, or both, gastric adenocarcinoma." | 5.11 | Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). ( Battaglia, C; Colucci, G; Di Bisceglie, M; Gebbia, N; Gebbia, V; Giuliani, F; Maiello, E; Molica, S; Vinciarelli, G, 2005) |
| "The aim of this phase II study was to investigate the therapeutic value of second-line treatment with oxaliplatin, irinotecan (CPT-11) and mitomycin C (MMC) in patients with metastatic colorectal cancer pretreated with 5-fluorouracil (5-FU)-based chemotherapy." | 5.09 | Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer. ( Brodowicz, T; Hejna, M; Köstler, WJ; Raderer, M; Scheithauer, W; Tomek, S; Wiltschke, C; Zielinski, CC, 2000) |
| " The pharmacokinetics of mitomycin C (MMC) were investigated in 12 colorectal cancer patients with liver metastases undergoing chemoembolisation." | 5.08 | Pharmacokinetics of intraarterial mitomycin C in the chemoembolisation treatment of liver metastases. ( Biederbick, W; Botvinik-Helling, S; Fischbach, R; Heindel, W; Klaus, W; Lackner, K; Rump, AF; Schierholz, JM; Stemmler, M; Theisohn, M, 1996) |
| "We evaluated the technical feasibility of isolated liver perfusion (ILP) in the treatment of patients with colorectal cancer metastases confined to the liver, and investigated whether ILP allows exposure of the tumor to high concentrations of mitomycin C (MMC)." | 5.08 | Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver. ( Beerman, H; de Brauw, LM; Keizer, HJ; Marinelli, A; Tjaden, UR; van Bockel, JH; van de Velde, CJ, 1996) |
| "Mitomycin C has been found clinically useful in the treatment of colorectal cancer when administered via the hepatic artery." | 5.08 | Superselective intra-arterial chemotherapy with mitomycin C in hepatic metastases from colorectal cancer. ( Kairaluoma, M; Kantola, R; Kiviniemi, H; Laitinen, S; Leinonen, S; Mäkelä, J; Siniluoto, T; Tikkakoski, T, 1997) |
| "Mitomycin C (MMC)-vinblastine (VBL) is a regimen that has commonly been used as salvage therapy for advanced breast cancer for many years." | 5.08 | Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC). ( Awada, A; Geurs, F; Habboubi, N; Kerger, J; Kusenda, Z; Piccart, MJ; Van Vreckem, A, 1997) |
| "A prospective, controlled randomized trial of hepatic arterial infusion of 5-fluorouracil (5-FU), adriamycin (ADM) and mitomycin C (MMC) [FAM group] versus 5-FU, epirubicin (EPIR) and MMC [FEM group] in patients with unresectable liver metastasis from colorectal cancer is reported." | 5.07 | [A randomized trial of intrahepatic infusion chemotherapy for unresectable colorectal liver metastases. Sendai Study Group]. ( Kunii, Y; Mashiko, H; Momono, S; Muto, I; Nakagawa, K; Ouchi, A; Shiiba, K; Wada, M; Yamamoto, K; Yamazaki, T, 1993) |
| "A total of 135 patients with hepatocellular carcinoma (HCC) were treated by intra-arterial injection of an Adriamycin/mitomycin C oil (lipiodol) suspension (ADMOS) alone or of ADMOS plus cis-diammine-dichloroplatinum (CDDP)." | 5.07 | Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection. ( Ikeda, K; Inoue, H; Kobayashi, H; Nakajo, M; Yano, T, 1992) |
| "Effectiveness, toxicity and complications of 5-fluorouracil (FU) and mitomycin-C (MMC) treatment were analyzed in 30 patients with metastatic colorectal cancer confined to the liver." | 5.07 | Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer. ( Largiadèr, F; Metzger, U; Röthlin, M; Weder, W, 1991) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Background The aim of the study was to evaluate the safety and feasibility of intra-arterial mitomycin C (MMC) infusion after selective internal radiation therapy (SIRT) using Yttrium-90 (90Y) resin microspheres in liver metastatic breast cancer (LMBC) patients." | 3.96 | Sequential intra-arterial infusion of 90Y-resin microspheres and mitomycin C in chemo refractory liver metastatic breast cancer patients: a single centre pilot study. ( Aarts, BM; Beets-Tan, RGH; Deroose, CMALO; Dresen, RC; Klompenhouwer, EG; Maleux, G; Neven, P; Punie, K; Wildiers, H, 2020) |
| "The aim of this study was to determine the safety and efficacy of Mitomycin C (MMC) infusion in a large cohort of advanced liver metastatic breast cancer patients (LMBC) and to determine factors influencing overall survival (OS)." | 3.91 | Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival. ( Aarts, BM; Beets-Tan, RGH; Dresen, RC; Klompenhouwer, EG; Laenen, A; Maleux, G; Neven, P; Punie, K; Wildiers, H, 2019) |
| "Previously, a pilot genome-wide association study has identified candidate single nucleotide polymorphism predictors for the therapeutic response of 5-fluorouracil, mitoxantrone and cisplatin (FMP) combination chemotherapy in advanced hepatocellular carcinoma (HCC)." | 3.80 | A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma. ( Chang, ML; Hsu, CL; Hung, CF; Liang, KH; Lin, CC; Yeh, CT, 2014) |
| "The aim of the present study was to compare clinical outcomes in patients with intermediate-stage hepatocellular carcinoma (HCC) who underwent the following treatments: transcatheter arterial chemoembolization (TACE) using an epirubicin-mitomycin-lipiodol (EML) emulsion at initial therapy (TACE group; n=145), and transcatheter chemotherapy infusion (TACI) using an EML emulsion at initial therapy (TACI group; n=81)." | 3.80 | Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma. ( Kimura, T; Kita, R; Komekado, H; Nasu, A; Nishiguchi, S; Nishijima, N; Nishikawa, H; Ohara, Y; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H, 2014) |
| "FOLFOXIRI demonstrated higher efficacy compared to 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) as first-line treatment of metastatic colorectal cancer." | 3.78 | Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen. ( Allegrini, G; Baldi, GG; Brunetti, IM; Cortesi, E; Cremolini, C; Cupini, S; Falcone, A; Fornaro, L; Granetto, C; Loupakis, F; Masi, G; Ricci, S; Salvatore, L; Tuzi, A; Vasile, E, 2012) |
| "To compare local control effects of superselective transcatheter arterial chemoembolization (TACE) using epirubicin (EPI) plus mitomycin C (M) and miriplatin (MPT) for hepatocellular carcinoma (HCC)." | 3.78 | Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. ( Hashimoto, M; Matsui, O; Miyayama, S; Shibata, Y; Toshima, F; Tsuji, K; Yamashiro, M; Yoshida, M, 2012) |
| "The aim of the present study was to elucidate the effectiveness of transcatheter arterial infusion chemotherapy (TAI) of the whole liver using an epirubicin-mitomycin-lipiodol emulsion, prior to radiofrequency thermal ablation (RFA), in preventing intrahepatic distant recurrence (IDR) from single hepatocellular carcinoma (HCC)." | 3.78 | Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence. ( Hatamaru, K; Henmi, S; Inuzuka, T; Kimura, T; Kita, R; Matsuda, F; Nakajima, J; Nasu, A; Nishikawa, H; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H, 2012) |
| "The purpose of our study was to retrospectively evaluate the feasibility, toxicity and impact on overall (OS) and disease-free (DFS) survival of intra-arterial liver perfusion with mitomycin-C (MMC) [hypoxic liver perfusion with MMC (HLPM)] in patients with multifocal liver metastases or with unresectable primary liver tumours." | 3.77 | Hypoxic liver perfusion with mitomycin-C for treating multifocal metastases and unresectable primary tumours: a single-centre series of 42 patients. ( Baggiani, A; Bagliani, A; Belli, L; Belloni, P; Bregni, M; Campagnoli, E; Caspani, B; Crocchiolo, R; Ierardi, AM; Motta, F; Setola, E; Tempini, S; Toniolo, D, 2011) |
| "The objective of our study was to retrospectively determine the effectiveness of hepatic transarterial chemotherapy using two therapeutic protocols-mitomycin C alone and combined mitomycin C and gemcitabine-on local tumor control and survival rate in patients with liver metastases from neuroendocrine tumors." | 3.75 | Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. ( Gruber, T; Hammerstingl, R; Naguib, NN; Nour-Eldin, NE; Vogl, TJ, 2009) |
| "The objective of our study was to describe survival outcome in 124 patients with unresectable hepatocellular carcinoma treated with triple-drug transcatheter arterial chemoembolization (TACE) using doxorubicin, cisplatin, and mitomycin C using a standardized regimen." | 3.75 | Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients. ( Amado, RG; Busuttil, RW; Gomes, AS; Monteleone, PA; Rosen, PJ; Rosove, MH; Sayre, JW, 2009) |
| "In the treatment of extensive liver metastasis of breast cancer (LMBC), locally administered Mitomycin C (MMC) to the liver might be an effective approach with limited toxicity." | 3.74 | Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer. ( Demey, W; Heye, S; Maes, T; Maleux, G; Neven, P; Paridaens, R; Van Oosterom, AT; Wildiers, H, 2008) |
| "The significance of hepatic arterial infusion chemotherapy for unresectable liver metastases from colorectal cancer was evaluated in 50 patients, who received either of the following regimens: 1 shot 5-FU + epirubicin + MMC (FAM group); hepatic arterial infusion of 5-FU for 2 hours + MMC (MF group); hepatic arterial infusion of 5-FU for 2 hours (5-FU group)." | 3.72 | [Validity of two-hour continuous hepatic arterial infusion chemotherapy with low-dose 5-FU for unresectable liver metastasis from colorectal cancer]. ( Hirakawa, K; Kosaka, K; Nishihara, T; Nishino, H; Ohira, M; Yamada, N, 2003) |
| "We histologically examined the effect of hepatic arterial infusion of degradable starch microspheres mixed with adriamycin and mitomycin C (DSM therapy) for liver metastases of colorectal cancer." | 3.72 | [Histological examination of the effect of hepatic arterial infusion of degradable starch microspheres mixed with adriamycin and mitomycin C for liver metastases of colorectal cancer--second report]. ( Hashimoto, D; Hoshino, T; Ishida, H; Mastumoto, Y; Miura, T; Ohsawa, T; Osada, H; Takeuchi, I; Yokoyama, M, 2004) |
| "Combined infusion of 5-FU and mitomycin C by hepatic artery catheter port is an effective treatment for liver metastases from colorectal cancer." | 3.71 | Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer. ( Jiang, HC; Liu, LX; Piao, DX; Qi, SY; Wu, LF; Zhang, WH; Zhu, AL, 2002) |
| "mitomycin C (MMC) on aged patients with liver metastases of colorectal cancer." | 3.71 | [Audit of the safety of hepatic arterial infusion of degradable starch microspheres (DSM). Adriamycin (ADM).mitomycin C (MMC) on aged patients with liver metastases of colorectal cancer]. ( Hashimoto, D; Ishida, H; Kashimada, A; Kuwabara, K; Matumoto, Y; Miura, T; Osada, H; Takeuchi, I, 2002) |
| "Measurement of serum pancreastatin levels is an easy and useful method to predict success in patients who undergo HACE plus somatostatin therapy for metastatic neuroendocrine tumors to the liver." | 3.71 | Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. ( Desai, DC; Jung, SS; Khabiri, H; Martin, EW; O'Dorisio, TM; Schirmer, WJ; Villanueva, V, 2001) |
| "The aim of this study is to clarify whether the expression of metallothionein (MT) is related with the malignant potential in primary colorectal cancer and/or synchronous liver metastasis." | 3.71 | Expression of metallothionein in colorectal cancers and synchronous liver metastases. ( Dhar, DK; Hishikawa, Y; Kimoto, T; Kohno, H; Koji, T; Kubota, H; Nagasue, N; Tachibana, M; Ueda, S, 2001) |
| "Little is known about the histological effect of hepatic arterial infusion with degradable starch microspheres (DSM), adriamycin (ADM), and mitomycin C (MMC) on liver metastasis of colorectal cancer." | 3.71 | [Histological evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin/mitomycin C]. ( Hashimoto, D; Hoshino, T; Inokuma, S; Ishida, H; Matsumoto, Y; Miura, T; Murata, N; Nakada, H; Ohsawa, T; Takeuchi, I, 2001) |
| "Between 1990 and 1997, 227 patients with hepatocellular carcinoma were treated by intrahepatic arterial injection of a Lipiodol-Epirubicin-Mitomycin C emulsion followed by intermittent hepatic artery infusion of Epirubicin, Mitomycin C and 5-FU, employing an implantable subcutaneous infusion port." | 3.70 | [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma]. ( An, M; Hamada, E; Ikawa, M; Matsumoto, Y; Miura, T; Murata, M; Nakasato, S; Takagi, S; Terakado, H; Watanabe, K, 1998) |
| "To determine the incidence of nausea and vomiting and the antiemetic effect of ondansetron hydrochloride (OND) in patients with hepatocellular carcinoma treated with arterial chemo-embolization, we studied 59 patients with hepatocellular carcinoma who were treated with transcatheter arterial embolization (TAE) or lipiodolized transcatheter arterial infusion (L-TAI)." | 3.70 | Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride. ( Abe, T; Hashimoto, Y; Kojima, A; Mori, M; Nagamine, T; Sohara, N; Takagi, H; Takahashi, H, 1999) |
| "In order to assess the efficacy of repeated hepatic arterial infusion (HAI) therapy for advanced hepatocellular carcinoma, we administered HAI therapy using 5-fluorouracil, epirubicin and mitomycin C, with an implanted drug delivery system." | 3.70 | Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C. ( Chiba, T; Ito, K; Kojima, K; Nakajima, N; Seno, H, 1999) |
| "The co-incubation of morin hydrate with either doxorubicin or mitomycin C could minimize the toxicity of these anti-tumor drugs on cardiovascular cells, such as red blood cells, human umbilical vein endothelial cells (ECV304) and primary mouse cardiomyocytes, whereas morin hydrate did not lower the cytotoxicity of the drugs on human hepatocellular carcinoma cells (HepG2)." | 3.70 | Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs. ( Chan, HC; Fung, KP; Kok, LD; Kwok, TT; Wong, YP; Wu, TW, 2000) |
| "The efficacy of transcatheter arterial Lipiodol chemoembolization (TALCE) using epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma (HCC) was assessed retrospectively." | 3.69 | Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. ( Kanematsu, M, 1995) |
| "Bifunctional antibody (BFA) HC-1 possessing one binding site for mitomycin C (MMC) and a companion site directed against human hepatocellular carcinoma (HCC) cell membrane was constructed by chemical conjugation of two Fab' fragments of McAb MMC-1 and McAb HCMP-1." | 3.69 | [Targeting treatment of human HCC xenografts implanted in nude mice using bifunctional antibody HC-1 combined with mitomycin C]. ( Liu, KD; Tang, ZY; Wei, C, 1994) |
| " We present herein the cases of three patients with multiple liver metastases from colorectal cancer in whom complete remission was achieved by treatment with an HAI of IL-2 in combination with mitomycin C (MMC) and 5-fluorouracil (5-FU)." | 3.69 | Complete remission of liver metastases from colorectal cancer by treatment with a hepatic artery infusion (HAI) of interleukin-2-based immunochemotherapy: reports of three cases. ( Akabane, Y; Koh, K; Kurooka, K; Nakajima, I; Ohnishi, H; Okuno, K; Shindo, K; Yasutomi, M, 1994) |
| "Seventy five patients with nodular type of hepatocellular carcinoma (HCC) non-occluding the main portal vein were divided into the following groups and were compared for the prognosis: (I) administered intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate (DBcAMP) and mitomycin C (MMC) (n = 13); (II) treated with transcatheter arterial embolization (TAE) (n = 62)." | 3.69 | [Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for nodular type of hepatocellular carcinoma non-occluding the main portal vein--in comparison with transcatheter arterial embolization]. ( Sugimoto, M, 1994) |
| "In this study, norcantharidin was compared with adriamycin and mitomycin C for its inhibitory action in the growth of cultured human hepatocellular carcinoma HepG2 cells." | 3.69 | Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. ( Cheng, LY; Mack, PO; Tang, WY; Yang, EB; Zhang, K, 1997) |
| "Mitomycin C (MC) was reductively activated by DT-diaphorase [DTD; NAD(P)H:quinone oxidoreductase] from rat liver carcinoma cells in the presence of Micrococcus lysodeicticus DNA at pH 5." | 3.69 | Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C. ( Cummings, J; Lipman, R; Suresh Kumar, G; Tomasz, M, 1997) |
| " In order to evaluate the HDRA with the 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide end point for clinical use, chemosensitivity to mitomycin C, doxorubicin, 5-fluorouracil, and cisplatin of 107 advanced gastric and 109 advanced colorectal cancers was determined in vitro in a correlative clinical trial." | 3.69 | Clinical applications of the histoculture drug response assay. ( Furukawa, T; Hoffman, RM; Kubota, T, 1995) |
| "One hundred thirty-five patients with hepatocellular carcinoma (HCC) were treated by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone (59 cases) and ADMOS plus cis-diaminodichloroplatinum (CDDP) (76 cases)." | 3.68 | [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum]. ( Fukukura, Y; Hokotate, H; Hori, A; Ida, K; Ikeda, K; Inoue, H; Kanetsuki, I; Miyazono, N; Tanaka, D; Tsuchimochi, S, 1993) |
| "We evaluated the effects of intraarterial injection of Adriamycin/Mitomycin C oil (Lipiodol) suspension (ADMOS) alone and ADMOS+cis-diaminodichloroplatinum (CDDP) in 135 patients with hepatocellular carcinoma (HCC)." | 3.68 | Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP). ( Hori, A; Ikeda, K; Inoue, H; Kanetsuki, I; Miyake, S; Miyazono, N; Nakajo, M; Nishida, H; Satake, M, 1993) |
| "A total of 77 patients with advanced colorectal cancer, including postoperative patients with liver, lung and peritoneal metastases, were treated with single or multiple injections of monoclonal antibody A7-neocarzinostatin (A7-NCS)." | 3.68 | Follow-up study of patients treated with monoclonal antibody-drug conjugate: report of 77 cases with colorectal cancer. ( Honda, M; Kitamura, K; Noguchi, A; Otsuji, E; Takahashi, T; Yamaguchi, T, 1993) |
| "Intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate and mitomycin C was administered to 27 patients with hepatocellular carcinoma (HCC) occluding the main portal vein." | 3.68 | Is necrosis induction therapy relevant to hepatocellular carcinoma? Prognostic evaluation viewed from necrosing feature in HCC occluding the main portal vein after treatment with DBcAMP and MMC. ( Ishii, K; Kusano, S; Matama, S; Matsuki, S; Shibata, H; Sugimoto, M, 1992) |
| "Dibutyryl cyclic AMP was administered to 7 cases with hepatocellular carcinoma and its tumor thrombosis in portal vein, combined with intraarterial infusion of Mitomycin C or Adriamycin with implanted reservoir." | 3.68 | [Effect of dibutyryl cyclic AMP in the treatment of hepatocellular carcinoma--intraarterial infusion therapy combined with anticancer agent for hepatocellular carcinoma with portal vein thrombosis]. ( Fukui, H; Kitagami, K; Matsumoto, M; Nakano, H; Nakayama, M; Okamoto, Y; Tsujii, T, 1992) |
| "Of 210 patients with hepatocellular carcinoma (n = 135), metastatic liver cancer (n = 71) and cholangiocarcinoma (n = 4) who underwent intra-arterial infusion of adriamycin and/or mitomycin C oil suspension (ADMOS) and cisplatin, and both regimens, pyogenic liver abscess occurred in seven (3." | 3.68 | [Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS)]. ( Hori, A; Ikeda, K; Inoue, H; Kanetsuki, I; Kobayashi, H; Nakajo, M; Nishida, H; Satake, M; Ueno, K, 1992) |
| "An advanced breast cancer patient refractory to CAF (Cyclophosphamide, Adriamycin, 5-fluorouracil), 5-FU-Methotrexate sequential therapy and Tamoxifen was treated with the combination 5' DFUR, MMC, Etoposide and MPA." | 3.68 | [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]. ( Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K, 1991) |
| "As part of a Phase II chemotherapy trial using mitomycin-C, adriamycin, and vindesine, 57 patients with adenocarcinoma of unknown primary site were assessed for prognostic variables predictive of response and survival." | 3.68 | Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results. ( Chapman, D; Fiore, J; Kambhu, SA; Kelsen, DP; Niedzwiecki, D; Rosenbluth, R; Vinciguerra, V, 1990) |
| "The concentration of adriamycin (ADR) and mitomycin C (MMC) were measured in serum and dialysate in a patient with hepatocellular carcinoma complicating chronic renal failure." | 3.68 | [A case of hepatocellular carcinoma treated by intrahepatic arterial administration of anticancer agents: serial determination of the concentration of the chemotherapeutic agents in serum and dialysate during hemodialysis]. ( Chiba, S; Goto, T; Katayama, S; Kondoh, K; Moriai, O; Nakamura, Y; Ohsawa, K; Sasaki, S; Sekine, K; Yoshida, T, 1990) |
| "1-Hexylcarbamoyl-5-fluorouracil (HCFU) was orally administered at doses of 300-600 mg daily for 7-360 days to 27 inoperable cirrhotics with hepatocellular carcinoma." | 3.67 | [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma]. ( Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y, 1984) |
| "A regimen combining hepatic irradiation and intravenous dacarbazine and mitomycin C for treating colorectal adenocarcinoma with liver metastases offers no advance in the management of patients with this disease." | 3.67 | Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract. ( Evans, M; Hellmann, K; Jones, R; Newton, K; Peters, N; Phillips, RH; Smith, BJ, 1984) |
| "Thirty-six patients with hepatocellular carcinoma were treated by hepatic arterial chemoembolization of microencapslated mitomycin C (MMCmc)." | 3.67 | [Transcatheter hepatic arterial chemoembolization using microencapsulated mitomycin C (MMCmc)]. ( Fujii, M; Kamata, R; Sakabe, T; Takano, S; Tanaka, T; Yamaguchi, T, 1988) |
| "Intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate and mitomycin C was administered to 8 patients with hepatocellular carcinoma occluding the main portal vein." | 3.67 | Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for hepatocellular carcinoma occluding main portal vein: case studies. ( Ishii, K; Karube, H; Okabe, H; Okudaira, M; Shibata, H; Tsuchiya, M, 1989) |
| "A 46-year-old male (performance status 1) with hepatocellular carcinoma (HCC), which diffusely involved the anterior segment of the right lobe, occluded the second portal branch and metastased to the left lobe (stage IV-A), was on combined therapy with TAE of lipiodol (LPD), mitomycin C (MMC) 10 mg and gelatin sponge at the time of angiography on March 16, 1987." | 3.67 | [Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report]. ( Inagaki, Y; Miyairi, M; Miyamoto, K, 1989) |
| "Of 66 patients with hepatocellular carcinoma, 32 were treated by intraarterial injection of mitomycin C microcapsules (group A) and 34 patients by intraarterial injection of mitomycin C microcapsules followed by transcatheter hepatic artery embolization (group B)." | 3.67 | Arterial chemoembolization with mitomycin C microcapsules followed by transcatheter hepatic artery embolization for hepatocellular carcinoma. ( Iida, S; Nomura, F; Ohnishi, K; Sugita, S; Tanabe, Y, 1987) |
| "An intra-arterial injection of an Adriamycin-Lipiodol emulsion and a Mitomycin C microcapsule has been given to two patients of hepatocellular carcinoma (HCC) complicated with a tumor thrombosis of the portal trunk." | 3.67 | [Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis]. ( Abe, T; Iizuka, H; Katakai, S; Nagamine, T; Ojima, T; Saitoh, S; Takagi, H; Takayama, H; Takezawa, J; Uehara, M, 1988) |
| " Lp-TAE through the hepatic artery was performed on ten primary hepatocellular carcinoma patients using Gelfoam in combination with adriamycin (40 mg) or mitomycin C (20 mg), emulsified in Lipiodol (10 ml) and 60% Urografin (2 ml)." | 3.67 | [Cytofluorometric and histopathological studies on non-cancerous liver lesions after lipiodol-transcatheter arterial embolization]. ( Ashihara, T; Kagawa, K; Kamachi, M; Sawai, K; Shimamura, Y; Shimotsuma, M; Takahashi, T; Taniguchi, H, 1988) |
| "In 23 patients with hepatocellular carcinoma, accumulating patterns of Lipiodol on CT and therapeutic effects in combination therapy with adriamycin/mitomycin C-oil suspension (ADMOS) and Cis-diamminedichloroplatinum II (CDDP)two-route infusion were evaluated." | 3.67 | [Accumulating patterns of lipiodol and therapeutic effect of combination therapy with ADMOS and CDDP two-route infusion in hepatocellular carcinoma]. ( Hiraki, Y; Ikeda, K; Itoh, Y; Kobayashi, H; Shinohara, S; Sonoda, T; Yano, T, 1988) |
| "DNA adducts of mitomycin C (MMC) were detected by 32P-postlabeling analysis in both surgical specimens and an autopsy sample of the liver of patients with hepatocellular carcinoma who had received chemotherapy with MMC." | 3.67 | Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis. ( Kato, S; Kim, T; Onda, M; Sato, S; Tajiri, T; Yamashita, K, 1988) |
| "An analysis is done of 40 evaluable patients treated with a combination of 5-Fluorouracil, adriamycin and mitomycin-C for primary hepatocellular carcinoma in Saudi Arabia." | 3.67 | Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C. ( Abdel Satir, A; Al-Idrissi, HY; Al-Kasem, S; Al-Qurain, A; Ibrahim, EM; Satti, MB, 1985) |
| "Four patients with advanced hepatocellular carcinoma, but with stage I functional disease, were treated with intrahepatic arterial lipoidal mixed with small doses of Adriamycin (20 mg) and Mitomycin C (10 mg)." | 3.67 | Treatment of irresectible hepatocellular carcinoma with intrahepatic arterial lipoidal mixed with adriamycin and mitomycin C. ( Chin, JH; Oon, CJ; Tan, L; Yong, YM, 1986) |
| "Forty-nine patients with liver metastases of breast cancer were treated with arterial infusion involving simultaneous use of adriamycin: 30-50 mg and mitomycin C: 10-20 mg through the hepatic artery by Seldinger catheter." | 3.67 | [Arterial infusion of combination chemotherapy consisting of adriamycin and mitomycin C for liver metastases of breast cancer]. ( Horikoshi, N; Inagaki, J; Inoue, K; Ito, Y; Mukaiyama, T; Nakamura, T; Ogawa, M; Tada, A; Ueno, K; Yamazaki, H, 1986) |
| "Survival period of 28 cases with unresectable hepatocellular carcinoma treated with transhepatic arterial one-shot infusion of 30 mg mitomycin C (MMC) were retrospectively reviewed from the standpoint of hepatic angiographic findings, scintigraphic existence of liver cirrhosis and changes of AFP value." | 3.66 | [Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C]. ( Kobayashi, H, 1982) |
| "Twenty elderly patients with hepatocellular carcinoma were treated with 5-fluorouracil (5-FU) at a daily dose of 200-300 mg per os, and with a combination of 0." | 3.66 | [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil]. ( Asano, K; Ejiri, T; Fujii, M; Matsuka, Y; Murakami, N, 1982) |
| "Three women with adenocarcinoma of cardia, adenocarcinoma of liver or ileum carcinoid tumor, respectively, were treated with mitomycin C (MMC) and 5-fluoro-uracil (5-FU)." | 3.66 | [Mytomycin C nephrotoxicity. 3 new cases and review of the literature]. ( Ang, KS; Cledes, J; Hervé, JP; Leguy, P; Leroy, JP; Ramée, MP; Simon, P; Vignoud, J, 1982) |
| "This phase II prospective study investigates possible benefits of radiofrequency ablation (RFA) combined with hepatic arterial chemoembolization using degradable starch microsphere (DSM) mixed with mitomycin C (MMC) in non-surgical candidates with colorectal liver metastases." | 2.84 | Radiofrequency Ablation Combined with Hepatic Arterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Liver Metastasis from Colorectal Cancer: A Prospective Multicenter Study. ( Hayashi, S; Inaba, Y; Nakatsuka, A; Nobata, K; Sato, Y; Takaki, H; Yamakado, K; Yamanaka, T; Yasumoto, T, 2017) |
| "The MTDs were determined as 5FU 800 mg/m(2) on RT days 1-4 and 29-32 and MMC 8 mg/m(2) on days 1 and 29 when combined with IMRT/VMAT with SIB and cetuximab in locally advanced anal cancer." | 2.80 | Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer. ( Gunnlaugsson, A; Guren, MG; Johnsson, A; Leon, O; Radu, C, 2015) |
| "Twenty patients with hepatocellular carcinoma treated with chemoembolization were included in the study." | 2.78 | Objective assessment of transcatheter arterial chemoembolization angiographic endpoints: preliminary study of quantitative digital subtraction angiography. ( Beilner, J; Chen, JJ; Chi, JC; Kowarschik, M; Xu, JR; Ye, H; Zhang, XB; Zhuang, ZG, 2013) |
| "A total of 29 patients (n=13 for chronic hepatitis Band n=16 for chronic hepatitis C) showed significant changes of the viral loads after TACE." | 2.76 | Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma. ( Chen, SH; Chuang, WL; Hsieh, MY; Huang, CF; Lin, CI; Lin, ZY, 2011) |
| "Treatment with mitomycin-C only showed median and mean survival times of 13." | 2.75 | Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. ( Eichler, K; Gruber-Rouh, T; Naguib, NN; Nour-Eldin, NE; Vogl, TJ; Zangos, S, 2010) |
| "The incidence of liver metastasis in group A was 34% which was lower than 50% in group B." | 2.74 | Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma. ( Fu, DL; Jin, C; Long, J; Ni, QX; Xu, J; Yang, F; Yao, L; Yu, XJ, 2009) |
| "Twenty-nine colorectal cancer patients with non-resectable hepatic metastases were consecutively enrolled for HAI alternating with systemic chemotherapy (HA + SC group)." | 2.72 | Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer. ( Chang, HM; Ha, HK; Kim, HC; Kim, JC; Kim, JH; Kim, TW; Lee, KH; Lee, MG; Ryu, MH; Yu, CS, 2006) |
| "To evaluate the effect of tamoxifen (TAM) combined with a somatostatin analogue, octretide (OCT) on advanced liver cancer and whether tamoxifen combined with OCT is superior to regular chemotherapeutic agents 5-Fu and mitomycin C (MMC)." | 2.71 | Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial. ( Chen, JW; Huo, YC; Pan, DY; Qiao, JG; Shi, HA; Zhou, YK, 2003) |
| " The aim was to investigate the therapeutic efficacy and tolerance of mitomycin C (MMC) in combination with gemcitabine (GEM) or capecitabine (CAPE) in previously untreated patients with advanced biliary tract cancer." | 2.71 | Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. ( Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B, 2004) |
| "To evaluate the clinical efficacy of capecitabine combined with transcatheter arterial chemoembolization (TACE) for advanced liver cancer." | 2.71 | [Capecitabine combined with TACE for advanced liver cancer]. ( Chen, AJ; Hu, MD; Li, L; Li, XY; Ran, JH; Sun, F; Tang, JH, 2004) |
| "To investigate the effects of the dosage of anticancer agents during transcatheter arterial chemoembolization (TACE) on the T cell subsets in patients with hepatocellular carcinoma (HCC)." | 2.70 | Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma. ( Chen, Y; He, XF; Li, YH; Lu, W; Qiu, YR; Zeng, QL, 2002) |
| "Recurrence of hepatocellular carcinoma (HCC) after curative hepatic resection is frequent and is an important factor adversely influencing long-term survival." | 2.69 | Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. ( Chang, FY; Chau, GY; Chiang, JH; Huang, YH; Huo, TI; King, KL; Lee, SD; Lui, WY; Tsay, SH; Wu, JC, 2000) |
| " However, BW12C in combination with MMC for 5-FU-resistant colorectal cancer is not an effective regimen." | 2.69 | Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer. ( Braybrooke, JP; Dixon, RM; Ganesan, TS; Harris, AL; Levitt, NC; Littlewood, TJ; O'Byrne, K; Propper, DJ; Rajagopalan, B; Talbot, DC; Thompson, CH, 2000) |
| "In the present study, repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy was performed in patients with unresectable tumors of the liver." | 2.68 | [Efficacy of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy for unresectable tumors of the liver]. ( Hashimoto, N; Hayashi, T; Kohno, H; Kubota, H; Nagasue, N; Ono, T; Uchida, M; Yamanoi, A, 1995) |
| "To evaluate the efficacy of intra-arterial chemotherapy combined with hyperthermia for metastatic liver cancer, our cooperative study group carried out a randomized clinical trial comparing intra-arterial chemotherapy alone and intra-arterial chemotherapy combined with hyperthermia." | 2.68 | [A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer]. ( Hiraoka, M; Itani, K; Kondo, M; Miura, K; Noguchi, M; Tanaka, Y; Watanabe, N; Yoshikawa, T, 1995) |
| "Fourteen advanced gastric cancer patients allocated to RT and Control group randomly and received each amino acid as protein source for 7 days TPN with 5-FU administration." | 2.68 | [Clinical evaluation of anticancer effect of methionine-depleting total parenteral nutrition with 5-fluorouracil and/or mitomycin C]. ( Endo, M; Goseki, N; Kando, F; Maruyama, M; Nagai, K; Shimoju, K; Wada, Y, 1995) |
| "For the local recurrence of rectal cancer, it was observed in Dukes C and cases of relative curative resection." | 2.68 | [Cooperative study of surgical adjuvant chemotherapy for colorectal cancer. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan]. ( Kikuchi, K; Kunii, Y, 1995) |
| " The aim of this phase I study was to determine the toxicity profile and the optimal dosage of KW-2149." | 2.68 | Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149. ( Ardiet, C; Catimel, G; De Bruijn, E; Dirix, L; Dumortier, A; Evene, E; Joossens, E; Koier, I; Provè, A; Schrijvers, D, 1995) |
| "In the 110 patients with metastatic liver cancer, the carcinoembryonic antigen level and tumor size were reduced." | 2.67 | Targeted chemotherapy for unresectable primary and metastatic liver cancer. ( Kai, Y; Kimura, M; Konno, T; Nagamitsu, A; Yamashita, R, 1994) |
| "Mitomycin C was injected via the indwelling catheter placed in the proper hepatic artery, when the mean systolic blood pressure rose to 50 percent above the level in the untreated state by intravenous administration of noradrenaline." | 2.67 | [Effects and problems of intraarterial noradrenaline-induced hypertensive chemotherapy for liver metastasis of gastric cancer]. ( Arai, K; Iwasaki, Y; Kitamura, M, 1994) |
| "Mitomycin was used in 40 patients and dihydroxyanthracenedione (DADH) in 58 patients." | 2.67 | [The treatment of hepatocellular carcinoma by chemoembolization]. ( Bortolasi, L; Dal Dosso, I; Facci, E; Mansueto, GC; Marchiori, L; Nicoli, N; Nifosi, F; Perus, G, 1994) |
| "Vascular invasion and intrahepatic metastasis by hepatocellular carcinoma are important factors predisposing to tumor recurrence." | 2.67 | Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. ( Ii, T; Iyobe, T; Izumi, R; Matsui, O; Miyazaki, I; Nonomura, A; Shimizu, K; Yagi, M, 1994) |
| "Fifty-two patients with unresectable hepatocellular carcinoma were divided into 2 groups." | 2.67 | Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma. ( Lu, CD; Peng, SY; Qi, YG, 1994) |
| "Mitomycin C was used as the anticancer drug and given at the dose of 8mg/m2 per time." | 2.67 | [Comparative clinical study in metastatic liver cancer between intra-arterial infusion of mitomycin C alone and intra-arterial infusion of mitomycin C combined with PJ-203 (degradable starch microspheres)]. ( Kondo, M; Nakamura, H; Ogawa, N; Okawa, T; Taguchi, T; Tanikawa, K, 1993) |
| "A total of 49 patients with metastatic renal cell cancer underwent recombinant interferon-alpha 2a therapy combined with chemotherapy." | 2.67 | Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer. ( Amato, R; Dexeus, FH; Fitz, K; Kilbourn, R; Logothetis, CJ; Sella, A; Wallace, S, 1992) |
| "Twenty-six cases of hepatocellular carcinoma were divided randomly into 3 groups, treated by transcatheter hepatic arterial chemo-embolizations with agents of MMC 20 mg, MMC 20 mg plus lipiodol 10 ml, and MMC 20 mg plus MTXmc 150 mg, respectively, 2 to 3 weeks before surgery." | 2.67 | [Histologic assessment on resected hepatocellular carcinoma specimens with preoperative transcatheter hepatic arterial chemo-embolizations]. ( Chen, H, 1991) |
| " In all patients, the area under the concentration time curve (AUC) was significantly lower when the drug was co-administrated with DSM, but the terminal half-life (t1/2) of mitomycin C was unchanged." | 2.66 | Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancer. ( Andersson, M; Aronsen, KF; Balch, C; Domellöf, L; Eksborg, S; Hafström, LO; Howell, SB; Kåresen, R; Midander, J; Teder, H, 1989) |
| "Patients (1,256 with colon cancer, 1,221 with rectal cancer) were divided into the treatment group (group A) and the control group (surgical resection only, group B)." | 2.66 | [Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): a preliminary report. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan]. ( Abe, O; Hattori, T; Inokuchi, K; Kikuchi, K; Kodaira, S; Komi, N; Kondo, T; Ogawa, N; Taguchi, T; Uchino, J, 1989) |
| "As the prevalence of liver cancer increases, so does the demand for nonsurgical, minimally invasive alternatives to surgery, since many patients have tumors that cannot be surgically resected." | 2.52 | Catheter-based transarterial therapies for hepatocellular cancer. ( Laroia, AT; Laroia, ST; Morales, SA, 2015) |
| "Resectability of liver-limited colorectal cancer metastases should be considered as an endpoint for all patients." | 2.44 | Regional chemotherapy for liver-limited metastatic colorectal cancer. ( Healey-Bird, BR; Kemeny, NE; Power, DG, 2008) |
| " Despite its pharmacokinetic advantages, the aortic stop flow technique is currently not recommendable for routine use." | 2.43 | Pharmacokinetics of the antineoplastic drug mitomycin C in regional chemotherapy using the aortic stop flow technique in advanced pancreatic carcinoma. ( Gebauer, T; Grote, R; Lippert, H; Martens-Lobenhoffer, J; Meyer, F; Ridwelski, K, 2005) |
| "The recurrence rate of resected gastric cancer with curative intent was around 20%." | 2.40 | [Treatment of recurrent gastric cancer]. ( Sakata, Y; Tsushima, K, 1998) |
| "In an attempt to improve tumor response and survival among patients with colorectal cancer metastases confined to the liver, we developed an experimental (rats and pigs) and clinical isolated hepatic perfusion (IHP) technique to exploit maximally the steep dose-response relation of may anticancer drugs." | 2.40 | Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases. ( Marinelli, A; Vahrmeijer, AL; van de Velde, CJ, 1998) |
| "It is well-known that the patients with pancreatic cancer are vulnerable for recurrence such as local relapse and liver metastasis after surgical resection." | 2.40 | [Therapeutic strategy for the recurrence of pancreatic cancer following pancreatectomy]. ( Egawa, S; Kobari, M; Matsuno, S; Shibuya, K; Shimamura, H; Sunamura, M; Takeda, K, 1999) |
| "Sixty-six patients with colorectal cancer were studied regarding effects of prevention of hepatic recurrence in completely performed portal infusion chemotherapy." | 2.40 | [Is portal infusion chemotherapy uneffective for hepatic recurrence after resection for colorectal cancer?]. ( Akaishi, O; Tsukikawa, S; Yabe, K; Yamaguchi, S; Yamamura, T, 1999) |
| "20 patients had Barcelona Clinic Liver Cancer (BCLC) stage B, while 8 patients obtained chemoembolization for bridging purposes (BCLC stage A)." | 1.48 | Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients. ( Beeres, M; Eichler, K; Gruber-Rouh, T; Kamal, A; Langenbach, M; Naguib, NN; Vogl, TJ, 2018) |
| "HAIC offers a safe and effective salvage treatment strategy in heavily pretreated patients with LMBC and no further treatment options." | 1.46 | Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters. ( Bogner, S; Peis, MW; Reinboldt, MP; Schuler, M; Tewes, M; Theysohn, JM; Welt, A, 2017) |
| "Stage IV squamous cell carcinoma of the anus outcomes are poor, but first-line chemotherapy can enable good response rates." | 1.46 | Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience. ( Benezery, K; Cavaglione, G; Doyen, J; Evesque, L; Follana, P; François, E; Reure, J; Tuan Falk, A, 2017) |
| "For patients with liver metastases from gastric cancer (LMGC), combination chemotherapy with fluoropyrimidines and platinum agents has been recognized as standard treatment." | 1.43 | Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin. ( Ohi, H; Ozaki, T; Seki, H; Yabusaki, H, 2016) |
| "The treatment efficacy of unresectable hepatocellular carcinoma (HCC) is still not promising." | 1.43 | Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study. ( Bao, Y; Dai, Y; Dong, X; Feng, W; Shen, J; Tang, C; Zhang, J; Zheng, Y, 2016) |
| "On day 0 a solid Morris Hepatoma 3924A was subcapsullary implanted in the liver." | 1.43 | Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol. ( Bechstein, WO; Gruber-Rouh, T; Hamidavi, Y; Hammerstingl, R; Imlau, U; Korkusuz, H; Naguib, NN; Nour-Eldin, NE; Oppermann, E; Qian, J; Tran, A; Vogl, TJ, 2016) |
| "Pseudomyxoma peritonei was the primary indication, and a glissonectomy was more frequently performed for patients with high peritoneal cancer index." | 1.43 | Digital Glissonectomy: A Safe Perihepatic Peritonectomy. ( Bakrin, N; Bonnefoy, I; Cotte, E; Glehen, O; Kepenekian, V; Kim, BJ; Passot, G; Vaudoyer, D, 2016) |
| "Extra-hepatic cancer relapse, involving intra-thoracic and abdominal lymph nodes, was observed not long after the initial intra-hepatic almost complete response." | 1.42 | Mitomycin-based hepatic arterial infusion chemotherapy for solitary ampullary cancer liver metastasis: an unusual treatment for an uncommon disease. ( Colina, P; Ferraù, F; Luciani, B; Raffaele, M; Romeo, P; Vitale, FV, 2015) |
| "The clinicopathological parameters and adverse effects were similar between the 2 groups (P > 0." | 1.42 | Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection. ( Burns, M; Hong, Y; Lei, X; Li, JL; Li, QL; Li, YG; Liu, C; Liu, HC; Liu, JS; Qiu, XX; Wang, XH; Wu, QF; Xia, M; Xiao, H; Xu, RC; Zhu, HZ; Zuo, CH, 2015) |
| "A major challenge of combinatorial therapy is the unification of the pharmacokinetics and cellular uptake of various drug molecules with precise control of the dosage thereby maximizing the combined effects." | 1.42 | Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy. ( Cao, Y; Gu, Y; Guo, P; He, H; Huang, X; Lei, S; Liu, M; Luo, S; Mukerabigwi, JF; Zhang, Y, 2015) |
| "Many advanced hepatocellular carcinoma (HCC) cases can be successfully downstaged into the Milan criteria; however, immediate radical therapy cannot be applied to all such patients for various reasons." | 1.40 | Immediate radical therapy or conservative treatments when meeting the Milan criteria for advanced HCC patients after successful TACE. ( Jiang, L; Lei, JY; Li, B; Wang, WT; Wei, YG; Wen, TF; Xu, MQ; Yan, LN; Yang, JY, 2014) |
| "The prognosis of hepatocellular carcinoma (HCC) with macroscopic vascular invasion is extremely poor even after hepatic resection." | 1.39 | Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion. ( Baba, H; Beppu, T; Chikamoto, A; Hayashi, H; Imai, K; Nitta, H, 2013) |
| "A total of 40 patients with hepatocellular carcinoma treated with transarterial chemoembolization between January 2007 and March 2011 were included." | 1.39 | Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience. ( Altundağ, K; Balkancı, F; Bayraktar, Y; Cil, BE; Doğanay Erdoğan, B; Idilman, I; Kav, T; Peynircioğlu, B; Yalçın, S, 2013) |
| " In conclusion, even after particle therapy, PIHP is a safe treatment and is associated with a good local control rate for remnant HCCs." | 1.39 | [Analysis of the safety and efficacy of percutaneous isolated hepatic perfusion after particle therapy for advanced hepatocellular carcinoma]. ( Ajiki, T; Demizu, Y; Fujii, O; Fukumoto, T; Fukushima, K; Fuwa, N; Kido, M; Kinoshita, H; Komatsu, S; Ku, Y; Kuramitsu, K; Matsumoto, I; Shinzeki, M; So, S; Takebe, A; Tanaka, M; Terashima, K; Urade, T, 2013) |
| "Twenty-four hepatocellular carcinomas were targeted in 18 patients (14 men, four women; mean age, 66 years), and segmental or lobar chemoembolization with intraprocedural transcatheter intraarterial perfusion MRI was successful in all 18." | 1.38 | Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI. ( Gaba, RC; Jin, B; Larson, AC; Lewandowski, RJ; Omary, RA; Ragin, AB; Salem, R; Wang, D, 2012) |
| "Thirty-six hepatocellular carcinoma patients not indicated for surgical resection underwent super- selective transcatheter arterial chemoembolization, divided into small dose (n=15) and conventional dose (n=21) chemotherapy groups." | 1.38 | Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses. ( Hu, Y; Li, H; Li, N; Zhou, Y, 2012) |
| "To (a) evaluate the response of hepatocellular carcinoma (HCC) to chemoembolization after initial nonresponse, as determined with European Association for the Study of the Liver (EASL) criteria and modified Response Evaluation Criteria in Solid Tumors (mRECIST), and (b) compare posttreatment survival of initial nonresponders versus that of initial responders." | 1.38 | Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment? ( Frangakis, C; Georgiades, C; Geschwind, JF; Harrison, N; Hines-Peralta, A; Hong, K; Kamel, I; Liapi, E; Wu, Z, 2012) |
| "Patients had different sources of liver metastasis." | 1.38 | Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol. ( Akhlaghpoor, S; Amoui, M; Aziz-Ahari, A; Poorbeigi, H; Sheybani, S; Tolooee, S, 2012) |
| "Unresectable intrahepatic cholangiocarcinoma has a poor prognosis, with a median survival of 5 to 8 months without treatment." | 1.37 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. ( Albert, M; Christians, K; Fraker, D; Kiefer, MV; McNally, M; Olthoff, K; Pappas, S; Rilling, W; Robertson, M; Soulen, MC; Sun, W, 2011) |
| "The recurrence of hepatocellular carcinoma is still high even after surgery." | 1.37 | Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy. ( Hayami, S; Ozawa, S; Shigekawa, Y; Tani, M; Uchiyama, K; Ueno, M; Yamaue, H, 2011) |
| "Among 11,030 patients with unresectable hepatocellular carcinoma, 8,507 underwent TACE, and 2,523 underwent transarterial infusion therapy with an emulsion of iodized oil and an anticancer agent as initial treatment." | 1.36 | Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. ( Arii, S; Ikai, I; Kojiro, M; Kudo, M; Makuuchi, M; Matsuyama, Y; Takayasu, K, 2010) |
| "We retrospectively assessed the benefits of 5-fluorouracil (5-FU)- and heparin-based portal infusion chemotherapy combined with systemic administration of mitomycin C (MMC) and cisplatin (CDDP) for 4 weeks following surgery (PI4W)." | 1.36 | Beneficial effects of 5-Fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer. ( Aiura, K; Kitagawa, Y; Matsui, J; Takahashi, S; Ueda, M, 2010) |
| "Established human hepatocellular carcinoma adriamycin (ADM) multi-drug resistant cell sub-lines models Bel-7402/ADMV, Bel-7402/ADML and Bel-7402/ADMS by three methods of in vitro concentration gradient increased induction, nude mice liver-implanted induction and subcutaneous-implanted induction respectively." | 1.36 | Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods. ( Gong, R; Meng, X; Xiong, M; Zhong, X, 2010) |
| "We report on a 45-year-old breast cancer patient with disseminated hepatic metastases." | 1.36 | Successful remission of extensive liver metastases in a breast cancer patient with acute liver failure using a combined chemotherapy regimen with mitomycin, folinate, and 5-fluorouracil (Mi/Fo/FU). ( Eichbaum, MH; Hauser, N; Hohl, MK; Sohn, C; Stoiber, B; Stoiber, N, 2010) |
| "We herein report a case of advanced hepatocellular carcinoma (HCC) with Vp4 portal vein thrombosis (PVTT)." | 1.36 | [A case of Vp4 portal vein tumor thrombosis--a complete remission achieved with dual treatment of surgery plus percutaneous isolated hepatic perfusion]. ( Awazu, M; Chuma, M; Fukumoto, T; Hori, Y; Kataoka, Y; Kido, M; Ku, Y; Kuroda, D; Kusunoki, N; Matsumoto, I; Takahashi, M; Tsuchida, S; Tsugawa, D, 2010) |
| "A case of hepatocellular carcinoma, successfully treated with multimodal loco-regional treatments, is reported." | 1.36 | [Successful treatment of multiple pulmonary and peritoneal recurrence of hepatocellular carcinoma with bronchial artery infusion therapy and PEIT followed by surgery--a case report]. ( Akiyama, H; Amikura, K; Kawashima, Y; Nakajima, T; Nishimura, Y; Sakamoto, H; Tanaka, Y; Yamagata, Y; Yamaura, T; Yatsuoka, T; Yokoyama, Y, 2010) |
| "There were upper gastrointestinal hemorrhage in 3 cases, hepatic failure in 4, pulmonary embolism in 1, cholecystitis in 4, hepatic encephalopathy in 2, gastric perforation in 1, and intrahepatic biloma in 2 cases." | 1.35 | [Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma]. ( Feng, B; Liang, SN; Liu, LL; Su, HY; Xu, K; Zhao, GS, 2008) |
| "Patients with liver cancer were examined with diffusion-weighted MRI at two b values (0 and 500 s/mm(2)) before and after chemoemblization." | 1.35 | [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer]. ( Dong, S; Sun, ZC; Xiao, XS; Xu, LC; Ye, XD; Yuan, Z, 2009) |
| "To evaluate the outcomes of patients with unresectable massive primary liver cancer (PLC) receiving three-dimensional conformal radiotherapy (3-DCRT) combined with transcatheter arterial chemoembolization (TACE)." | 1.35 | [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer]. ( Chen, LH; Guan, J; Li, QS; Sun, HW; Wei, CJ; Zheng, XK, 2009) |
| " Since a curative operation is impossible in this case, we started systemic chemotherapy employing S-1 combined with hepatic arterial infusion using epirubicin hydrochloride and mitomycin C." | 1.34 | [A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion]. ( Ishiguro, A; Itoh, J; Munakata, A; Munakata, M; Sakata, Y; Shitara, K; Suzuki, K; Takahata, T, 2007) |
| "For 14 patients with metastatic breast cancer, MR imaging studies before and after TACE were evaluated." | 1.34 | Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. ( Buijs, M; Georgiades, CS; Geschwind, JF; Hong, K; Kamel, IR; Vossen, JA, 2007) |
| " The TACE-procedure was carried out in regular intervals using a suspension consisting of a fixed dosage of Mitomycin C (10 mg) and 10-20 ml Lipiodol." | 1.34 | [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences]. ( Düber, C; Herber, S; Junginger, T; Kanzler, S; Kummer, I; Manzl, N; Mönch, C; Otto, G; Pitton, M; Schneider, J; Schuchmann, M, 2007) |
| "Prognosis of advanced hepatocellular carcinoma (HCC) treated by conventional therapies has been considered to be poor." | 1.33 | [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C]. ( Ahn, SH; Cho, KB; Choi, JS; Chung, WJ; Hwang, JS; Hwang, JY; Jang, BK; Kim, GC; Kim, YH; Kwon, JH; Kwon, KM; Park, KS, 2005) |
| " Low-output RFA combined with TACE is a safe, effective therapy for HCC." | 1.33 | [Low-output radiofrequency ablation combined with transcatheter arterial oily-chemoembolization for hepatocellular carcinoma]. ( Higashi, K; Kimura, M; Maeda, M; Nakai, M; Sahara, S; Sato, M; Shiraki, T; Takeuchi, N; Terada, M, 2005) |
| "To assess the effect of transcatheter arterial chemoembolization (TACE) combined with laser-induced thermotherapy (LITT) for treatment of liver metastases in an animal model." | 1.33 | Liver metastases in rats: chemoembolization combined with interstitial laser ablation for treatment. ( Bechstein, WO; Khan, MF; Maataoui, A; Mack, MG; Oppermann, E; Qian, J; Roozru, M; Schmidt, S; Vogl, TJ, 2005) |
| "These results suggest that gastric cancer,in which liver metastasis is considered to be a prognostic factor,can be effectively treated by combination therapy with hepatic arterial infusion therapy, followed by thermochemotherapy for the primary lesion." | 1.33 | [A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy]. ( Aoki, T; Hamaya, M; Kouno, T; Nishida, J; Ogata, T; Sato, S; Seo, K; Tsuchida, A; Yoshida, K, 2005) |
| "A patient with liver metastasis of pancreatic cancer received chemotherapy using mitomycin C and degradable starch microspheres." | 1.32 | Liver metastasis of pancreatic cancer managed by intra-arterial infusion chemotherapy combined with degradable starch microspheres. ( Aoki, T; Kato, F; Katsumata, K; Koyanagi, Y; Sumi, T; Suzuki, Y; Takagi, M; Tomioka, H; Yamasaki, T, 2003) |
| "Hepatic resection for huge hepatocellular carcinoma (HCC) is challenging." | 1.32 | Multimodality management of hepatocellular carcinoma larger than 10 cm. ( Chen, IS; Chen, YC; Chou, NH; Liang, HL; Liu, SI; Lo, GH; Mok, KT; Tsai, CC; Wang, BW; Yeh, MH, 2003) |
| "Hepatic angiosarcoma has two distinct presentations: multiple tumors and a solitary tumor." | 1.32 | Five years and 4 months of recurrence-free survival in hepatic angiosarcoma. ( Acarli, K; Bilge, O; Cevikbaş, U; Erkan, M; Ozden, I, 2003) |
| "He then underwent excision of the brain metastases and consecutive radiation by X-knife." | 1.32 | [A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy]. ( Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Takahashi, K; Yamaguchi, T, 2003) |
| "Large hepatocellular carcinoma tumors are being treated increasingly with a combination of transcatheter arterial chemoembolization (TACE) and radiofrequency (RF) ablation." | 1.32 | 2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. ( Ahrar, K; Newman, RA; Pang, J; Vijjeswarapu, MK; Wallace, MJ; Wright, KC, 2004) |
| "The prognosis of gastric cancer with liver metastasis is very poor." | 1.32 | [Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Shirouzu, K; Takeda, J; Yano, S, 2004) |
| "We report a case of liver metastases of rectal cancer in which F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) was useful for evaluating the therapeutic efficacy for transient hepatic arterial chemoembolization." | 1.32 | [Usefulness of F-18-fluorodeoxyglucose positron emission tomography for evaluating the efficacy of transient hepatic arterial chemoembolization for liver metastases of rectal cancer--a case report]. ( Hashimoto, D; Hoshino, T; Ishida, H; Nakada, H; Ohsawa, T; Okada, N; Ozawa, F; Takeuchi, I; Yokoyama, M, 2004) |
| "To explore the change of T cell subsets in patients suffered from hepatocellular carcinoma (HCC) before and after hepatectomy, and study the value of Roferon-A (interferon alpha-2a) combined with hepatic artery chemoembolization (HACE) and portal vein chemotherapy (PVC) after radical resection of HCC for preventing recurrence." | 1.32 | [The value of Roferon-A combined with hepatic artery chemoembolization and portal vein chemotherapy after radical resection in hepatocellular carcinoma for preventing recurrence]. ( Chen, JS; Duan, ZH; Li, HH; Wang, J; Zhang, HW, 2004) |
| "We report a case of inoperable gastric cancer with multiple liver metastases, which responded significantly to the short-term administration of TS-1 following intravenous FMP therapy." | 1.31 | [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization]. ( Chinzei, T; Okada, Y; Tasaka, K; Tomofuji, Y, 2002) |
| "In patients with pancreatic cancer, the overall response rate was 42% with a median survival of 8 months." | 1.31 | Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen. ( Gallagher, CJ; Shamash, J; Slater, S; Slevin, ML; Wilson, P, 2002) |
| " The pharmacokinetic parameters were computed assuming an open two-compartment model and linear kinetics." | 1.31 | Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres. ( Fischbach, R; Heindel, W; Klaus, W; Lackner, K; Rump, AF; Theisohn, M; Woschée, U, 2002) |
| "Bile duct necrosis is a serious complication in arterial infusion chemotherapy, and the infusion chemotherapy should be suspended or the dose should be reduced for patients with abnormalities shown by hepato-biliary function tests." | 1.31 | [A case of intrahepatic bile duct necrosis following hepatic arterial infusion chemotherapy]. ( Arai, K; Iwasaki, Y; Kimura, Y; Takahashi, K; Takahashi, T; Yamaguchi, T, 2002) |
| "A 73-year old man with multiple hepatocellular carcinomas underwent 4 transarterial chemoembolizations, but a tumor thrombus appeared in the left portal vein." | 1.31 | [A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization]. ( Esumi, K; Furukawa, H; Imamura, H; Inoue, Y; Ishida, H; Katoh, H; Kitani, K; Masuda, N; Masutani, S; Onishi, H; Shimizu, J; Tatsuta, M; Tomotsu, K; Tsuda, K; Usui, T, 2002) |
| "Synergistic inhibition of hepatoma BEL-7402 cell proliferation was achieved by the combination of MMC and CA-Na." | 1.31 | [Synergistic antitumor effect of sodium caffeate and mitomycin]. ( Song, DQ; Xu, F; Zhen, YS, 2002) |
| "Transplantable murine hepatoma 22 model was used to evaluate the antitumor activity of drugs in vivo." | 1.31 | Synergistic effects of geldanamycin and antitumor drugs. ( Liao, ZY; Zhang, SH; Zhen, YS, 2001) |
| " MMC was assayed by high-pressure liquid chromatography (HPLC), and pharmacokinetic parameters were determined using an open, two-compartment model and linear kinetics." | 1.31 | Pharmacokinetics of intraarterial mitomycin C in hypoxic hepatic infusion with embolization in the treatment of liver metastases. ( Cerretani, D; Civeli, L; Correale, P; De Manzoni, G; Francini, G; Giorgi, G; Marrelli, D; Pieraccini, M; Pinto, E; Roviello, F, 2002) |
| "We report a case of advanced rectal cancer accompanied by unresectable liver metastasis in which remission has been achieved for 7 years." | 1.31 | [A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective]. ( Baba, H; Kikunaga, H; Matsudo, A; Miura, H; Morisue, A; Nakai, H; Osakabe, Y; Sotome, K; Takao, M, 2000) |
| "Our experience of arterial infusion chemotherapy combined with regional hyperthermia in the treatment of non-resectable pancreatic cancer was presented." | 1.31 | [Intra-arterial infusion chemotherapy in combination with microwave hyperthermia for cancer of head of pancreas and liver metastasis--a case of 16 years survival]. ( Endo, Y; Ikeda, H; Matumoto, Y; Miura, T, 2000) |
| "For both of the two patients with pancreatic cancer, although they were responsive to the therapy, there was no prolongation of survival." | 1.31 | [Hepatic arterial infusion chemotherapy for unresectable liver metastasis of gastrointestinal cancers]. ( Hirakawa, K; Nishino, H; Ohira, M; Shimizu, S; Tamamori, Y; Tanaka, H; Yamada, N, 2000) |
| "A total of 18 patients (13: colon cancer, 5: gastric cancer) with multiple liver metastases (H3) underwent hepatic arterial infusion chemotherapy (HAI) using an implanted arterial port with portable syringe pumps in our outpatient clinic." | 1.31 | [Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases]. ( Fukunaga, M; Goda, F; Maeba, T; Maeta, H; Mihara, T; Mori, S; Ohkawa, M; Okada, H; Okano, K; Senda, S; Uchida, Y; Usuki, H; Wakabayashi, H, 2000) |
| "We have experienced a case of advanced gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion of 5-fluorouracil (5-FU), mitomycin C (MMC) and peroral administration of 5-FU." | 1.31 | Advanced gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion of 5-FU, MMC and peroral administration of 5-FU: a case report. ( Aoyagi, K; Koufuji, K; Murakami, N; Shirouzu, K; Takeda, J; Terasaki, Y; Yamasaki, Y; Yano, S, 2000) |
| "A 67-year-old female with rectal cancer and multiple liver metastases underwent low anterior resection by total mesorectal excision (TME), cholecystectomy and hepatic arterial cannulation in June 1995." | 1.31 | [Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)]. ( Kusunoki, M; Noda, M; Yamamura, T; Yanagi, H; Yoshikawa, R, 2001) |
| "The aim of this study was to evaluate the clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and the possibility of predicting the effectiveness of the chemotherapy by pretreatment diagnostic imaging." | 1.31 | [Clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and prediction of effectiveness by diagnostic imaging]. ( Majima, T; Nakajima, T; Nozu, S; Okayasu, K; Saitou, AY; Yagi, A, 2001) |
| "For most patients with primary liver cancer surgical treatment is not feasible and prognosis without treatment is poor." | 1.31 | Chemoembolization for primary liver cancer. ( Achenbach, T; Junginger, T; Pitton, MB; Schunk, K; Seifert, JK, 2002) |
| "We report three patients with recurrent gastric cancer responding to TS-1 therapy after combination chemotherapy with 5-fluorouracil, mitomycin C and cisplatin." | 1.31 | [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin]. ( Hayashi, K; Iijima, S; Koyama, Y; Miyazawa, K; Morikawa, A; Murakami, M; Okabe, R; Ozaki, K; Sugiyama, A; Suzuki, A, 2002) |
| "Reports about arteritis during TACE treatments are discussed." | 1.30 | Arteritis following intra-arterial chemotherapy for liver tumors. ( Belli, L; Colombo, E; Cornalba, GP; Damiani, G; Magistretti, G; Puricelli, GP, 1997) |
| "We diagnosed the patient as recurrent breast cancer metastatic to liver, 14 years postoperatively." | 1.30 | [Liver metastases from breast cancer 14 years after radical mastectomy; successful treatment with hepatic arterial infusion chemotherapy and systemic endocrine therapy--a case report]. ( Arai, K; Imai, R; Ito, K; Kojima, K; Muro, H; Nakagami, K; Nakajima, N; Nishimura, K; Onogawa, S; Suzuki, M; Tohyama, K; Umeda, Y, 1997) |
| "Fifty-five colorectal cancer patients who had continuous intraportal chemotherapy between 1990 and 1993 (treated group) and 130 colorectal cancer patients who did not have portal chemotherapy between 1982 and 1993 (untreated group) were studied to clarify the effects of continuous intraportal chemotherapy on the prognosis." | 1.30 | [Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer]. ( Adachi, W; Amano, J; Kajikawa, S; Koide, N; Koike, S; Kuroda, T; Mihara, M; Nakata, S; Watanabe, H; Yazawa, K, 1998) |
| "Eleven colorectal cancer patients underwent hepatic resection for liver metastasis." | 1.30 | [Adjuvant intra-arterial chemotherapy with gastrin receptor antagonist after hepatic resection in colorectal cancer metastasis]. ( Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Murata, K; Nakano, H; Ohigashi, H; Sasaki, Y; Tsugawa, T; Yasuda, T, 1998) |
| "Many cases with metastatic hepatic cancer have a poor prognosis because of the appearance of extrahepatic lesions in spite of the fact that a partial response can be obtained by hepatic arterial infusion chemotherapy." | 1.30 | [Appearance of extrahepatic lesions in the superior lip and orbit of a patient with liver metastases of gastric cancer following partial response by hepatic arterial infusion chemotherapy]. ( Hasegawa, K; Ichikawa, T; Kawai, S; Kirihara, M; Kume, S; Maruo, H; Tominaga, S, 1998) |
| "Mitomycin C pretreatment also significantly increased the sensitivity of cancer cells to subsequent killing by the P-glycoprotein substrate doxorubicin, decreasing the ED50 by 5- to 10-fold." | 1.30 | Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. ( Blaxall, JR; Hamilton, JW; Ihnat, MA; La Ronde, N; Lariviere, JP; Pierre, KM; Turpie, BW; Warren, AJ, 1997) |
| "Mitomycin C (20 mg) was injected through out the induced hypertension (1." | 1.30 | [A case of liver metastases from gastric cancer responding to induced hypertensive chemotherapy with angiotensin II]. ( Arai, K; Iwasaki, Y; Kitamura, M; Nakajima, Y, 1999) |
| "Advanced hepatocellular carcinoma (HCC) with extensive tumour growth through the hepatic vein still has an extremely poor prognosis, even after cancer chemotherapy and/or transarterial embolization." | 1.30 | Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. ( Ambiru, S; Furuya, S; Ito, H; Kaiho, T; Kashima, Y; Miyazaki, M; Nakagawa, K; Nakajima, N; Shimizu, H, 1999) |
| "Mitomycin C was injected for 10 minutes via implanted port, whose tip was located in the hepatic artery, when the mean systolic blood pressure rose to 50 percent above the level in the untreated state by intravenous administration of angiotensin II." | 1.30 | [Efficacy and problems of hepatic arterial chemotherapy with angiotensin II for liver metastasis from gastric cancer]. ( Arai, K; Iwasaki, Y; Ohashi, M; Takahashi, T, 1999) |
| "A case of unresectable pancreatic cancer in a 76-year-old female was reported, in which a tumor had liver involvement." | 1.29 | [A case of pancreatic cancer surviving for 7 years 11 months following intra-arterial and portal infusion chemotherapy]. ( Endo, T; Ichikawa, J; Ishii, H; Kenmotsu, M; Tsunemitsu, K, 1995) |
| "A patient with advanced gastric cancer with multiple liver metastases was treated by reduction surgery at the primary site as well as by the intraarterial administration of mitomycin C (MMC) and cisplatin (CDDP) through a reservoir catheter inserted into the proper hepatic artery." | 1.29 | Combination chemotherapy with mitomycin C and cisplatin for advanced gastric cancer with multiple liver metastases. ( Furukawa, T; Ishibiki, K; Kitajima, M; Kubota, T; Kumai, K; Saikawa, Y; Yoshino, K, 1994) |
| "A case of far advanced gastric cancer with multiple liver metastasis (H3) was treated with transarterial intermittent chemotherapy (5-FU: 250 mg/week, Farmorubicin: 10 mg/4 weeks, MMC: 4 mg/2 weeks) and intradermal administration of low molecular lipopolysaccharide (LPSp) extracted from Pantoea agglomerans." | 1.29 | [A case report of far advanced gastric cancer with multiple liver metastasis (H3) treated with transarterial intermittent chemotherapy and intradermal administration of low molecular lipopolysaccharide (LPSp) extracted from Pantoea agglomerans]. ( Fukuma, E; Goto, S; Imai, I; Ishiyama, J; Kano, N; Kasugai, H; Kera, J; Miyajima, N; Takeuchi, S; Yamakawa, T, 1995) |
| "Lovastatin-treated cells also exhibited decreased adherence to substrate (p < 0." | 1.29 | Effect of lovastatin alone and as an adjuvant chemotherapeutic agent on hepatoma tissue culture-4 cell growth. ( Buchwald, H; Furcht, LL; Morris, TJ; Palm, SL, 1995) |
| "Two cases of hepatic metastasis of colorectal cancer were treated effectively by intrahepatic-arterial infusion immunotherapy using OK-432 (2 KE/week or 2 weeks), recombinant IL-2 (35 x 10(4) JRU or 40 x 10(4) JRU/week or 2 weeks), MMC (4 mg/week or 2 weeks) and 5-FU (250 mg/day during admission, 250 mg/week or 2 weeks during outpatient treatment)." | 1.29 | [Two cases of hepatic metastasis of colorectal cancer treated effectively by intrahepatic arterial infusion immunotherapy using OK-432, rIL-2, MMC and 5-FU]. ( Akiyama, T; Kiriyama, M; Kita, I; Kosaka, T; Kurosaka, Y; Matsushita, M; Takashima, S; Tomita, F, 1994) |
| "Mitomycin C was also used in four cases." | 1.29 | Multiple intrahepatic aneurysms following transcatheter arterial embolization. Work in progress. ( Aikawa, H; Ashizawa, K; Aso, N; Fukuda, T; Fukushima, T; Hayashi, K; Isomoto, I; Matsunaga, N; Morikawa, M; Sakamoto, I, 1994) |
| "7% tumor growth inhibition, and these conditions for hyperthermia were subsequently used as a criterion for evaluating the effects of its combination with various anticancer agents." | 1.29 | Studies of effects of anticancer agents in combination with/without hyperthermia on metastasized human bladder cancer cells in chick embryos using the polymerase chain reaction technique. ( Endo, Y; Kunimi, K; Lee, SW; Noguchi, M; Ohkawa, M; Sasaki, T; Uchibayashi, T, 1994) |
| "A 67-year-old man with advanced gastric cancer with multiple liver metastases was treated by a new combination chemotherapy using 5-FU, THP and MMC (FTM)." | 1.29 | [A case of advanced gastric cancer with multiple liver metastases showing marked response to new combination chemotherapy using 5-FU, THP and MMC (FTM)]. ( Kusano, F; Maekawa, N; Sakai, Y; Sasaki, N; Tajiri, K; Tazawa, J; Yamamoto, C, 1994) |
| "We describe a case of hepatoma, a 66-year-old woman, presenting with obstructive jaundice, whom we treated with intra-arterial infusion of the anticancer drug, MMC." | 1.29 | [A case of icteric type hepatoma responding to MMC infusion therapy via cannulation into the hepatic artery]. ( Kato, S; Kobayashi, H; Nakagawa, T, 1993) |
| "All the gastric cancer lesions without liver metastases were resected 14 days after implantation of VX2 cancer cells into the stomach, and all the animals were autopsied 14 days after resection." | 1.29 | [Prophylactic effects of mitomycin C (MMC) on the liver recurrence in a rabbit gastric VX2 cancer model with high frequency of the recurrence]. ( Nakamura, T; Saitoh, Y; Tabuchi, Y; Tada, Y, 1993) |
| "Nine gastric cancer patients with simultaneous liver metastases were given intermittent transarterial administration of chemotherapeutics (adriamycin, mitomycin C or 5-fluorouracil) and biological response modifiers (BRM; OK-432 and interleukin (IL) -2) after gastrectomy." | 1.29 | [Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer]. ( Azuma, S; Furuta, T; Kato, M; Kida, H; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Umemoto, T, 1993) |
| "Since 1980, 89 patients with colorectal cancer showed liver metastasis." | 1.29 | [Efficacy of hepatic arterial and intraportal infusion chemotherapy for liver metastasis of colorectal cancer]. ( Akaike, M; Okamoto, T; Sugimasa, Y; Takemiya, S, 1993) |
| "125 cases of hepatocellular carcinoma (HCC) were treated by transarterial approach." | 1.29 | [Treatment of hepatocellular carcinoma by transarterial approach]. ( Luo, PF, 1993) |
| "We have investigated the therapeutic effect of CH-271 fusion polypeptide containing both cell-binding domain (C-274) and heparin-binding domain (H-271) of fibronectin in combination with anticancer drugs such as doxorubicin (DOX) or mitomycin C (MMC) on tumor metastasis of different types of tumors." | 1.29 | Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs. ( Azuma, I; Igarashi, Y; Ishizaki, Y; Kato, I; Kobayashi, H; Komazawa, H; Saiki, I; Yoneda, J, 1993) |
| "Mitomycin C 26 mg was given intravenously on the day of operation and 5-fluorouracil (5-FU) 150 mg/day orally since postoperative 14th day as adjuvant chemotherapy." | 1.29 | [A case of advanced gastric cancer with liver metastasis with no recurrence and long survival]. ( Kajiura, Y; Kondo, Y; Mitomi, T; Miyaji, M; Nakamura, K; Ogoshi, K; Tajima, T, 1996) |
| "We experienced 522 patients with breast carcinoma and 14 cases (2." | 1.29 | [A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy]. ( Matsumine, T; Matsumoto, J; Minami, T; Takami, M; Takanishi, K, 1996) |
| "A 51-year-old man with 2 type gastric cancer (H0) underwent subtotal gastrectomy (D2)." | 1.29 | [Effective transcatheter arterial embolization for hepatic metastasis in a case of AFP producing gastric cancer]. ( Hirose, K; Katayama, K; Kobayashi, T; Nakagawara, G; Niimoto, S; Yamaguchi, A, 1996) |
| " Pharmacokinetic examination after intravenous injection of low-dose MMC (0." | 1.29 | A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics. ( Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S, 1996) |
| "A case of gastric cancer with liver metastasis who responded well to low-dose PMUE (CDDP, MMC, UFT, etoposide) therapy is reported." | 1.29 | [A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy]. ( Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y, 1996) |
| "A 64-year-old male was admitted for treatment of hepatocellular carcinoma." | 1.28 | [A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C]. ( Eto, T; Ishinoda, Y; Iwaki, Y; Kawano, T; Kitamura, M; Kitamura, T; Komura, K; Maruyama, T; Shimada, Y; Tamaki, N, 1992) |
| "Mitomycin C was observed potentially to have enhanced cytotoxicity under hypoxic conditions for both hepatoma cell lines." | 1.28 | The difference in chemosensitivity to antineoplastic agents of human hepatocellular carcinoma cells under normo-oxygenated or hypoxic conditions. ( Ikeda, Y; Kanematsu, T; Matsumata, T; Sugimachi, K; Utsunomiya, T; Yamagata, M, 1992) |
| "Hepatectomy has been performed as a treatment for hepatocellular carcinoma (HCC) and metastatic liver carcinoma." | 1.28 | [Intermittent intra-arterial chemotherapy using subcutaneously implanted reservoir for hepatocellular carcinoma and liver metastasis of colorectal carcinoma]. ( Hanawa, S; Hasebe, Y; Kuramoto, S; Maeda, T; Nakazaki, H; Suzuki, Y; Watanabe, M; Yanagita, K; Yoshio, T, 1992) |
| "Nine patients with inoperable hepatoma were treated by using hepatic arterial embolization 131I and chemotherapeutic agent gelatin microsphere (131I-CA-GM)." | 1.28 | [Hepatic carcinoma treated by hepatic arterial embolization using 131I and chemotherapeutic agent gelatin microspheres: report of 9 cases]. ( Chen, X; Li, L; Li, X; Tan, T; Wu, Y; Xie, X; Yan, C; Zhong, D, 1992) |
| " The portal concentration of MMC increased rapidly to the maximum concentration of 826 +/- 364 ng/ml at 5 minutes after administration, when the dosage was 20 mg (four cases)." | 1.28 | [Portal blood levels of mitomycin C after intraperitoneal administration]. ( Kakizaki, K; Yamada, Y; Yamauchi, H, 1992) |
| "Ten patients with unresectable primary liver cancer, eight of whom had elevated serum alpha-fetoprotein levels, were treated with intrahepatic fluorodeoxyuridine (FUDR) and mitomycin C administered through an implantable pump." | 1.28 | Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump. ( Atiq, OT; Botet, J; Kemeny, N; Niedzwiecki, D, 1992) |
| "Often operations for gastric cancer accompanied with multiple liver metastasis meet with little success, and almost no case of prolonged survival has been reported." | 1.28 | [A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy]. ( Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K, 1992) |
| "Repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy was performed in 29 patients with unresectable primary or secondary cancer of the liver." | 1.28 | [Evaluation of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy of unresectable primary or secondary cancer of the liver]. ( Hayashi, T; Kimoto, T; Kohno, H; Makino, Y; Nagasue, N; Ohiwa, K; Ono, T; Takemoto, Y; Taniura, H; Uchida, M, 1992) |
| "A 74-year-old man with advanced gastric cancer of Borrmann type III and liver metastasis was treated by combined administration of UFT (400 mg/day, p." | 1.28 | [A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan]. ( Hatayama, H; Kitamura, H; Mashiko, H; Satoh, J, 1992) |
| "We reported a case of metastatic liver cancer from rectal carcinoma, which was successfully treated by systemic continuous 5-Fluorouracil and intermittent Mitomycin C chemotherapy." | 1.28 | [A case report of complete remission of liver metastasis from rectal carcinoma treated with intra-arterial infusion chemotherapy]. ( Noguchi, S; Shibata, N, 1992) |
| "Mitomycin C was injected intermittently in the hepatic artery more than 10 times." | 1.28 | [Intra-arterial infusion chemotherapy using implantable reservoir for liver metastasis of the lung cancer--an effective case]. ( Ishihara, T; Kawamura, M; Kikuchi, K; Kobayashi, T; Mouri, M; Watanabe, M, 1992) |
| "Etoposide was administered orally at 25-50 mg/day to the gastric cancer patient with liver metastasis." | 1.28 | [A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT]. ( Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K, 1992) |
| "21 cases of hepatocellular carcinoma (HCC) were surgically resected about 14 or 21 days after transcatheter hepatic arterial chemo-embolization (TACE) mostly for histopathologic assessment of effectiveness." | 1.28 | [Histopathologic study on resected hepatocellular carcinoma after transcatheter hepatic arterial chemo-embolization]. ( Dai, Y, 1991) |
| "A care system for cancer bearing patients at a highly advanced stage should be informed by a better quality of life based on a life style of the patients and their families." | 1.28 | [Nutritional support for cancer bearing patients]. ( Yamada, S, 1991) |
| "Chemosensitivity of hepatocellular carcinoma tissues from 72 patients to 6 antitumor agents was assayed using the succinate dehydrogenase inhibition test." | 1.28 | Human hepatocellular carcinoma sensitivity to antitumor drugs assayed using the succinate dehydrogenase inhibition test. ( Akazawa, K; Kanematsu, T; Maehara, Y; Matsumata, T; Shirabe, K; Sugimachi, K, 1991) |
| "There are few reports about the methods, amounts, and kinds of dosage about intermittent intra-arterial chemotherapy of liver metastases from primal pathological type's squamous cell carcinoma." | 1.28 | [Study of intermittent intra-arterial infusion chemotherapy in liver metastases from squamous cell carcinoma]. ( Aoki, T; Kasuya, K; Kimura, K; Koyanagi, Y; Ozawa, T; Sato, S; Tsuchida, A; Yasuda, D; Yoshimatsu, A, 1991) |
| " In this study, the pharmacokinetic profile of intrahepatic arterial mitomycin C microcapsules is reported." | 1.28 | Mitomycin C-loaded microcapsules in the treatment of colorectal liver metastases. Pharmacokinetics of regionally administered particulate chemotherapy. ( Blackie, R; Goldberg, JA; Kato, T; Kerr, DJ; McArdle, CS; Pettit, L; Whately, TL, 1991) |
| "Thermochemotherapy was performed on gastric cancer cases of hepato-metastasis." | 1.28 | [Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer]. ( Fujimura, T; Fushida, S; Kamata, T; Matuki, N; Matumoto, H; Sawa, T; Takegawa, S; Tsugawa, K; Urade, M; Yonemura, Y, 1991) |
| "Chemotherapy for colorectal cancer with liver metastases following surgical operation for primary tumor should be selected following surgical intervention." | 1.28 | [Continuous infusion chemotherapy using an infusional port in colorectal cancer with liver metastases]. ( Ishida, Y; Kojima, N; Kusumoto, S; Nakayoshi, A; Oka, H, 1991) |
| "With colorectal cancer, the therapeutic outcome for multiple hepatic metastasis extending to the bilateral lobe, even when various chemotherapies are administered, is extremely poor." | 1.28 | [Intra-arterial infusion chemotherapy using an implantable reservoir in the treatment of hepatic metastases in colorectal cancer]. ( Gotohda, H; Katoh, M; Kinami, Y; Kumaki, T; Saitoh, H; Takashima, S; Takegawa, S; Tomita, F, 1991) |
| "A total of 22 patients (12 cases of gastric cancer, 6 of colon cancer, 2 of pancreas cancer, 1 of gall bladder cancer and 1 of biliary tract carcinoid) were treated according to the following schedule: both 10 mg of ADM (or MMC) and 0." | 1.28 | [Therapeutic effect of transarterial infusion immunochemotherapy for metastatic liver cancer]. ( Azuma, S; Furuta, T; Kawai, M; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Tanemura, H; Umemoto, T, 1991) |
| "Because the subjects studied were gastric cancer cases exceeding H2, the present investigation resulted in the increase of metastatic liver lesions, a problem to be studied in future." | 1.28 | [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis]. ( Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K, 1991) |
| "Seventeen patients with colorectal cancer metastatic to the liver underwent hepatic resection." | 1.28 | Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis. ( Furusawa, M; Kakeji, Y; Maehara, Y; Sugimachi, K; Tomoda, H; Tsujitani, S; Watanabe, A, 1991) |
| "A case of iatrogenic sclerosing cholangitis secondary to hepatic intra-arterial 5-fluorouracil (5FU) and Mitomycin C (MMC) chemotherapy is described." | 1.28 | Serious chemical sclerosing cholangitis associated with hepatic arterial 5FU and MMC chemotherapy. ( Fukuzumi, S; Makuuchi, M; Moriya, Y; Terui, S, 1990) |
| "These two cases showed no recurrent liver cancers." | 1.28 | [Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases]. ( Houjo, K; Kawano, N; Moriya, Y; Sugihara, K, 1990) |
| "In 93 cases of stomach cancer with liver metastasis, the influence of surgery and chemotherapy on the patients' prognosis was examined." | 1.28 | [Multivariate analysis of gastric cancer patients with liver metastases]. ( Fujimura, T; Hasegawa, H; Kamata, T; Katayama, K; Kimura, H; Matsuki, N; Ohyama, S; Sakuma, H; Sawa, T; Yonemura, Y, 1990) |
| "Chemotherapy for liver metastasis of breast cancer has rarely been found effective." | 1.28 | [Clinical efficacy of ifosfamide for liver metastasis of breast cancer]. ( Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y, 1990) |
| "From 1986 to 1988, 35 patients with a hepatoma judged either inoperable or unresectable because of coexistent cirrhosis were treated with hepatic arterial embolization of mitomycin C microcapsules." | 1.28 | Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. ( Audisio, RA; Bellegotti, L; Damascelli, B; DeFazio, C; Doci, R; Marchianò, A; Mazzaferro, V; Montalto, F; Piva, A; Tommasini, M, 1990) |
| "Of the 15 patients who developed brain metastases after prior chemotherapy, 12 had received MAC at least once prior to the diagnosis of brain metastases, and in 5 patients, MAC was the first chemotherapy given after the diagnosis of brain metastases." | 1.28 | Intracerebral choriocarcinoma. ( Jones, WB; Lewis, JL; Wagner-Reiss, KM, 1990) |
| "In 36 patients with hepatocellular carcinoma treated with transcatheter arterial infusion and embolization, the arithmetic mean survival time after treatment was 412." | 1.28 | [Evaluation of quality of life in arterial infusion chemotherapy of hepatocellular carcinoma]. ( Akai, S; Kato, K; Kato, T; Nashimoto, A; Niwa, M; Ogoshi, K; Saito, Y; Shimizu, K, 1990) |
| "Some 222 of H." | 1.28 | [Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer]. ( Akaza, K; Harada, A; Isshiki, K; Katoh, H; Kishimoto, W; Nakao, A; Nonami, T; Takagi, H, 1990) |
| " Thus, both intraarterial and intraportal chemotherapy combined with decollateralization by silicone rubber sheeting seems to be effective for advanced cholangiocarcinoma and metastatic carcinoma." | 1.28 | [Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer]. ( Fukuda, I; Furukawa, H; Imaoka, S; Ishikawa, O; Masutani, S; Nagano, H; Ohashi, I; Oohigashi, H; Sasaki, Y; Yasuda, T, 1990) |
| "Reported is the case of a hepatocellular carcinoma with a complete remission of the bone metastasis by arterial chemotherapy." | 1.28 | [Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy]. ( Aoki, Y; Fujimoto, T; Fukushima, H; Hirai, K; Iwai, I; Majima, Y; Nakashima, O; Shimada, M; Tanaka, M; Yamashita, K, 1990) |
| "A new immunotherapy for hepatocellular carcinoma (HCC) using Freund's adjuvant and recombinant interleukin-2 (IL-2) combined with conventional transarterial chemoembolization therapy was performed." | 1.28 | Immunotherapy using Freund's adjuvant and recombinant interleukin-2 combined with transarterial chemoembolization for hepatocellular carcinoma. ( Higashi, T; Ikeda, N; Ito, T; Nouso, K; Ohsawa, T; Okamoto, T; Sue, K; Tsuji, T; Ukida, M; Watanabe, A, 1989) |
| "Six cases of unresectable hepatic cancer in infant were treated with intra-arterial infusion therapy." | 1.28 | [Clinical study of intrahepatic arterial infusion of unresectable hepatoblastoma and hepatocarcinoma in children]. ( Abe, T; Hamada, H; Hata, Y; Saito, H; Sasaki, F; Sato, N; Sawada, H; Tamura, M; Uchino, J; Une, Y, 1989) |
| "Excisions of metastatic liver cancer were performed in 36 patients and 23 had nonresectable metastatic liver cancer." | 1.28 | [Results of intra-arterial infusion chemotherapy of colorectal cancer in patients with metastatic liver cancer]. ( Hojo, K; Moriya, Y; Sawada, T, 1989) |
| "Fifty-five gastric cancer patients with liver metastasis received arterial infusion chemotherapy." | 1.28 | [Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment]. ( Arai, K; Kitamura, M; Kosaki, G; Miyashita, K, 1989) |
| "Seven cases of liver cancer with replaced right hepatic artery were treated with arterial infusion therapy using implanted reservoir." | 1.28 | [Reservoir implanted arterial infusion therapy in liver cancer with replaced right hepatic artery]. ( Gondo, H; Ishimura, M; Kamiyama, T; Matsuoka, S; Misawa, K; Nagabuchi, E; Nakajima, Y; Ogasawara, K; Tamura, M; Une, Y, 1989) |
| "Excisions of metastatic liver cancer were performed in 36 patients and 23 had nonresectable metastatic liver cancer." | 1.28 | [Complications of intra-arterial infusion chemotherapy in patients with colorectal cancer with liver metastasis, with special reference to IA-5-FU induced sclerosing cholangitis]. ( Hojo, K; Moriya, Y; Sawada, T, 1989) |
| " The dosage was 250 mg/day for 5-FU continuously, 10 mg/week for MMC and 5 KE/week for OK-432, respectively." | 1.28 | [Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer]. ( Hamada, H; Mori, N; Nakajima, I; Nakamura, T; Nakamura, Y; Tanaka, A; Wada, T; Yasutomi, M, 1989) |
| "Hepatocellular carcinoma is the most common cause of cancer death in Thai males." | 1.28 | High-dose mitomycin C: activity in hepatocellular carcinoma. ( Auethaveekiat, V; Cheirsilpa, A; Kangsumrit, N; Leelasethakul, S; Maoleekulpriroj, S; Phanthumjida, P; Thanakaravit, P, 1989) |
| "In the case of gall bladder cancer cell line (NOZ), combination of adriamycin and hyperthermia showed more effective inhibition for cell proliferation than MMC + hyperthermia and 5-FU + hyperthermia." | 1.28 | [Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro]. ( Fujise, K; Hasumura, S; Homma, S; Kameda, H; Matsuura, T; Nagamori, S; Niiya, M; Shimizu, K; Sujino, H, 1989) |
| "Three cases of ruptured hepatocellular carcinomas were treated: one case by emergency hepatectomy, and two cases by hepatectomy following TAE." | 1.28 | [Influence of hepatic ischemia on liver regeneration following hepatectomy, with special reference to the therapeutic choice for ruptured hepatoma]. ( Itoh, H; Kaiho, T; Kanno, Y; Kimura, F; Koshikawa, H; Matsumoto, J; Miyazaki, M; Nakajima, T; Teramoto, O; Udagawa, I, 1989) |
| "Lipiodol-ADM was injected for hepatocellular carcinoma every 2 months and MMC-5-FU was injected for liver metastasis of colorectal carcinoma every one or two weeks." | 1.28 | [Usefulness of subcutaneously implanted reservoir for postoperative therapy in hepatocellular carcinoma and liver metastases of colorectal carcinoma]. ( Adachi, W; Hanasaki, K; Horigome, N; Iida, F; Kajikawa, S; Kinosita, T; Kuroda, T; Sodeyama, H, 1989) |
| "In 24 cases of unresectable hepatocellular carcinoma, we performed hepatic arterial catheterization and intra-arterial infusion chemotherapy." | 1.28 | [Hepatic arterial infusion chemotherapy of hepatocellular carcinoma]. ( Amioka, K; Hara, H; Iga, C; Ishibashi, T; Isozaki, H; Morita, S; Nakata, E; Nishimura, J; Okajima, K; Tanimura, M, 1989) |
| "Of the 8 patients having hepatoma with increased AFP, all the patients showed a decrease of AFP following the therapy with an average ratio of 65% decrease." | 1.28 | [Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies]. ( Haida, K; Miura, T, 1989) |
| "Hepatocellular carcinoma was diagnosed by various imaging techniques and the patient was treated by 3 transarterial embolizations and 2 courses of systemic chemotherapy with CDDP." | 1.28 | [A resected case of hepatocellular carcinoma effectively treated by hepatic artery embolization and systemic chemotherapy]. ( Araki, I; Kobayashi, T; Noda, M; Sekikawa, H; Shinagawa, T; Yoshida, M, 1989) |
| "Overall median survival was 352 days in colon cancer and 449 days in gastric cancer." | 1.28 | [A 5-FU, ADR, MMC combined hepatic arterial infusion therapy in non-resectable liver metastases from colon and gastric cancer]. ( Arai, Y; Endo, T; Kido, C; Miyake, Y; Sakamoto, K, 1989) |
| "Twelve of the patients had primary hepatocellular carcinoma and six had metastatic liver carcinoma originating from an unknown primary site." | 1.27 | Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver. ( Benjamin, RS; Chuang, VP; Fuqua, R; Mavligit, GM; Patt, YZ; Wallace, S, 1983) |
| "Eleven unresectable hepatoma patients and three metastatic tumor patients with colonic cancer underwent ligation and/or catheterization of the hepatic artery of the main tumor-bearing zone." | 1.27 | Ligation and catheterization of the hepatic artery for palliative treatment of malignant hepatic tumors. ( Ashizawa, T; Kido, C; Morimoto, T; Ochiai, E; Takagi, H; Yamada, E; Yasue, M, 1983) |
| "Sixty-seven patients with advanced hepatoma were treated with intra-arterial MMC-mc during the period from 1978 to 1982." | 1.27 | [Chemo-embolization with mitomycin C microcapsules for hepatoma]. ( Kato, T; Tamakawa, Y; Unno, K, 1984) |
| "Of 20 patients with inoperable hepatocellular carcinoma (HCC) treated with one or more courses via a hepatic arterial catheter, a change in tumor size could be measured in 16." | 1.27 | Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules. ( Goto, N; Hiyama, Y; Iwama, S; Kono, K; Nakajima, Y; Nakayama, T; Ohnishi, K; Ohtsuki, T; Takashi, M; Tsuchiya, S, 1984) |
| " At this time the ITC therapy is used in combination with induced-hypertension-chemotherapy (IHC therapy)." | 1.27 | [The clinical effect of hyperthermia combined with induced hypertension chemotherapy]. ( Hayashida, S; Kobayashi, T; Sugimoto, K, 1984) |
| "Retreatment of patients with colon cancer and liver metastases by hepatic arterial infusion of fluorodeoxyuridine and mitomycin C can result in significant prolongation of survival in patients with response to this treatment." | 1.27 | Effective retreatment of patients with colorectal cancer and liver metastases. ( Chuang, VP; Mavligit, G; Patt, YZ; Peters, RE; Wallace, S, 1983) |
| "In patients with metastatic colorectal cancer involving only the liver, hepatic arterial FUDR alone and with the addition of mitomycin C provided excellent control of hepatic tumor." | 1.27 | Regional chemotherapy of colorectal cancer metastatic to the liver. ( Cozzi, E; Ensminger, W; Gyves, J; Niederhuber, JE; Thrall, J; Walker, S, 1984) |
| "Especially in liver metastasis of the breast cancer, MMC-m." | 1.27 | [Comparison between continuous arterial infusion chemotherapy and mitomycin C microcapsule administration in primary and metastatic liver cancer]. ( Itoh, J; Katoh, T; Nakagawa, H; Sasaki, H; Takahashi, T, 1983) |
| "Twenty liver cancer patients, including 9 hepatocellular carcinoma and 11 with metastatic liver cancer, were treated by intra-arteral one-shot chemotherapy." | 1.27 | [Alteration of blood coagulation and fibrinolysis after intra-arterial one-shot chemotherapy in liver cancer]. ( Fujii, H; Katake, K; Miyoshi, M; Nishimura, S; Nishitani, T; Seki, S; Suyama, Y; Tada, M; Tanaka, Y, 1983) |
| "We studied 161 gastric cancer patients with P0, H(+) and 51 colorectal cancer patients with P0, H(+) from among cancer patients of the digestive organs and obtained the following conclusions." | 1.27 | [Basic and clinical studies on metastatic cancer--with special reference of multidisciplinary treatment of gastric and colorectal cancer patients with hepatic metastasis]. ( Hanaoka, A; Isono, K; Kimura, M; Koide, Y; Okuyama, K; Onoda, S; Ryu, M; Satoh, H; Tohnosu, N; Yamamoto, Y, 1983) |
| "To study the effectiveness of CDDP for hepatic cancer, intra-hepato-arterial administration of CDDP (0." | 1.27 | [Intra-hepato-arterial administration of cis-diammine-dichloroplatinum II (CDDP) for primary or metastatic hepatic cancer]. ( Hirooka, Y; Kanayama, H; Koga, S; Maeta, M; Murakami, A; Oda, M; Osaki, Y, 1984) |
| "We report 19 patients with metastatic colon cancer whose bulk disease was limited to the liver, but was not amenable to surgical resection." | 1.27 | Hepatic artery ligation and portal vein infusion for liver metastases from colon cancer. ( Courter, S; Guy, JF; Guy, JT; Laufman, LR; Nims, TA, 1984) |
| "The PR cases were 4 of stomach cancer and 2 of lung cancer, the former being all undifferentiated adenocarcinoma." | 1.27 | [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers]. ( Harashima, S; Kanko, T; Nakao, I; Nishi, I; Ohashi, Y; Saito, T; Yokoyama, T, 1984) |
| "Eighty-four patients with advanced gastric cancer treated in four centres in Scotland between June 1980 and December 1982 were reviewed following treatment with 5-fluorouracil, adriamycin and mitomycin-C (FAM)." | 1.27 | Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C. ( Allan, SG; Calman, KC; Carter, DC; Cunningham, D; Hutcheon, AW; Kaye, SB; McArdle, CS; Sangster, G; Smyth, JF; Soukop, M, 1984) |
| "Fourty eight patients with cancer of head of pancreas have been treated by the intra-arterial infusion of 5-FU and Mitomycin C alone or in combination with regional hyperthermia, employing microwave machine operating at a frequency of 2450 MHz." | 1.27 | [Hyperthermia: microwave hyperthermia in combination with intra-arterial infusion chemotherapy of cancer of the pancreas]. ( Endo, Y; Funatomi, H; Hatta, Y; Hirose, N; Miura, T; Sassa, T; Taguchi, S; Yoshikawa, N, 1985) |
| "Thirty-two patients with inoperable hepatic cancer underwent intra-arterial hepatic infusion using mitomycin C (MMC) and 5-fluorouracil (5-FU) or intra-arterial hepatic chemoembolization using heated albumin microspheres containing MMC with an average diameter 45 +/- 8 micron." | 1.27 | Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. ( Endoh, F; Fujimoto, S; Miyazaki, M; Morimoto, Y; Okui, K; Takahashi, O, 1985) |
| "A 64-year-old male with advanced gastric cancer with multiple liver metastasis was treated with intensive chemotherapy including mitomycin C and tegafur after palliative gastrectomy." | 1.27 | [A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy]. ( Akita, N; Furukawa, H; Iwanaga, T; Koyama, H; Wada, A; Wada, T; Yasutomi, M, 1988) |
| "One patient with hepatocellular carcinoma shunted only 24% of the macroaggregated albumin, and flow through the liver was reduced to 48% by DSM therapy." | 1.27 | Initial clinical experience with degradable starch microspheres. ( Giles, GR; Mavor, AI; O'Brien, T; Parkin, A; Riley, A; Robinson, PJ; Smye, S, 1987) |
| "Of the 8 patients with hepatoma with increased AFP, all the patients showed a decrease of AFP following therapy with an average decrease ratio of 64%." | 1.27 | [Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies]. ( Haida, K; Miura, T, 1988) |
| "Adriamycin + DSM was administered for hepatocellular carcinoma, and Mitomycin C + DSM was used for metastatic liver cancer." | 1.27 | [Multidisciplinary treatment of unresectable liver cancer]. ( Hattori, T; Kodama, H; Kuninobu, H; Niimoto, M; Nishiyama, M; Saeki, T; Toge, T; Yoshinaka, K, 1988) |
| "In the patients with metastatic liver cancer, tumor regression over 50% was observed in 65% of the patients treated with chemoembolization alone and in 33% of those with chemoembolization and HT." | 1.27 | [Chemoembolization and regional hyperthermia with degradable starch microspheres in the treatment of malignant hepatic tumors]. ( Itani, K; Kondo, M; Oyamada, H; Seto, O; Sugino, S; Tainaka, K; Yoshikawa, T, 1988) |
| " No significant side effect was noted in any case." | 1.27 | [Chemoembolization therapy of hepatocellular carcinoma-antitumor effect and side effect]. ( Ikami, I; Kanehira, J; Midorikawa, H; Saito, Y; Sasaki, T; Takekawa, SD; Tarusawa, K; Yodono, H, 1988) |
| "Twenty patients with colon cancer metastatic to the liver underwent successful hepatic resection and adjuvant perioperative therapy that included hepatic arterial mitomycin C and floxuridine (FUDR)." | 1.27 | Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. ( Ames, FC; Boddie, AW; Charnsangavej, C; Claghorn, LJ; Cleary, KR; Mavligit, GM; McBride, CM; Patt, YZ, 1987) |
| "Forty-one patients with colorectal cancer, including ten patients with postoperative metastasis, were given A7-NCS." | 1.27 | Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma. ( Hashimoto, Y; Honda, M; Kitamura, K; Kotanagi, H; Suzuyama, H; Takahashi, M; Takahashi, T; Yamaguchi, T; Yokota, T, 1988) |
| "Namely, most solid tumors possess four different unique features: hypervasculature, enhanced permeability even to macromolecules, architectural differences, and lack of the lymphatic recovery system." | 1.27 | [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome]. ( Konno, T; Maeda, H, 1985) |
| "A multidisciplinary treatment for hepatocellular carcinoma including preoperative chemo-embolization with resection treatment was introduced." | 1.27 | [Preoperative chemo-embolization for treatment of hepatocellular carcinoma]. ( Kuroda, C; Monden, M; Mori, T; Okamura, J; Sakon, M; Sakurai, M; Wakasa, K; Yoshioka, H, 1985) |
| "Twenty-two patients with hepatocellular carcinoma were treated with transcatheter arterial embolization therapy." | 1.27 | [Retrospective study of short survival cases in hepatocellular carcinoma after transcatheter arterial embolization therapy]. ( Fujii, H; Iwai, M; Miyoshi, M; Suyama, Y, 1985) |
| "A total of 850 patients with hepatocellular carcinoma seen during the last 8 years were analyzed retrospectively for survival in relation to treatment and disease stage." | 1.27 | Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. ( Hasegawa, H; Nakajima, Y; Obata, H; Ohnishi, K; Ohtsuki, T; Okazaki, N; Okuda, K; Tomimatsu, M, 1985) |
| "407 cases of unresectable hepatocellular carcinoma (HCC) occurring from 1970 to March 1985, including 107 cases receiving conservative therapy, 176 cases receiving one-shot therapy and 124 cases receiving transcatheter arterial embolization (TAE) therapy, were studied and the efficacy of chemotherapy was compared with that of TAE therapy." | 1.27 | [One-shot therapy and transcatheter arterial embolization (TAE) therapy of unresectable hepatocellular carcinoma]. ( Abe, M; Hirai, K; Kawazoe, Y; Kumagai, M; Tanikawa, K; Yamashita, K, 1985) |
| "The patient also had autoimmune hemolytic anemia." | 1.27 | [Chemotherapy of balloon-occluded arterial infusion in a patient with unresectable hepatocellular carcinoma and autoimmune hemolytic anemia]. ( Fujio, N; Hirohashi, K; Iwasa, R; Kinoshita, H; Kubo, S; Nakatsuka, H; Sakai, K; Takashima, S, 1986) |
| "In metastatic liver cancer, tumor regression of over 50% was observed in 4 of 8 cases." | 1.27 | [Chemoembolization with degradable starch microspheres in malignant hepatic tumors]. ( Hotta, T; Itani, K; Kondo, M; Naito, Y; Seto, O; Sugino, S; Tainaka, K; Yoshikawa, T, 1987) |
| " the same therapy in combination with UFT as a maintenance therapy (group B; 8 patients)." | 1.27 | [Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma]. ( Matsuo, SK; Ohmura, K; Ohtsuka, Y; Suzuki, M, 1987) |
| "The MMC MS treatment for metastatic hepatic cancer had superiority to the conventional infusion treatment at p = 0." | 1.27 | [Intra-arterial chemoembolization with albumin microspheres including mitomycin C in inoperable hepatic cancer]. ( Endoh, F, 1987) |
| "The mitomycin C and BCNU were alternated monthly at the start of each FUDR cycle." | 1.27 | Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy. ( Cohen, AM; Higgins, J; Schaeffer, N, 1986) |
| "The effectiveness of arterial embolization using DSM (Degradable Starch Microspheres, Spherex, Sweden) combined with hyperthermia were investigated in the treatment of VX2 carcinoma in rabbits and also in human hepatic tumors." | 1.27 | [Enhancement of anti-tumor effects by arterial embolization combined with hyperthermia in the treatment of hepatic tumors]. ( Kawa, S; Murata, T; Sawada, S; Tanaka, Y; Yoshida, M, 1987) |
| " An apparent chemical hepatic arteritis developed in five patients after multiple courses, however, its relationship to prior hepatic arterial infusion therapies, Mitomycin, starch microspheres, and repeated dosing of the drug-microsphere mixture remains unclear." | 1.27 | Phase II study of hepatic arterial degradable starch microspheres and mitomycin. ( Ensminger, WD; Smith, JE; Walker-Andrews, SC; Wollner, IS, 1986) |
| "When mitomycin C (MMC) was administered into the superior mesenteric vein 15 min after the inoculation of tumor cells, the number of metastatic foci in the liver was strongly inhibited; 81." | 1.27 | Liver metastasis of colon 26 cells implanted into the superior mesenteric vein in mice. ( Kitamura, M; Kosaki, G; Tominaga, T; Yoshida, Y, 1987) |
| "Mitomycin C (15 mg/m2) was injected intra-arterially mixed with 900 mg of DSM every six weeks." | 1.27 | Intra-arterial mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres. ( Håkansson, L; Morales, O; Starkhammar, H; Svedberg, J, 1987) |
| "Excisions of metastatic liver cancer were performed in 23 pts and 15 pts had nonresectable metastatic liver cancer." | 1.27 | [Results of intra-arterial infusion chemotherapy in colorectal cancer patients with metastatic liver cancer]. ( Hojo, K; Moriya, Y; Sawada, T, 1988) |
| " Intra-arterial chemotherapy combined with MMC and DSM was performed on eight cases of unresectable metastatic liver carcinoma." | 1.27 | [Intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in unresectable metastatic liver carcinoma]. ( Arai, K; Awane, Y; Kitamura, M; Mori, T; Takahashi, T; Yoshikawa, T, 1988) |
| "Intra-arterial chemotherapy combined with mitomycin C (MMC) and degradable starch microspheres (DSM) was prescribed repeatedly for 14 patients with inoperable hepatic metastasis." | 1.27 | [Repeated intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in inoperable metastatic hepatic cancer]. ( Endoh, F; Fujimoto, S; Guhji, M; Kiuchi, S; Kobayashi, K; Koike, S; Kokubun, M; Okui, K; Ooi, T; Shrestha, RD, 1988) |
| " The degree of blockade of arterial blood flow was correlated with the dosage of DSM, and estimated by the angiographic change." | 1.27 | [Experimental and clinical studies on degradable starch microspheres (DSM) in the treatment of hepatic neoplasms]. ( Kaminou, T; Manabe, T; Matsuo, R; Murata, K; Nakamura, K; Nakatsuka, H; Takashima, S; Tsubakimoto, M; Usuki, N; Yamada, T, 1988) |
| " Since the usefulness of DSM combined with anticancer agents had been indicated by the experimental results mentioned above, we carried out a clinical study (phage II)." | 1.27 | [Fundamental and clinical studies of intra-arterial chemotherapy combined with degradable starch microspheres (DSM)]. ( Hattori, T; Jinushi, K; Kodama, H; Niimoto, M; Saeki, T; Toge, T; Yoshinaka, K, 1988) |
| "Three patients with primary liver cancer were treated with DSM (600-1200 mg) and ADR (20-60 mg), and five with metastatic liver cancer were treated with DSM and MMC (10-20 mg)." | 1.27 | [Hepatic arterial infusion of degradable starch microspheres (DSM) with adriamycin or mitomycin C in liver cancer]. ( Fujita, M; Nakamura, H; Ota, J; Taguchi, T, 1988) |
| "A 75-year-old man with gastric cancer metastatic to the liver was treated by combined administration of Tegafur (800 mg/body/day), 5-fluorouracil (300 mg/body/day) and Mitomycin C (hepatic arterial infusion of 20 mg/body and intravenous infusion of 8 mg/body)." | 1.27 | [Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C]. ( Ito, T; Nehashi, Y; Sasaki, J; Sasaki, Y, 1988) |
| "Chemical cholecystitis has been recognized recently as a complication of hepatic artery infusion chemotherapy." | 1.27 | Hepatobiliary scintigraphy in patients receiving hepatic artery infusion chemotherapy. ( Dakhil, SR; Housholder, DF; Hynes, HE; Marymont, JV, 1985) |
| "Five patients with colorectal cancer and unresectable synchronous liver metastases have survived for over five years at this writing." | 1.27 | Long-term survivors of colorectal cancer with unresectable hepatic metastases. ( Fujimoto, S; Higuchi, M; Kitsukawa, Y; Miyazaki, M; Okui, K, 1985) |
| "A 61-year-old man with double colon cancers and a solitary hepatic metastasis underwent right hemicolectomy and catheterization of the proper hepatic artery in April 1979." | 1.27 | [A long survival case of carcinoma of the colon with hepatic metastasis following intra-arterial infusion chemotherapy]. ( Itoh, J; Koyama, K; Masuda, T; Narisawa, T, 1985) |
| "Two patients who had advanced gastric cancer and metastatic liver tumors were treated with a combined chemotherapy using UFT and mitomycin C." | 1.27 | [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases]. ( Hanawa, S; Hara, S; Joya, K; Nakata, K; Sato, K; Shigemitsu, M, 1985) |
| "The median survival periods for stomach cancer (Stage 4) after non-radical surgery by means of intraarterial chemotherapy with and without noradrenaline were, respectively, 12 months (n = 8) and 5." | 1.27 | [Intra-arterial infusion chemotherapy combine with noradrenalin administration (an improved antitumor effect using a cancerous blood vessel]. ( Katsumi, S; Kawaguchi, T; Murai, T; Sato, T, 1985) |
| "Multimodality therapy for colorectal cancer is composed of surgery, chemotherapy and irradiation; and hyperthermia joins them recently." | 1.27 | [Multimodality therapy of colorectal cancer]. ( Fujimoto, S; Miyazaki, M; Okui, K, 1985) |
| "The effects of reduction surgery combined with chemotherapy used by MMC and ADM for DAB induced hepatoma were investigated." | 1.27 | [Experimental and clinical study of reduction surgery combined with chemotherapy of primary liver cancer]. ( Nakanishi, Y; Sano, H, 1985) |
| "In 161 cases of gastric cancer with liver metastasis but without peritoneal dissemination, evaluations were executed to find effective treatment." | 1.27 | Evaluation of treatment for gastric cancer with liver metastasis. ( Isono, K; Juan, IK; Koide, Y; Ochiai, T; Okuyama, K; Onoda, S; Satoh, H; Yamamoto, Y, 1985) |
| "Forty patients with hepatoma and metastatic tumors of liver were treated with rapid arterial infusion administered simultaneously using 30-40 mg of adriamycin and 10-20 mg of mitomycin C into the hepatic artery by Seldinger catheter." | 1.26 | [Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumors of the liver]. ( Aiba, K; Domyo, M; Ezaki, K; Horikoshi, N; Inagaki, J; Inoue, K; Miyamoto, H; Nagata, T; Ogawa, M, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 256 (28.60) | 18.7374 |
| 1990's | 331 (36.98) | 18.2507 |
| 2000's | 196 (21.90) | 29.6817 |
| 2010's | 107 (11.96) | 24.3611 |
| 2020's | 5 (0.56) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, X | 1 |
| Zhang, Q | 1 |
| Tian, L | 1 |
| Guo, Z | 1 |
| Liu, C | 3 |
| Chen, J | 1 |
| Ebrahim, W | 1 |
| Liu, Z | 1 |
| Proksch, P | 1 |
| Zou, K | 1 |
| Hund, HC | 2 |
| Frantz, SK | 2 |
| Wu, H | 2 |
| Adeniran, OR | 2 |
| Wong, TY | 2 |
| Borgmann, AJ | 2 |
| Matsuoka, L | 2 |
| Geevarghese, S | 3 |
| Alexopoulos, S | 2 |
| Shingina, A | 2 |
| Meranze, SG | 2 |
| Baker, JC | 3 |
| Garbett, S | 2 |
| Brown, DB | 7 |
| Aarts, BM | 2 |
| Klompenhouwer, EG | 2 |
| Dresen, RC | 2 |
| Deroose, CMALO | 1 |
| Beets-Tan, RGH | 2 |
| Punie, K | 2 |
| Neven, P | 3 |
| Wildiers, H | 3 |
| Maleux, G | 3 |
| Hori, A | 4 |
| Ohira, R | 1 |
| Nakamura, T | 7 |
| Kimura, Y | 3 |
| Ueda, S | 2 |
| Torii, M | 1 |
| Kennoki, N | 1 |
| Hori, S | 3 |
| Mei, N | 1 |
| Zhao, N | 1 |
| Tian, T | 1 |
| Jiao, M | 1 |
| Li, C | 3 |
| Tewes, M | 1 |
| Peis, MW | 1 |
| Bogner, S | 1 |
| Theysohn, JM | 1 |
| Reinboldt, MP | 1 |
| Schuler, M | 1 |
| Welt, A | 1 |
| Evesque, L | 2 |
| Benezery, K | 1 |
| Follana, P | 2 |
| Tuan Falk, A | 1 |
| Doyen, J | 1 |
| Reure, J | 1 |
| Cavaglione, G | 1 |
| François, E | 2 |
| Pernot, S | 1 |
| Velut, G | 1 |
| Kourie, RH | 1 |
| Amouyal, G | 1 |
| Sapoval, M | 1 |
| Pointet, AL | 1 |
| Landi, B | 1 |
| Zaimi, Y | 1 |
| Lepère, C | 1 |
| Pellerin, O | 1 |
| Taieb, J | 1 |
| Gruber-Rouh, T | 7 |
| Schmitt, C | 1 |
| Naguib, NNN | 1 |
| Nour-Eldin, NA | 1 |
| Eichler, K | 10 |
| Beeres, M | 2 |
| Vogl, TJ | 17 |
| Fritsche, MR | 1 |
| Watchmaker, JM | 1 |
| Lipnik, AJ | 1 |
| Banovac, F | 1 |
| Omary, RA | 4 |
| Lahrsow, M | 1 |
| Albrecht, MH | 1 |
| Hammerstingl, R | 6 |
| Thompson, ZM | 1 |
| Kissane, J | 1 |
| Waybill, P | 1 |
| Zhen, N | 1 |
| Jin, L | 1 |
| Ma, J | 1 |
| Zhu, J | 1 |
| Gu, S | 1 |
| Wang, J | 5 |
| Pan, Q | 1 |
| Ni, X | 1 |
| Xu, M | 1 |
| Kamal, A | 1 |
| Naguib, NN | 7 |
| Langenbach, M | 1 |
| Moiseenko, AV | 1 |
| Polikarpov, AA | 1 |
| Tarazov, PG | 1 |
| Korovina, YV | 1 |
| Rozengauz, EV | 1 |
| Shelkoplyas, EN | 1 |
| Granov, DA | 1 |
| Miyata, T | 1 |
| Beppu, T | 3 |
| Imamura, YU | 1 |
| Hayashi, H | 2 |
| Imai, K | 2 |
| Chikamoto, A | 2 |
| Yamashita, YI | 1 |
| Fukubayashi, K | 1 |
| Ishiko, T | 1 |
| Baba, H | 5 |
| Laenen, A | 1 |
| He, M | 1 |
| Li, Q | 5 |
| Shen, J | 3 |
| Tan, G | 1 |
| Lai, J | 1 |
| Wei, W | 1 |
| Zhang, Y | 2 |
| Zou, R | 2 |
| Chen, M | 1 |
| Guo, R | 1 |
| Shi, M | 3 |
| Nitta, H | 1 |
| Yu, SJ | 1 |
| Lee, JH | 2 |
| Jang, ES | 1 |
| Cho, EJ | 1 |
| Kwak, MS | 1 |
| Yoon, JH | 2 |
| Lee, HS | 2 |
| Kim, CY | 1 |
| Kim, YJ | 2 |
| Farshid, P | 2 |
| Darvishi, A | 1 |
| Naguib, N | 1 |
| Bazrafshan, B | 1 |
| Paul, J | 1 |
| Mbalisike, E | 1 |
| Zhang, XB | 1 |
| Zhuang, ZG | 1 |
| Ye, H | 1 |
| Beilner, J | 1 |
| Kowarschik, M | 1 |
| Chen, JJ | 1 |
| Chi, JC | 1 |
| Xu, JR | 1 |
| Yip, D | 1 |
| Cho, CH | 1 |
| Liu, FY | 2 |
| Wang, MQ | 2 |
| Duan, F | 1 |
| Fan, QS | 1 |
| Song, P | 1 |
| Wang, Y | 3 |
| Idilman, I | 1 |
| Peynircioğlu, B | 1 |
| Cil, BE | 1 |
| Doğanay Erdoğan, B | 1 |
| Yalçın, S | 1 |
| Bayraktar, Y | 1 |
| Kav, T | 1 |
| Altundağ, K | 1 |
| Balkancı, F | 1 |
| Agito, MD | 1 |
| Gacad, R | 1 |
| Lupinacci, RM | 1 |
| Simon, JM | 1 |
| Spano, JP | 1 |
| Menegaux, F | 1 |
| Yeh, CT | 2 |
| Liang, KH | 1 |
| Lin, CC | 1 |
| Chang, ML | 2 |
| Hsu, CL | 1 |
| Hung, CF | 1 |
| Nasyrov, AR | 1 |
| Pirtskhalava, TL | 1 |
| Korovina, IaV | 1 |
| Fukumoto, T | 4 |
| Tominaga, M | 3 |
| Kido, M | 3 |
| Takebe, A | 2 |
| Tanaka, M | 8 |
| Kuramitsu, K | 2 |
| Matsumoto, I | 3 |
| Ajiki, T | 2 |
| Ku, Y | 5 |
| Nishikawa, H | 3 |
| Osaki, Y | 4 |
| Kita, R | 3 |
| Kimura, T | 3 |
| Ohara, Y | 1 |
| Takeda, H | 2 |
| Sakamoto, A | 2 |
| Saito, S | 2 |
| Nishijima, N | 1 |
| Nasu, A | 2 |
| Komekado, H | 1 |
| Nishiguchi, S | 1 |
| Xiang, J | 1 |
| Xiang, Y | 1 |
| Lin, S | 1 |
| Xin, D | 1 |
| Liu, X | 1 |
| Weng, L | 1 |
| Chen, T | 1 |
| Zhang, M | 1 |
| Zhuo, LJ | 1 |
| Chen, H | 3 |
| Wu, MX | 1 |
| Gao, MQ | 1 |
| Chen, SP | 1 |
| Huang, AM | 1 |
| Oashi, K | 1 |
| Tsutsumida, A | 1 |
| Namikawa, K | 1 |
| Tanaka, R | 2 |
| Omata, W | 1 |
| Yamamoto, Y | 4 |
| Yamazaki, N | 1 |
| Kinoshita, H | 3 |
| Komatsu, S | 1 |
| Fukushima, K | 1 |
| Urade, T | 1 |
| So, S | 1 |
| Shinzeki, M | 1 |
| Terashima, K | 1 |
| Fujii, O | 1 |
| Demizu, Y | 1 |
| Fuwa, N | 1 |
| Jiang, L | 1 |
| Lei, JY | 1 |
| Wang, WT | 1 |
| Yan, LN | 1 |
| Li, B | 3 |
| Wen, TF | 1 |
| Xu, MQ | 1 |
| Yang, JY | 1 |
| Wei, YG | 1 |
| Vitale, FV | 1 |
| Romeo, P | 1 |
| Luciani, B | 1 |
| Raffaele, M | 1 |
| Colina, P | 1 |
| Ferraù, F | 1 |
| Kim, K | 2 |
| Chie, EK | 1 |
| Jang, JY | 1 |
| Kim, SW | 1 |
| Han, SW | 1 |
| Oh, DY | 1 |
| Im, SA | 1 |
| Kim, TY | 1 |
| Bang, YJ | 1 |
| Ha, SW | 1 |
| Tsai, WL | 1 |
| Lai, KH | 4 |
| Liang, HL | 3 |
| Hsu, PI | 2 |
| Chan, HH | 1 |
| Chen, WC | 1 |
| Yu, HC | 2 |
| Tsay, FW | 1 |
| Wang, HM | 1 |
| Tsai, HC | 1 |
| Cheng, JS | 2 |
| Li, Z | 3 |
| Cai, Z | 1 |
| Dai, S | 1 |
| Deng, H | 1 |
| Ji, F | 1 |
| Xi, Q | 1 |
| Gao, N | 1 |
| Zhang, X | 3 |
| Zhang, B | 4 |
| Ye, W | 1 |
| Wu, J | 1 |
| Lin, CL | 1 |
| Chien, RN | 1 |
| Yeh, C | 1 |
| Hsu, CW | 1 |
| Chen, YC | 2 |
| Huang, J | 1 |
| Zheng, Y | 2 |
| Yuan, Y | 1 |
| Patkowski, W | 1 |
| Stankiewicz, R | 1 |
| Grąt, M | 1 |
| Krasnodębski, M | 1 |
| Kornasiewicz, O | 1 |
| Krawczyk, M | 1 |
| Liu, B | 1 |
| Huang, JW | 1 |
| Li, Y | 2 |
| Hu, BS | 1 |
| He, X | 1 |
| Zhao, W | 1 |
| Zheng, YB | 1 |
| Lu, LG | 2 |
| Zuo, CH | 1 |
| Xia, M | 1 |
| Liu, JS | 1 |
| Qiu, XX | 1 |
| Lei, X | 1 |
| Xu, RC | 1 |
| Liu, HC | 1 |
| Li, JL | 1 |
| Li, YG | 1 |
| Li, QL | 1 |
| Xiao, H | 1 |
| Hong, Y | 1 |
| Wang, XH | 1 |
| Zhu, HZ | 1 |
| Wu, QF | 1 |
| Burns, M | 1 |
| Luo, S | 1 |
| Gu, Y | 1 |
| Guo, P | 1 |
| Mukerabigwi, JF | 1 |
| Liu, M | 1 |
| Lei, S | 1 |
| Cao, Y | 2 |
| He, H | 2 |
| Huang, X | 2 |
| Seki, H | 2 |
| Ohi, H | 1 |
| Ozaki, T | 3 |
| Yabusaki, H | 1 |
| Leon, O | 1 |
| Guren, MG | 1 |
| Radu, C | 1 |
| Gunnlaugsson, A | 1 |
| Johnsson, A | 1 |
| Laroia, ST | 1 |
| Morales, SA | 1 |
| Laroia, AT | 1 |
| Mouli, SK | 1 |
| Hickey, R | 1 |
| Thornburg, B | 1 |
| Sato, KT | 2 |
| Desai, K | 1 |
| Gabr, A | 1 |
| Kallini, JR | 1 |
| Niemeri, H | 1 |
| Kircher, S | 1 |
| Mulcahy, MF | 2 |
| Benson Iii, AB | 1 |
| Gupta, R | 1 |
| Salem, R | 4 |
| Lewandowski, RJ | 4 |
| Tang, C | 1 |
| Feng, W | 1 |
| Bao, Y | 1 |
| Dong, X | 1 |
| Dai, Y | 2 |
| Zhang, J | 2 |
| Oppermann, E | 2 |
| Qian, J | 2 |
| Imlau, U | 1 |
| Tran, A | 1 |
| Hamidavi, Y | 1 |
| Korkusuz, H | 1 |
| Bechstein, WO | 3 |
| Nour-Eldin, NE | 6 |
| Passot, G | 1 |
| Kim, BJ | 1 |
| Vaudoyer, D | 1 |
| Kepenekian, V | 1 |
| Bonnefoy, I | 1 |
| Bakrin, N | 1 |
| Cotte, E | 1 |
| Glehen, O | 1 |
| Makary, MS | 1 |
| Kapke, J | 1 |
| Yildiz, V | 1 |
| Pan, X | 1 |
| Dowell, JD | 1 |
| Navez, J | 1 |
| Remue, C | 1 |
| Leonard, D | 1 |
| Bachmann, R | 1 |
| Kartheuser, A | 1 |
| Hubert, C | 1 |
| Coubeau, L | 1 |
| Komuta, M | 1 |
| Van den Eynde, M | 1 |
| Zech, F | 1 |
| Jabbour, N | 1 |
| Yamakado, K | 1 |
| Inaba, Y | 3 |
| Sato, Y | 7 |
| Yasumoto, T | 1 |
| Hayashi, S | 1 |
| Yamanaka, T | 2 |
| Nobata, K | 1 |
| Takaki, H | 1 |
| Nakatsuka, A | 1 |
| Power, DG | 1 |
| Healey-Bird, BR | 1 |
| Kemeny, NE | 2 |
| Shelgikar, CS | 1 |
| Loehle, J | 1 |
| Scoggins, CR | 1 |
| McMasters, KM | 1 |
| Martin, RC | 1 |
| Laffer, U | 5 |
| Metzger, U | 6 |
| Aeberhard, P | 5 |
| Lorenz, M | 6 |
| Harder, F | 1 |
| Maibach, R | 1 |
| Zuber, M | 1 |
| Herrmann, R | 1 |
| Ishida, K | 1 |
| Hirooka, M | 1 |
| Hiraoka, A | 1 |
| Kumagi, T | 1 |
| Uehara, T | 1 |
| Hiasa, Y | 1 |
| Horiike, N | 1 |
| Onji, M | 1 |
| Shiraishi, R | 1 |
| Yamasaki, T | 2 |
| Saeki, I | 1 |
| Okita, K | 1 |
| Yamaguchi, Y | 2 |
| Uchida, K | 1 |
| Terai, S | 1 |
| Sakaida, I | 1 |
| Gruber, T | 3 |
| Balzer, JO | 4 |
| Zangos, S | 10 |
| Liang, SN | 1 |
| Liu, LL | 1 |
| Su, HY | 1 |
| Feng, B | 1 |
| Zhao, GS | 1 |
| Xu, K | 1 |
| Xiao, YP | 1 |
| Xiao, EH | 1 |
| Luo, JG | 1 |
| Bian, DJ | 1 |
| Li, MQ | 1 |
| He, Z | 1 |
| Shang, QL | 1 |
| Liang, B | 1 |
| Jin, C | 1 |
| Yao, L | 2 |
| Long, J | 1 |
| Fu, DL | 1 |
| Yu, XJ | 1 |
| Xu, J | 1 |
| Yang, F | 1 |
| Ni, QX | 1 |
| Dayani, PN | 1 |
| Gould, JE | 1 |
| Sharma, KV | 1 |
| Linette, GP | 1 |
| Harbour, JW | 1 |
| Varban, O | 1 |
| Levine, EA | 1 |
| Stewart, JH | 1 |
| McCoy, TP | 1 |
| Shen, P | 1 |
| Yuan, Z | 2 |
| Ye, XD | 2 |
| Dong, S | 2 |
| Xu, LC | 2 |
| Sun, ZC | 1 |
| Xiao, XS | 2 |
| Li, SL | 1 |
| Huang, ZN | 1 |
| Hsieh, HH | 1 |
| Yu, WC | 1 |
| Tzeng, WY | 1 |
| Lee, GY | 1 |
| Chen, YP | 1 |
| Chang, CY | 1 |
| Chuu, JJ | 1 |
| Sun, HW | 1 |
| Chen, LH | 1 |
| Wei, CJ | 1 |
| Zheng, XK | 1 |
| Li, QS | 1 |
| Guan, J | 1 |
| Sun, B | 1 |
| Luo, M | 1 |
| Lu, Z | 1 |
| Meng, Y | 1 |
| Wu, S | 1 |
| Wu, M | 1 |
| Kumari, R | 1 |
| Sharma, A | 1 |
| Ajay, AK | 1 |
| Bhat, MK | 1 |
| Gomes, AS | 1 |
| Rosove, MH | 1 |
| Rosen, PJ | 1 |
| Amado, RG | 1 |
| Sayre, JW | 1 |
| Monteleone, PA | 1 |
| Busuttil, RW | 1 |
| Takada, J | 3 |
| Kenno, S | 1 |
| Aoki, T | 14 |
| Hamada, H | 6 |
| Katsuki, Y | 5 |
| Watanabe, K | 4 |
| Otake, T | 1 |
| Yasuda, M | 1 |
| Takenoshita, S | 1 |
| Kanagavel, D | 1 |
| Pokataev, IA | 1 |
| Fedyanin, MY | 1 |
| Tryakin, AA | 1 |
| Bazin, IS | 1 |
| Narimanov, MN | 1 |
| Yakovleva, ES | 1 |
| Garin, AM | 1 |
| Tjulandin, SA | 1 |
| Takayasu, K | 2 |
| Arii, S | 1 |
| Ikai, I | 1 |
| Kudo, M | 2 |
| Matsuyama, Y | 1 |
| Kojiro, M | 1 |
| Makuuchi, M | 4 |
| Lustberg, MB | 1 |
| Bekaii-Saab, T | 1 |
| Young, D | 1 |
| Otterson, G | 1 |
| Burak, W | 1 |
| Abbas, A | 1 |
| McCracken-Bussa, B | 1 |
| Lustberg, ME | 1 |
| Villalona-Calero, MA | 1 |
| Aiura, K | 1 |
| Takahashi, S | 1 |
| Matsui, J | 1 |
| Ueda, M | 1 |
| Kitagawa, Y | 2 |
| Hiramine, Y | 1 |
| Imamura, Y | 1 |
| Uto, H | 1 |
| Baba, Y | 1 |
| Hiwaki, T | 1 |
| Sho, Y | 1 |
| Tahara, K | 1 |
| Tsubouchi, H | 1 |
| Huang, CS | 1 |
| Lee, YR | 1 |
| Chen, CS | 1 |
| Tu, SH | 1 |
| Wang, YJ | 1 |
| Lee, CH | 1 |
| Chen, LC | 1 |
| Chang, HW | 1 |
| Chang, CH | 1 |
| Chih-Ming, S | 1 |
| Wu, CH | 1 |
| Ho, YS | 1 |
| Gaba, RC | 3 |
| Carroll, JJ | 1 |
| Bui, JT | 1 |
| Carrillo, TC | 1 |
| Knuttinen, MG | 1 |
| Owens, CA | 1 |
| Zhong, X | 1 |
| Xiong, M | 1 |
| Meng, X | 2 |
| Gong, R | 1 |
| Albert, M | 2 |
| Kiefer, MV | 2 |
| Sun, W | 2 |
| Haller, D | 1 |
| Fraker, DL | 1 |
| Tuite, CM | 2 |
| Stavropoulos, SW | 2 |
| Mondschein, JI | 2 |
| Soulen, MC | 6 |
| Noura, S | 1 |
| Ohue, M | 1 |
| Shingai, T | 3 |
| Kano, S | 1 |
| Ohigashi, H | 4 |
| Yano, M | 2 |
| Ishikawa, O | 5 |
| Takenaka, A | 1 |
| Murata, K | 3 |
| Kameyama, M | 3 |
| Stoiber, N | 1 |
| Hauser, N | 1 |
| Stoiber, B | 1 |
| Hohl, MK | 1 |
| Sohn, C | 1 |
| Eichbaum, MH | 2 |
| Dufour, JF | 1 |
| Hoppe, H | 1 |
| Heim, MH | 1 |
| Helbling, B | 1 |
| Maurhofer, O | 1 |
| Szucs-Farkas, Z | 1 |
| Kickuth, R | 1 |
| Borner, M | 1 |
| Candinas, D | 1 |
| Saar, B | 1 |
| Mack, MG | 4 |
| Abskharon, JE | 1 |
| Jost, A | 1 |
| Chuma, M | 1 |
| Kusunoki, N | 1 |
| Tsuchida, S | 2 |
| Takahashi, M | 6 |
| Tsugawa, D | 1 |
| Awazu, M | 1 |
| Kataoka, Y | 1 |
| Hori, Y | 1 |
| Kuroda, D | 1 |
| Sakamoto, H | 1 |
| Amikura, K | 1 |
| Tanaka, Y | 7 |
| Nishimura, Y | 3 |
| Kawashima, Y | 1 |
| Yatsuoka, T | 1 |
| Yamagata, Y | 1 |
| Yamaura, T | 1 |
| Yokoyama, Y | 1 |
| Akiyama, H | 2 |
| Nakajima, T | 4 |
| Chung, GE | 1 |
| Kim, HY | 1 |
| Hwang, SY | 1 |
| Kim, JS | 1 |
| Chung, JW | 3 |
| Choi, JW | 1 |
| Kim, HC | 2 |
| Kim, JD | 1 |
| Kim, GM | 1 |
| Lee, IJ | 1 |
| Jae, HJ | 1 |
| Park, JH | 2 |
| McNally, M | 1 |
| Robertson, M | 1 |
| Fraker, D | 1 |
| Olthoff, K | 1 |
| Christians, K | 1 |
| Pappas, S | 1 |
| Rilling, W | 1 |
| Ueno, M | 2 |
| Uchiyama, K | 1 |
| Ozawa, S | 1 |
| Hayami, S | 1 |
| Shigekawa, Y | 1 |
| Tani, M | 1 |
| Yamaue, H | 1 |
| Chen, D | 1 |
| Zhao, P | 1 |
| Liu, L | 1 |
| Qi, C | 1 |
| Liu, Y | 2 |
| Wang, Q | 2 |
| Chen, S | 1 |
| Choi, SY | 1 |
| Shen, YN | 1 |
| Woo, SR | 1 |
| Yun, M | 1 |
| Park, JE | 1 |
| Ju, YJ | 1 |
| Jeong, J | 1 |
| Shin, HJ | 1 |
| Joo, HY | 1 |
| Park, ER | 1 |
| Lee, JK | 1 |
| Kim, SH | 1 |
| Cho, MH | 1 |
| Kong, IS | 1 |
| Lee, KH | 2 |
| Bagliani, A | 1 |
| Baggiani, A | 1 |
| Ierardi, AM | 1 |
| Caspani, B | 1 |
| Motta, F | 1 |
| Toniolo, D | 1 |
| Belloni, P | 1 |
| Setola, E | 1 |
| Campagnoli, E | 1 |
| Tempini, S | 1 |
| Crocchiolo, R | 1 |
| Bregni, M | 1 |
| Belli, L | 2 |
| Fornaro, L | 1 |
| Vasile, E | 1 |
| Masi, G | 1 |
| Loupakis, F | 1 |
| Baldi, GG | 1 |
| Allegrini, G | 1 |
| Salvatore, L | 1 |
| Cremolini, C | 1 |
| Cupini, S | 1 |
| Cortesi, E | 1 |
| Tuzi, A | 1 |
| Granetto, C | 1 |
| Brunetti, IM | 1 |
| Ricci, S | 2 |
| Falcone, A | 1 |
| Hsieh, MY | 2 |
| Lin, ZY | 3 |
| Chen, SH | 2 |
| Chuang, WL | 2 |
| Antoch, G | 1 |
| Roelle, G | 1 |
| Ladd, SC | 1 |
| Kuehl, H | 1 |
| Heusner, TA | 1 |
| Sotiropoulos, GC | 1 |
| Hilgard, P | 1 |
| Forsting, M | 1 |
| Verhagen, R | 1 |
| Ito, K | 7 |
| Ito, H | 3 |
| Gonen, M | 2 |
| Allen, PJ | 1 |
| Paty, PB | 1 |
| Fong, Y | 1 |
| Dematteo, RP | 1 |
| Blumgart, LH | 1 |
| Jarnagin, WR | 1 |
| D'Angelica, MI | 1 |
| Lehnert, T | 3 |
| Lin, CI | 1 |
| Huang, CF | 1 |
| Miyayama, S | 2 |
| Yamashiro, M | 1 |
| Shibata, Y | 1 |
| Hashimoto, M | 3 |
| Yoshida, M | 3 |
| Tsuji, K | 3 |
| Toshima, F | 1 |
| Matsui, O | 5 |
| Kuhlmann, JB | 1 |
| Euringer, W | 1 |
| Spangenberg, HC | 1 |
| Breidert, M | 1 |
| Blum, HE | 1 |
| Harder, J | 1 |
| Fischer, R | 1 |
| Engels, KS | 1 |
| Morse, MA | 1 |
| Hanks, BA | 1 |
| Suhocki, P | 1 |
| Doan, PL | 1 |
| Liu, EA | 1 |
| Frost, P | 1 |
| Bernard, SA | 1 |
| Tsai, A | 1 |
| Moore, DT | 1 |
| O'Neil, BH | 1 |
| Sahara, S | 2 |
| Kawai, N | 1 |
| Sato, M | 9 |
| Tanaka, T | 10 |
| Ikoma, A | 1 |
| Nakata, K | 3 |
| Sanda, H | 1 |
| Minamiguchi, H | 1 |
| Nakai, M | 3 |
| Shirai, S | 1 |
| Sonomura, T | 1 |
| Weber, T | 1 |
| Roitman, M | 1 |
| Link, KH | 7 |
| Jin, B | 1 |
| Wang, D | 3 |
| Ragin, AB | 1 |
| Larson, AC | 3 |
| Chen, Y | 4 |
| Ge, N | 2 |
| Zhang, L | 1 |
| Xie, X | 2 |
| Chen, R | 1 |
| Xia, J | 2 |
| Gan, Y | 2 |
| Ren, Z | 2 |
| Ye, S | 2 |
| Inuzuka, T | 1 |
| Nakajima, J | 1 |
| Matsuda, F | 1 |
| Henmi, S | 1 |
| Hatamaru, K | 1 |
| Li, H | 2 |
| Hu, Y | 1 |
| Li, N | 1 |
| Zhou, Y | 1 |
| Georgiades, C | 1 |
| Geschwind, JF | 2 |
| Harrison, N | 1 |
| Hines-Peralta, A | 1 |
| Liapi, E | 1 |
| Hong, K | 2 |
| Wu, Z | 2 |
| Kamel, I | 1 |
| Frangakis, C | 1 |
| Peng, JW | 1 |
| Lin, GN | 1 |
| Xiao, JJ | 1 |
| Jiang, XM | 1 |
| Ooi, H | 1 |
| Eveno, C | 1 |
| Goéré, D | 1 |
| Dartigues, P | 1 |
| Honoré, C | 1 |
| Dumont, F | 1 |
| Tzanis, D | 1 |
| Benhaim, L | 1 |
| Malka, D | 1 |
| Elias, D | 1 |
| Smith, D | 1 |
| Dahan, L | 1 |
| Michel, C | 1 |
| Perrier, H | 1 |
| Mari, V | 1 |
| Seitz, JF | 1 |
| Chamorey, E | 1 |
| Akhlaghpoor, S | 1 |
| Aziz-Ahari, A | 1 |
| Amoui, M | 1 |
| Tolooee, S | 1 |
| Poorbeigi, H | 1 |
| Sheybani, S | 1 |
| Fang, WQ | 1 |
| Guo, RP | 1 |
| Chen, MS | 1 |
| Luo, J | 1 |
| Xu, L | 1 |
| Zou, RH | 1 |
| Lin, XJ | 1 |
| Zhang, YQ | 3 |
| Ye, T | 1 |
| Wang, YH | 2 |
| Xia, JL | 2 |
| Yang, BW | 1 |
| Ge, NL | 2 |
| Gan, YH | 2 |
| Ren, ZG | 2 |
| Arimoto, A | 1 |
| Wakasa, T | 1 |
| Zhuo, L | 1 |
| Liu, J | 1 |
| Wang, B | 1 |
| Gao, M | 1 |
| Huang, A | 1 |
| Petruzzi, NJ | 1 |
| Frangos, AJ | 1 |
| Fenkel, JM | 1 |
| Herrine, SK | 1 |
| Hann, HW | 1 |
| Rossi, S | 2 |
| Rosato, EL | 1 |
| Eschelman, DJ | 1 |
| Gonsalves, CF | 1 |
| Liu, LX | 1 |
| Zhang, WH | 1 |
| Jiang, HC | 1 |
| Zhu, AL | 1 |
| Wu, LF | 1 |
| Qi, SY | 1 |
| Piao, DX | 1 |
| Yano, S | 3 |
| Koufuji, K | 3 |
| Aoyagi, K | 4 |
| Murakami, N | 4 |
| Terasaki, Y | 2 |
| Miyagi, M | 2 |
| Takeda, J | 4 |
| Shirouzu, K | 4 |
| Lu, W | 1 |
| Li, YH | 2 |
| He, XF | 1 |
| Zeng, QL | 1 |
| Qiu, YR | 1 |
| Tasaka, K | 1 |
| Okada, Y | 1 |
| Tomofuji, Y | 1 |
| Chinzei, T | 1 |
| Slater, S | 1 |
| Shamash, J | 1 |
| Wilson, P | 1 |
| Gallagher, CJ | 1 |
| Slevin, ML | 2 |
| Rump, AF | 3 |
| Woschée, U | 2 |
| Theisohn, M | 3 |
| Fischbach, R | 3 |
| Heindel, W | 3 |
| Lackner, K | 3 |
| Klaus, W | 3 |
| Arai, K | 15 |
| Iwasaki, Y | 10 |
| Takahashi, K | 3 |
| Yamaguchi, T | 10 |
| Takahashi, T | 17 |
| Ochiai, T | 5 |
| Maruyama, M | 2 |
| Ebuchi, M | 1 |
| Nagahama, T | 1 |
| Takashima, I | 1 |
| Hasegawa, K | 3 |
| Natsui, S | 1 |
| Sakoma, T | 1 |
| Tsuji, Y | 6 |
| Shizawa, R | 1 |
| Nagahori, Y | 1 |
| Kumamoto, N | 1 |
| Yamamoto, H | 3 |
| Takeda, K | 2 |
| Hamaguchi, Y | 1 |
| Fukushima, T | 2 |
| Yamamoto, M | 3 |
| Mogaki, M | 1 |
| Fukasawa, S | 1 |
| Eguchi, K | 1 |
| Kawahara, M | 1 |
| Nagahori, K | 1 |
| Hosoi, H | 1 |
| Ohara, T | 1 |
| Takanashi, K | 2 |
| Homma, H | 2 |
| Mezawa, S | 1 |
| Doi, T | 1 |
| Akiyama, T | 3 |
| Machida, T | 1 |
| Murakami, K | 2 |
| Hirata, K | 2 |
| Iyama, S | 1 |
| Takeuchi, I | 8 |
| Ishida, H | 12 |
| Kuwabara, K | 1 |
| Hashimoto, D | 8 |
| Osada, H | 4 |
| Kashimada, A | 2 |
| Matumoto, Y | 2 |
| Miura, T | 17 |
| Masutani, S | 4 |
| Shimizu, J | 2 |
| Tatsuta, M | 3 |
| Katoh, H | 2 |
| Kitani, K | 1 |
| Esumi, K | 1 |
| Masuda, N | 1 |
| Imamura, H | 1 |
| Furukawa, H | 6 |
| Onishi, H | 2 |
| Tsuda, K | 2 |
| Inoue, Y | 4 |
| Tomotsu, K | 2 |
| Usui, T | 2 |
| Ball, DS | 1 |
| Heckman, R | 1 |
| Olenick, SW | 1 |
| Folander, HL | 1 |
| Reed, J | 1 |
| Yi, J | 2 |
| Liao, X | 2 |
| Yang, Z | 2 |
| Li, X | 3 |
| Kigami, Y | 1 |
| Kobayashi, H | 11 |
| Umeoka, S | 1 |
| Emoto, T | 1 |
| Akuta, K | 1 |
| Janciauskiene, R | 1 |
| Juozaityte, E | 1 |
| Pavalkis, D | 1 |
| Xu, F | 1 |
| Song, DQ | 1 |
| Zhen, YS | 2 |
| Liao, ZY | 1 |
| Zhang, SH | 1 |
| Cerretani, D | 1 |
| Roviello, F | 1 |
| Pieraccini, M | 1 |
| Civeli, L | 1 |
| Correale, P | 1 |
| Francini, G | 1 |
| Marrelli, D | 1 |
| De Manzoni, G | 1 |
| Pinto, E | 1 |
| Giorgi, G | 1 |
| Katsumata, K | 1 |
| Tomioka, H | 1 |
| Sumi, T | 1 |
| Takagi, M | 1 |
| Kato, F | 1 |
| Suzuki, Y | 4 |
| Koyanagi, Y | 5 |
| Yamaguchi, K | 3 |
| Miyashita, K | 6 |
| Aizawa, K | 1 |
| Todoroki, H | 2 |
| Kiyonaga, H | 1 |
| Ahrar, K | 2 |
| Gupta, S | 1 |
| Wang, CS | 1 |
| Liao, LY | 1 |
| Wang, CK | 1 |
| Shih, LS | 1 |
| Chen, RC | 2 |
| Chen, PH | 1 |
| Sakaguchi, Y | 1 |
| Kabashima, A | 1 |
| Kuma, S | 1 |
| Kajiyama, K | 1 |
| Tokunaga, T | 1 |
| Sumimura, J | 1 |
| Yoshidome, K | 1 |
| Fujita, S | 1 |
| Oota, F | 1 |
| Tsuboyama, N | 1 |
| Nagai, I | 1 |
| Yu, J | 1 |
| Wang, L | 1 |
| Zhou, T | 1 |
| Zhai, L | 1 |
| Xing, L | 1 |
| FUJIMORI, M | 1 |
| SAKAUCHI, G | 1 |
| IZUO, M | 1 |
| ABE, C | 1 |
| MORITA, S | 3 |
| NASHIMOTO, T | 1 |
| ISHIKAWA, S | 1 |
| SADMITSU, H | 1 |
| KAWAI, T | 1 |
| ITO, I | 1 |
| HATTORI, T | 4 |
| KOYAMA, Y | 2 |
| OBOSHI, S | 1 |
| FUJITA, H | 1 |
| USUBUCHI, I | 1 |
| KAGEYAMA, T | 1 |
| UENO, K | 5 |
| KOIZUMI, A | 2 |
| YOSHIDA, K | 2 |
| YAMAGUCHI, I | 1 |
| MAJIMA, S | 1 |
| HAGIHARA, K | 1 |
| HIRONO, I | 1 |
| KOJIMA, K | 5 |
| KACHI, H | 1 |
| OHASHI, A | 1 |
| SASAOKA, I | 1 |
| KOSHIURA, R | 1 |
| KOSHIMURA, S | 1 |
| BANDO, Y | 1 |
| Deng, W | 1 |
| Tian, G | 1 |
| Maruyama, S | 1 |
| Mok, KT | 1 |
| Wang, BW | 1 |
| Lo, GH | 2 |
| Liu, SI | 1 |
| Chou, NH | 1 |
| Tsai, CC | 1 |
| Chen, IS | 1 |
| Yeh, MH | 1 |
| Pan, DY | 1 |
| Qiao, JG | 1 |
| Chen, JW | 1 |
| Huo, YC | 1 |
| Zhou, YK | 1 |
| Shi, HA | 1 |
| Ozden, I | 1 |
| Bilge, O | 1 |
| Erkan, M | 1 |
| Cevikbaş, U | 1 |
| Acarli, K | 1 |
| Xin, YL | 1 |
| Liu, DR | 1 |
| Takeno, A | 1 |
| Fujitani, K | 1 |
| Tsujinaka, T | 2 |
| Hirao, M | 1 |
| Takeda, Y | 2 |
| Kashiwazaki, M | 2 |
| Mishima, H | 3 |
| Ikenaga, M | 1 |
| Sawamura, T | 1 |
| Hasuike, Y | 3 |
| Okada, N | 3 |
| Yokoyama, M | 4 |
| Nakata, H | 1 |
| Matsumoto, Y | 4 |
| Kosaka, K | 1 |
| Nishino, H | 3 |
| Yamada, N | 3 |
| Nishihara, T | 2 |
| Ohira, M | 2 |
| Hirakawa, K | 3 |
| Mastumoto, Y | 2 |
| Katayanagi, S | 2 |
| Matsumoto, H | 4 |
| Miyamoto, H | 3 |
| Nishisyo, I | 1 |
| Nagano, H | 3 |
| Sakon, M | 5 |
| Monden, M | 6 |
| St Peter, SD | 1 |
| Moss, AA | 1 |
| Huettl, EA | 1 |
| Leslie, KO | 1 |
| Mulligan, DC | 1 |
| Kornek, GV | 1 |
| Schuell, B | 1 |
| Laengle, F | 1 |
| Gruenberger, T | 1 |
| Penz, M | 1 |
| Karall, K | 1 |
| Depisch, D | 1 |
| Lang, F | 1 |
| Scheithauer, W | 2 |
| Giroux, MF | 1 |
| Baum, RA | 3 |
| Kumada, T | 3 |
| Sone, Y | 3 |
| Toyoda, H | 1 |
| Kiriyama, S | 2 |
| Tanikawa, M | 1 |
| Hisanaga, Y | 2 |
| Kuzuya, T | 1 |
| Nonogaki, K | 1 |
| Yamauti, T | 1 |
| Kawase, N | 1 |
| Chen, XM | 1 |
| Luo, PF | 2 |
| Lin, HH | 1 |
| Zhou, ZJ | 1 |
| Shao, PJ | 1 |
| Fu, L | 1 |
| Li, WK | 1 |
| Rao, S | 1 |
| Cunningham, D | 2 |
| Price, T | 1 |
| Hill, ME | 1 |
| Ross, PJ | 1 |
| Tebbutt, N | 1 |
| Norman, AR | 1 |
| Oates, J | 1 |
| Shellito, P | 1 |
| Loibl, S | 1 |
| von Minckwitz, G | 1 |
| Schwedler, K | 1 |
| Schmidt, KA | 1 |
| Höper, D | 1 |
| Kaufmann, M | 1 |
| Costa, SD | 1 |
| Katsumata, D | 1 |
| Sasaki, K | 4 |
| Miyachi, K | 1 |
| Joujima, T | 1 |
| Tsumuraya, M | 1 |
| Onodera, S | 1 |
| Shimoda, W | 1 |
| Yoda, N | 1 |
| Ohkawa, T | 1 |
| Odaka, N | 1 |
| Kaneko, H | 2 |
| Sunagawa, M | 1 |
| Taki, K | 1 |
| Minami, T | 3 |
| Ito, C | 1 |
| Shinmura, R | 1 |
| Takamatsu, S | 1 |
| Kobayashi, M | 10 |
| Notsumata, K | 1 |
| Toya, D | 1 |
| Tanaka, N | 2 |
| Kozaka, K | 1 |
| Cheng, SQ | 1 |
| Wu, MC | 1 |
| Shen, F | 1 |
| Yang, JH | 1 |
| Cong, WM | 1 |
| Zhao, YX | 1 |
| Wang, PJ | 1 |
| Newman, RA | 1 |
| Pang, J | 1 |
| Vijjeswarapu, MK | 1 |
| Wallace, MJ | 1 |
| Wright, KC | 1 |
| Ren, H | 1 |
| Cheng, L | 2 |
| Fundakowski, CE | 2 |
| Lisker-Melman, M | 2 |
| Crippin, JS | 2 |
| Pilgram, TK | 2 |
| Chapman, W | 1 |
| Darcy, MD | 2 |
| Imaizumi, T | 1 |
| Nakada, H | 5 |
| Ohsawa, T | 5 |
| Ozawa, F | 1 |
| Hoshino, T | 3 |
| Hirakata, A | 1 |
| Kato, S | 4 |
| Kawano, Y | 1 |
| Mineta, S | 1 |
| Taniai, N | 1 |
| Mamada, Y | 1 |
| Yokomuro, S | 1 |
| Yoshida, H | 1 |
| Akimaru, K | 2 |
| Tajiri, T | 3 |
| Shirakawa, K | 1 |
| Hayashi, Y | 1 |
| Inokuma, S | 3 |
| Soma, I | 1 |
| Hayashi, N | 1 |
| Fukuchi, N | 1 |
| Izawa, H | 1 |
| Yoshida, T | 8 |
| Ebisui, C | 1 |
| Sakita, I | 1 |
| Fujimoto, T | 6 |
| Koshino, T | 1 |
| Izumiyama, K | 1 |
| Li, HH | 1 |
| Duan, ZH | 1 |
| Zhang, HW | 1 |
| Chen, JS | 1 |
| Li, L | 3 |
| Sun, F | 1 |
| Chen, AJ | 1 |
| Li, XY | 1 |
| Hu, MD | 1 |
| Ran, JH | 1 |
| Tang, JH | 1 |
| Wang, FS | 1 |
| Lei, ZY | 1 |
| Li, WL | 1 |
| Liu, JC | 1 |
| Tang, ZR | 1 |
| Zhou, GD | 1 |
| Schneeweiss, A | 1 |
| de Rossi, T | 1 |
| Bastert, G | 1 |
| Liu, MZ | 1 |
| Wang, XS | 1 |
| Cai, L | 1 |
| Gu, MF | 1 |
| Liu, H | 1 |
| Cui, NJ | 1 |
| Li, GH | 1 |
| Li, JQ | 2 |
| Asahara, S | 1 |
| Ikari, T | 1 |
| Kamei, A | 1 |
| Sato, E | 1 |
| Takano, K | 2 |
| Fujita, N | 1 |
| Shimizu, M | 2 |
| Fujita, R | 1 |
| Fiorentini, G | 2 |
| Poddie, DB | 1 |
| Cantore, M | 2 |
| Tumolo, S | 1 |
| Dentico, P | 1 |
| Bernardeschi, P | 1 |
| Guadagni, S | 2 |
| Rossi, G | 2 |
| Valori, VM | 1 |
| De Simone, M | 1 |
| Meyer, F | 1 |
| Ridwelski, K | 1 |
| Gebauer, T | 1 |
| Grote, R | 1 |
| Martens-Lobenhoffer, J | 1 |
| Lippert, H | 1 |
| Hwang, JY | 1 |
| Jang, BK | 1 |
| Kwon, KM | 1 |
| Chung, WJ | 1 |
| Park, KS | 1 |
| Cho, KB | 1 |
| Hwang, JS | 1 |
| Ahn, SH | 1 |
| Kim, GC | 1 |
| Kim, YH | 1 |
| Choi, JS | 1 |
| Kwon, JH | 1 |
| Li, CP | 1 |
| Chao, Y | 1 |
| Lin, CP | 1 |
| Lin, CK | 1 |
| Chen, HH | 1 |
| Lo, CC | 1 |
| Tseng, HH | 1 |
| Herber, S | 2 |
| Schneider, J | 3 |
| Brecher, B | 1 |
| Höhler, T | 1 |
| Thelen, M | 1 |
| Otto, G | 3 |
| Pitton, MB | 3 |
| Haruno, M | 1 |
| Shimamura, R | 1 |
| Ogawa, Y | 2 |
| Tanaka, H | 4 |
| Sakai, K | 4 |
| Araki, K | 1 |
| Shiraki, T | 1 |
| Higashi, K | 1 |
| Maeda, M | 1 |
| Takeuchi, N | 1 |
| Kimura, M | 6 |
| Terada, M | 1 |
| Pelz, JO | 1 |
| Doerfer, J | 1 |
| Hohenberger, W | 1 |
| Meyer, T | 1 |
| Kemeny, N | 3 |
| Eid, A | 1 |
| Stockman, J | 1 |
| Schwartz, L | 1 |
| Tetzlaff, E | 1 |
| Paty, P | 1 |
| Ye, SL | 1 |
| Li, LX | 1 |
| Shen, YF | 1 |
| Tang, ZY | 2 |
| Naito, H | 1 |
| Hamada, T | 1 |
| Shinohara, T | 2 |
| Mino, K | 1 |
| Shibazaki, W | 1 |
| Minagawa, N | 1 |
| Orimo, T | 1 |
| Ichimura, W | 1 |
| Trerotola, SO | 2 |
| Maataoui, A | 1 |
| Khan, MF | 1 |
| Roozru, M | 1 |
| Schmidt, S | 1 |
| Sano, O | 1 |
| Okabe, K | 1 |
| Giuliani, F | 1 |
| Molica, S | 1 |
| Maiello, E | 1 |
| Battaglia, C | 1 |
| Gebbia, V | 1 |
| Di Bisceglie, M | 1 |
| Vinciarelli, G | 1 |
| Gebbia, N | 1 |
| Colucci, G | 1 |
| Lii, JM | 1 |
| Chen, WT | 1 |
| Tu, HY | 1 |
| Chiang, LC | 1 |
| Ogata, T | 1 |
| Nishida, J | 2 |
| Seo, K | 1 |
| Hamaya, M | 1 |
| Kouno, T | 1 |
| Sato, S | 5 |
| Tsuchida, A | 5 |
| Gao, WB | 1 |
| Han, JD | 1 |
| Du, M | 1 |
| Chapman, WC | 1 |
| Shao, RH | 1 |
| Ye, HY | 1 |
| Wang, ZQ | 1 |
| Wang, ZP | 1 |
| Morise, Z | 1 |
| Sugioka, A | 1 |
| Kato, R | 1 |
| Fujita, J | 1 |
| Hoshimoto, S | 1 |
| Kato, T | 6 |
| Mizushima, T | 1 |
| Sugiura, T | 1 |
| Ito, T | 5 |
| Mizuno, H | 1 |
| Hoki, M | 1 |
| Souma, Y | 1 |
| Kainuma, S | 1 |
| Yamanaka, H | 1 |
| Ozawa, H | 5 |
| Kanou, T | 1 |
| Nakamori, Y | 1 |
| Iwase, K | 1 |
| Watanabe, D | 1 |
| Tanabe, A | 1 |
| Naruse, M | 1 |
| Tsuiki, M | 1 |
| Torii, N | 1 |
| Noshiro, T | 1 |
| Sharma, D | 1 |
| Lin, Z | 1 |
| Ma, Z | 1 |
| Fan, J | 1 |
| Qin, L | 2 |
| Zhou, X | 1 |
| Tang, Z | 1 |
| Yang, B | 1 |
| Kim, JC | 1 |
| Yu, CS | 1 |
| Kim, TW | 1 |
| Chang, HM | 1 |
| Ryu, MH | 1 |
| Kim, JH | 1 |
| Ha, HK | 1 |
| Lee, MG | 1 |
| Gadaleta, CD | 1 |
| Catino, A | 1 |
| Ranieri, G | 1 |
| Armenise, F | 1 |
| Console, G | 1 |
| Mattioli, V | 1 |
| Watanabe, M | 4 |
| Kodaira, S | 4 |
| Tominaga, T | 2 |
| Hojo, K | 6 |
| Kunitomo, K | 1 |
| Isomoto, H | 2 |
| Ohashi, Y | 2 |
| Yasutomi, M | 10 |
| Straub, R | 1 |
| Herzog, C | 2 |
| Heller, M | 1 |
| Thalhammer, A | 2 |
| Sun, Y | 1 |
| Cui, YL | 1 |
| Juzi, JT | 1 |
| Qian, BY | 1 |
| Hao, XS | 1 |
| Xi-Xiao, Y | 1 |
| Jan-Hai, C | 1 |
| Shi-Ting, L | 1 |
| Dan, G | 1 |
| Xv-Xin, Z | 1 |
| Vogl, T | 1 |
| Balzer, J | 1 |
| Gholami, A | 1 |
| Haraguchi, Y | 1 |
| Ueno, S | 1 |
| Sakamoto, F | 1 |
| Toyoyama, H | 1 |
| Ikeda, N | 2 |
| Kamikado, C | 1 |
| Aikou, T | 1 |
| Tsuchiya, M | 2 |
| Takita, W | 1 |
| Otsuka, Y | 1 |
| Tamura, A | 1 |
| Yamazaki, K | 2 |
| Koshino, H | 1 |
| Kurihara, A | 1 |
| Teramoto, T | 3 |
| Ling, MT | 1 |
| Wong, YC | 1 |
| Wang, X | 3 |
| Proietti, S | 1 |
| De Baere, T | 1 |
| Bessoud, B | 1 |
| Doenz, F | 1 |
| Qanadli, SD | 1 |
| Schnyder, P | 1 |
| Denys, A | 1 |
| Bessard, A | 1 |
| Frémin, C | 1 |
| Ezan, F | 1 |
| Coutant, A | 1 |
| Baffet, G | 1 |
| Zhao, QZ | 1 |
| Dou, KF | 1 |
| Gu, T | 1 |
| Li, CX | 1 |
| Feng, Y | 1 |
| Li, CH | 1 |
| Li, CF | 1 |
| Ruutiainen, AT | 1 |
| Clark, TW | 2 |
| Kim, YI | 6 |
| Zhang, JH | 2 |
| Hao, FR | 1 |
| Kong, ZL | 1 |
| Shen, ZF | 1 |
| Jin, YZ | 1 |
| Ishiguro, A | 1 |
| Munakata, M | 1 |
| Shitara, K | 1 |
| Suzuki, K | 8 |
| Takahata, T | 1 |
| Itoh, J | 3 |
| Sakata, Y | 4 |
| Munakata, A | 1 |
| Lyakhovich, A | 1 |
| Surralles, J | 1 |
| Buijs, M | 1 |
| Kamel, IR | 1 |
| Vossen, JA | 1 |
| Georgiades, CS | 1 |
| Xue, WJ | 1 |
| Zhou, XJ | 1 |
| Guan, HG | 1 |
| Li, P | 1 |
| Wang, ZW | 1 |
| Qian, HX | 1 |
| Pitton, M | 1 |
| Mönch, C | 1 |
| Manzl, N | 2 |
| Kummer, I | 2 |
| Kanzler, S | 1 |
| Schuchmann, M | 2 |
| Junginger, T | 2 |
| Düber, C | 2 |
| Maes, T | 1 |
| Heye, S | 1 |
| Demey, W | 1 |
| Van Oosterom, AT | 1 |
| Paridaens, R | 1 |
| Selby, JB | 1 |
| Bauer, RW | 1 |
| Nabil, M | 2 |
| Rao, P | 1 |
| Zeuzem, S | 1 |
| Abdelkader, A | 1 |
| Pournaras, JA | 1 |
| Chamot, L | 1 |
| Uffer, S | 1 |
| Zografos, L | 1 |
| Zhou, ZX | 1 |
| Zhang, LJ | 1 |
| Huang, XH | 1 |
| Liu, ZJ | 1 |
| Atassi, B | 1 |
| Ryu, RK | 2 |
| Nemcek, AA | 1 |
| Kulik, LM | 1 |
| Miller, FH | 2 |
| Yakoub, D | 1 |
| Ackermann, H | 1 |
| Herber, SC | 1 |
| Tepper, J | 1 |
| Ibrahim, S | 1 |
| Kulik, L | 1 |
| Mulcahy, M | 1 |
| Sato, K | 3 |
| Wu, XY | 1 |
| Qian, JJ | 1 |
| Lin, Y | 1 |
| Zheng, MH | 1 |
| Kajiya, Y | 3 |
| Hidaka, H | 4 |
| Onohara, S | 1 |
| Maeda, T | 4 |
| Ikeda, K | 10 |
| Inoue, H | 7 |
| Oyama, T | 2 |
| Sonoda, T | 3 |
| Shinohara, S | 4 |
| Akiharu, W | 1 |
| Higashi, T | 3 |
| Nakatsukasa, H | 1 |
| Fujiwara, M | 1 |
| Shiota, T | 1 |
| Yamauchi, Y | 1 |
| Nagashima, H | 1 |
| Hirai, K | 11 |
| Kumagai, M | 2 |
| Kawazoe, Y | 3 |
| Okubo, K | 1 |
| Yamaguchi, G | 1 |
| Nagasaki, Y | 1 |
| Abe, M | 7 |
| Tanikawa, K | 11 |
| Ando, K | 2 |
| Theodors, A | 1 |
| Bukowski, RM | 1 |
| Lavery, I | 1 |
| Hewlett, JS | 1 |
| Livingston, RB | 1 |
| Buonocore, E | 1 |
| Patt, YZ | 4 |
| Chuang, VP | 3 |
| Wallace, S | 4 |
| Benjamin, RS | 1 |
| Fuqua, R | 1 |
| Mavligit, GM | 3 |
| Okuyama, K | 5 |
| Isono, K | 3 |
| Satoh, H | 4 |
| Onoda, S | 4 |
| Hayashi, R | 1 |
| Tohnosu, N | 5 |
| Chin, F | 1 |
| Ryu, M | 2 |
| Kohzu, T | 1 |
| Odaka, M | 1 |
| Ohya, T | 2 |
| Kikuchi, S | 1 |
| Takagi, H | 9 |
| Morimoto, T | 2 |
| Yasue, M | 1 |
| Ochiai, E | 1 |
| Yamada, E | 1 |
| Ashizawa, T | 1 |
| Kido, C | 10 |
| Sheen, MC | 1 |
| Huang, TJ | 1 |
| Sheen, PC | 1 |
| Ho, YH | 1 |
| Sheu, HM | 1 |
| Ou, SC | 1 |
| Chen, CY | 1 |
| Wu, CC | 1 |
| Tamakawa, Y | 1 |
| Unno, K | 1 |
| Kawabata, M | 2 |
| Takashima, S | 11 |
| Mitsuzane, K | 1 |
| Maeda, C | 1 |
| Hamachi, J | 1 |
| Nomura, S | 2 |
| Toshiyuki, M | 1 |
| Kobayashi, N | 3 |
| Ohnishi, K | 5 |
| Tsuchiya, S | 3 |
| Nakayama, T | 4 |
| Hiyama, Y | 2 |
| Iwama, S | 2 |
| Goto, N | 2 |
| Takashi, M | 2 |
| Ohtsuki, T | 2 |
| Kono, K | 1 |
| Nakajima, Y | 6 |
| Hayashida, S | 1 |
| Sugimoto, K | 1 |
| Kobayashi, T | 6 |
| Cohen, AM | 2 |
| Kaufman, SD | 1 |
| Wood, WC | 1 |
| Greenfield, AJ | 1 |
| Peters, RE | 1 |
| Mavligit, G | 1 |
| Niederhuber, JE | 1 |
| Ensminger, W | 1 |
| Gyves, J | 1 |
| Thrall, J | 1 |
| Walker, S | 2 |
| Cozzi, E | 1 |
| Yamada, R | 4 |
| Nakatsuka, H | 6 |
| Nakamura, K | 8 |
| Shibakiri, I | 1 |
| Itami, M | 1 |
| Minakuchi, K | 3 |
| Yamaguchi, S | 4 |
| Onoyama, Y | 3 |
| Okuda, K | 6 |
| Monna, T | 2 |
| Kanno, T | 3 |
| Marumo, T | 1 |
| Harihara, S | 2 |
| Kuroki, T | 1 |
| Yamamoto, S | 3 |
| Ohto, M | 1 |
| Tsuchiya, Y | 3 |
| Saisho, H | 1 |
| Kimura, K | 3 |
| Morita, M | 1 |
| Mishima, A | 1 |
| Saito, M | 3 |
| Hatano, H | 1 |
| Nomura, F | 2 |
| Otsuki, T | 1 |
| Kohno, K | 2 |
| Nakagawa, H | 4 |
| Sasaki, H | 1 |
| Katoh, T | 1 |
| Fujii, M | 5 |
| Matsuka, Y | 2 |
| Ejiri, T | 2 |
| Asano, K | 2 |
| Ogawa, M | 3 |
| Inagaki, J | 2 |
| Horikoshi, N | 3 |
| Ezaki, K | 1 |
| Inoue, K | 5 |
| Nagata, T | 1 |
| Aiba, K | 3 |
| Domyo, M | 1 |
| Himori, T | 1 |
| Ujiie, S | 1 |
| Mimata, Y | 1 |
| Sugiyama, Z | 1 |
| Wakui, A | 1 |
| Okamura, J | 5 |
| Kuroda, C | 2 |
| Sakurai, M | 2 |
| Ichihashi, H | 1 |
| Kuzuya, H | 1 |
| Kondo, T | 2 |
| Hu, E | 1 |
| Howell, SB | 2 |
| Gyves, JW | 2 |
| Ensminger, WD | 2 |
| VanHarken, D | 1 |
| Niederhuber, J | 1 |
| Stetson, P | 1 |
| Ishibashi, H | 2 |
| Iguchi, K | 1 |
| Hashimoto, I | 1 |
| Suyama, Y | 5 |
| Seki, S | 1 |
| Tada, M | 1 |
| Fujii, H | 5 |
| Miyoshi, M | 4 |
| Nishimura, S | 1 |
| Nishitani, T | 1 |
| Katake, K | 1 |
| Kimoto, Y | 1 |
| Oota, J | 1 |
| Nakano, Y | 4 |
| Fujita, M | 5 |
| Taguchi, T | 7 |
| Ozaki, A | 1 |
| Saijo, N | 1 |
| Beppu, Y | 1 |
| Shimizu, E | 1 |
| Kimata, M | 1 |
| Hoshi, A | 1 |
| Murasawa, K | 1 |
| Smith, BJ | 1 |
| Evans, M | 1 |
| Hellmann, K | 1 |
| Jones, R | 1 |
| Newton, K | 1 |
| Peters, N | 1 |
| Phillips, RH | 1 |
| Koide, Y | 4 |
| Hanaoka, A | 1 |
| Kano, T | 1 |
| Kumashiro, R | 1 |
| Abe, Y | 1 |
| Notsuka, T | 1 |
| Tamada, R | 1 |
| Inokuchi, K | 2 |
| Schlangen, J | 3 |
| Wils, J | 3 |
| Fujimoto, S | 9 |
| Takahashi, O | 3 |
| Miyazaki, M | 9 |
| Endoh, F | 7 |
| Shimura, T | 1 |
| Sugasawa, H | 1 |
| Shrestha, RD | 4 |
| Kawata, S | 2 |
| Kurihara, M | 1 |
| Ohta, M | 2 |
| Ishidoya, T | 1 |
| Joko, Y | 1 |
| Kiyasu, Y | 1 |
| Kimura, S | 4 |
| Maeta, M | 2 |
| Koga, S | 2 |
| Kanayama, H | 1 |
| Oda, M | 2 |
| Murakami, A | 1 |
| Hirooka, Y | 1 |
| Corringham, RE | 1 |
| Dick, R | 1 |
| Gilmore, MJ | 1 |
| Prentice, HG | 1 |
| Boesen, EM | 1 |
| Tabuchi, Y | 3 |
| Nakae, S | 1 |
| Imanishi, K | 1 |
| Kawasaki, H | 3 |
| Ohyama, T | 1 |
| Murayama, Y | 1 |
| Takiguchi, Y | 1 |
| Saitoh, Y | 3 |
| Laufman, LR | 1 |
| Nims, TA | 1 |
| Guy, JT | 1 |
| Guy, JF | 1 |
| Courter, S | 1 |
| Nishi, I | 1 |
| Yokoyama, T | 1 |
| Nakao, I | 1 |
| Harashima, S | 1 |
| Kanko, T | 1 |
| Saito, T | 2 |
| Fornasiero, A | 1 |
| Cartei, G | 1 |
| Daniele, O | 1 |
| Fosser, V | 1 |
| Fiorentino, MV | 1 |
| Soukop, M | 1 |
| McArdle, CS | 4 |
| Carter, DC | 1 |
| Smyth, JF | 1 |
| Allan, SG | 1 |
| Kaye, SB | 1 |
| Sangster, G | 1 |
| Calman, KC | 1 |
| Hutcheon, AW | 1 |
| Naus, A | 2 |
| Conroy, JF | 1 |
| Roda, PI | 1 |
| Brodsky, I | 1 |
| Kahn, SB | 1 |
| Bulova, SI | 1 |
| Pequignot, E | 1 |
| Cowan, JD | 1 |
| Easterbrock, J | 1 |
| Mills, GM | 1 |
| McCracken, JD | 1 |
| Simon, P | 1 |
| Hervé, JP | 1 |
| Ramée, MP | 1 |
| Leroy, JP | 1 |
| Ang, KS | 1 |
| Leguy, P | 1 |
| Vignoud, J | 1 |
| Cledes, J | 1 |
| Kinami, Y | 3 |
| Konishi, K | 2 |
| Shinmura, K | 1 |
| Takada, M | 1 |
| Sakuma, H | 4 |
| Nagakawa, T | 1 |
| Miyazaki, I | 9 |
| Okui, K | 8 |
| Suzuoka, M | 1 |
| Katayama, T | 1 |
| Monden, K | 1 |
| Shimada, Y | 2 |
| Hirano, T | 2 |
| Kono, Y | 1 |
| Ogasawara, K | 2 |
| Bada, K | 1 |
| Obaya, M | 1 |
| Fujioka, J | 1 |
| Takasan, H | 1 |
| Kenmotsu, M | 1 |
| Endo, T | 9 |
| Ishii, H | 2 |
| Ichikawa, J | 1 |
| Tsunemitsu, K | 1 |
| Wiesner, J | 1 |
| Staib-Sebler, E | 2 |
| Encke, A | 3 |
| Nishimine, K | 2 |
| Uchida, H | 3 |
| Matsuo, N | 2 |
| Sakaguchi, H | 3 |
| Hirohashi, S | 2 |
| Guo, Q | 1 |
| Ohishi, H | 3 |
| Nagano, N | 2 |
| Yoshioka, T | 3 |
| Higuchi, T | 1 |
| Kikuchi, M | 1 |
| Okazaki, M | 2 |
| Konno, T | 4 |
| Kai, Y | 2 |
| Yamashita, R | 2 |
| Nagamitsu, A | 1 |
| Cheng, LF | 1 |
| Wang, HZ | 1 |
| Saikawa, Y | 1 |
| Kubota, T | 2 |
| Furukawa, T | 2 |
| Kumai, K | 1 |
| Yoshino, K | 1 |
| Ishibiki, K | 1 |
| Kitajima, M | 5 |
| Konno, H | 2 |
| Matsuda, I | 1 |
| Kanai, T | 4 |
| Maruo, Y | 1 |
| Nishino, N | 1 |
| Nakamura, S | 2 |
| Baba, S | 2 |
| Lygidakis, NJ | 1 |
| Kosmidis, P | 1 |
| Ziras, N | 1 |
| Parissis, J | 1 |
| Kyparidou, E | 1 |
| Nakashima, K | 5 |
| Aramaki, M | 4 |
| Kawano, K | 2 |
| Kitano, S | 2 |
| Hanada, H | 1 |
| Umekita, N | 3 |
| Maeshiro, T | 3 |
| Miyamoto, S | 3 |
| Yamada, F | 2 |
| Awane, Y | 4 |
| Kohashi, S | 1 |
| Shiroto, H | 1 |
| Kondo, M | 8 |
| Takahashi, N | 1 |
| Ikuta, K | 1 |
| Yamada, S | 2 |
| Uchino, J | 4 |
| Hyogo, H | 1 |
| Kido, S | 1 |
| Yamamoto, K | 6 |
| Kida, M | 2 |
| Matsuda, M | 3 |
| Matsuura, M | 2 |
| Nakajima, N | 7 |
| Akiyama, J | 1 |
| Hashimoto, N | 1 |
| Kohno, H | 5 |
| Kubota, H | 3 |
| Hayashi, T | 4 |
| Uchida, M | 2 |
| Yamanoi, A | 2 |
| Ono, T | 3 |
| Nagasue, N | 5 |
| Kitamura, M | 13 |
| Kasugai, H | 1 |
| Ishiyama, J | 1 |
| Imai, I | 1 |
| Fukuma, E | 1 |
| Miyajima, N | 2 |
| Kano, N | 1 |
| Yamakawa, T | 1 |
| Goto, S | 1 |
| Kera, J | 1 |
| Takeuchi, S | 1 |
| Itani, K | 6 |
| Yoshikawa, T | 7 |
| Watanabe, N | 2 |
| Hiraoka, M | 1 |
| Noguchi, M | 3 |
| Miura, K | 2 |
| Goseki, N | 1 |
| Nagai, K | 1 |
| Kando, F | 1 |
| Endo, M | 1 |
| Shimoju, K | 1 |
| Wada, Y | 1 |
| Takeda, S | 1 |
| Hisatomi, K | 1 |
| Nakano, S | 3 |
| Okamoto, K | 2 |
| Nagafuchi, Y | 1 |
| Itoh, H | 3 |
| Ohsato, K | 1 |
| Morris, TJ | 1 |
| Palm, SL | 1 |
| Furcht, LL | 1 |
| Buchwald, H | 1 |
| Ji, T | 1 |
| Sun, J | 1 |
| Gu, Q | 1 |
| Kunii, Y | 3 |
| Kikuchi, K | 3 |
| Khan, KN | 1 |
| Shima, M | 1 |
| Kusumoto, Y | 1 |
| Ishii, N | 1 |
| Koji, T | 2 |
| Nagataki, S | 1 |
| Shiina, S | 1 |
| Tagawa, K | 1 |
| Niwa, Y | 1 |
| Unuma, T | 1 |
| Komatsu, Y | 2 |
| Yoshiura, K | 1 |
| Hamada, E | 2 |
| Shiratori, Y | 1 |
| Terano, A | 1 |
| Kelm, C | 1 |
| Henneking, K | 1 |
| Zimmermann, T | 1 |
| Vollerthun, M | 1 |
| Padberg, W | 1 |
| Wang, ZY | 1 |
| Shi, ZH | 1 |
| Zai, RY | 1 |
| Dirix, L | 1 |
| Catimel, G | 1 |
| Koier, I | 1 |
| Provè, A | 1 |
| Schrijvers, D | 1 |
| Joossens, E | 1 |
| De Bruijn, E | 1 |
| Ardiet, C | 1 |
| Evene, E | 1 |
| Dumortier, A | 1 |
| Su, J | 1 |
| Zhen, YC | 1 |
| Qi, CQ | 1 |
| Hu, JL | 1 |
| Kanematsu, M | 1 |
| Furukawa, Y | 1 |
| Otani, Y | 3 |
| Ihara, A | 1 |
| Tsuji, R | 1 |
| Okamura, R | 1 |
| Hiki, Y | 1 |
| Shinohara, K | 1 |
| Hu, GD | 1 |
| Li, XM | 1 |
| Huang, ZC | 1 |
| Hu, DY | 1 |
| Riesener, KP | 2 |
| Winkeltau, G | 2 |
| Klemm, M | 1 |
| Schumpelick, V | 2 |
| Liermann, D | 1 |
| Gog, C | 1 |
| Kollath, J | 1 |
| Ikuta, H | 1 |
| Shibagaki, F | 1 |
| Wei, C | 1 |
| Liu, KD | 1 |
| Zhang, WZ | 1 |
| Gattoni, F | 1 |
| Pompili, GG | 1 |
| Dova, S | 1 |
| Baldini, U | 1 |
| Raiteri, R | 1 |
| Sacrini, A | 1 |
| Uslenghi, CM | 1 |
| Tomita, K | 1 |
| Arai, Y | 11 |
| Ohashi, K | 1 |
| Ariyoshi, Y | 3 |
| Tono, T | 3 |
| Tamaki, Y | 1 |
| Yagyu, T | 1 |
| Cho, G | 1 |
| Shin, E | 1 |
| Kobayashi, K | 6 |
| Takatsuka, Y | 2 |
| Kikkawa, N | 2 |
| Nakamori, S | 1 |
| Imaoka, S | 4 |
| Yasuda, T | 6 |
| Nakano, H | 3 |
| Hiratsuka, M | 3 |
| Sasaki, Y | 8 |
| Kabuto, T | 3 |
| Takano, S | 3 |
| Moriguchi, M | 1 |
| Seki, N | 2 |
| Higaki, T | 1 |
| Watanabe, Y | 4 |
| Ito, Y | 4 |
| Oishi, H | 1 |
| Nakata, Y | 1 |
| Kono, S | 1 |
| Kawasaki, T | 2 |
| Kimura, F | 2 |
| Okuyama, M | 1 |
| Yamada, M | 1 |
| Ishikawa, K | 1 |
| Satomi, T | 2 |
| Tomita, F | 5 |
| Kurosaka, Y | 1 |
| Matsushita, M | 3 |
| Kiriyama, M | 3 |
| Kosaka, T | 3 |
| Kita, I | 2 |
| Imai, M | 1 |
| Nishimura, A | 1 |
| Shiino, Y | 1 |
| Inagaki, Y | 2 |
| Okamoto, T | 3 |
| Miyakawa, A | 1 |
| Ono, M | 3 |
| Yokota, T | 2 |
| Ogawa, R | 1 |
| Nakamura, J | 2 |
| Nakasato, Y | 1 |
| Onda, K | 1 |
| Civalleri, D | 2 |
| Pector, JC | 2 |
| Håkansson, L | 2 |
| Arnaud, JP | 1 |
| Duez, N | 1 |
| Buyse, M | 1 |
| Aso, N | 1 |
| Matsunaga, N | 1 |
| Fukuda, T | 1 |
| Sakamoto, I | 1 |
| Ashizawa, K | 1 |
| Aikawa, H | 3 |
| Isomoto, I | 1 |
| Hayashi, K | 2 |
| Morikawa, M | 1 |
| Motohara, T | 1 |
| Ozawa, Z | 1 |
| Ozawa, T | 2 |
| Saito, H | 5 |
| Hashimoto, T | 4 |
| Maruhashi, Y | 1 |
| Hirose, S | 1 |
| Satomura, Y | 1 |
| Hayakawa, Y | 1 |
| Ohta, H | 2 |
| Demachi, H | 1 |
| Miwa, A | 1 |
| Nakanuma, Y | 1 |
| Bradley, C | 1 |
| Selby, P | 1 |
| Uchibayashi, T | 1 |
| Lee, SW | 1 |
| Kunimi, K | 1 |
| Ohkawa, M | 2 |
| Endo, Y | 4 |
| Sasaki, T | 2 |
| Tanaka, S | 4 |
| Tomoda, J | 1 |
| Yamada, G | 1 |
| Tsuji, T | 2 |
| Marchiori, L | 1 |
| Mansueto, GC | 1 |
| Nifosi, F | 1 |
| Bortolasi, L | 1 |
| Dal Dosso, I | 1 |
| Facci, E | 1 |
| Perus, G | 1 |
| Nicoli, N | 1 |
| Sakai, Y | 1 |
| Kusano, F | 1 |
| Yamamoto, C | 1 |
| Maekawa, N | 1 |
| Sasaki, N | 1 |
| Tajiri, K | 1 |
| Tazawa, J | 1 |
| Izumi, R | 5 |
| Shimizu, K | 6 |
| Iyobe, T | 3 |
| Ii, T | 2 |
| Yagi, M | 3 |
| Nonomura, A | 1 |
| Okuno, K | 6 |
| Ohnishi, H | 1 |
| Nakajima, I | 4 |
| Akabane, Y | 1 |
| Kurooka, K | 2 |
| Koh, K | 2 |
| Shindo, K | 3 |
| Nakamura, H | 8 |
| Akashi, H | 1 |
| Mizumoto, S | 1 |
| Yamasaki, K | 2 |
| Lu, CD | 1 |
| Qi, YG | 1 |
| Peng, SY | 1 |
| Egeli, R | 3 |
| Arma, S | 2 |
| Barras, JP | 1 |
| Martinoli, S | 3 |
| Müller, W | 2 |
| Castiglione, M | 1 |
| Schroeder, R | 2 |
| Sugimoto, M | 3 |
| Fujita, F | 1 |
| Inaba, H | 1 |
| Iwamiya, T | 2 |
| Sawada, S | 4 |
| Ohta, Y | 2 |
| Yasui, M | 3 |
| Nonami, T | 6 |
| Kurokawa, T | 3 |
| Nakao, A | 6 |
| Harada, A | 6 |
| Hashimoto, S | 2 |
| Kajikawa, M | 1 |
| Hiraoka, E | 1 |
| Oi, H | 2 |
| Kim, T | 2 |
| Kishimoto, H | 1 |
| Tateishi, H | 1 |
| Wen, YJ | 1 |
| Hagiwara, A | 1 |
| Masuda, S | 1 |
| Mokode, Y | 1 |
| Ishioh, M | 1 |
| Oba, H | 1 |
| Shibuya, T | 1 |
| Shoji, T | 1 |
| Sano, K | 1 |
| Okawa, T | 2 |
| Ogawa, N | 4 |
| Nakagawa, T | 2 |
| Tada, Y | 1 |
| Xu, HB | 1 |
| Yan, XQ | 1 |
| de Takats, PG | 1 |
| Kerr, DJ | 3 |
| Poole, CJ | 1 |
| Warren, HW | 1 |
| Kodama, I | 1 |
| Kumegawa, H | 1 |
| Ohta, J | 1 |
| Maruiwa, M | 1 |
| Kofuji, K | 1 |
| Kakegawa, T | 2 |
| Sugiyama, Y | 2 |
| Kato, M | 4 |
| Takao, H | 3 |
| Kida, H | 1 |
| Kunieda, K | 2 |
| Umemoto, T | 3 |
| Miya, K | 3 |
| Azuma, S | 3 |
| Furuta, T | 4 |
| Saji, S | 3 |
| Shiiba, K | 2 |
| Ouchi, A | 2 |
| Yamazaki, T | 3 |
| Momono, S | 3 |
| Nakagawa, K | 6 |
| Muto, I | 2 |
| Mashiko, H | 3 |
| Wada, M | 3 |
| Mori, M | 2 |
| Hidaka, K | 1 |
| Mashima, H | 1 |
| Katano, M | 1 |
| Kishikawa, T | 1 |
| Hisatsugu, T | 1 |
| Akaike, M | 1 |
| Takemiya, S | 1 |
| Sugimasa, Y | 1 |
| Satou, T | 2 |
| Takano, Y | 3 |
| Ishikawa, A | 2 |
| Ozawa, M | 1 |
| Toyama, K | 2 |
| Itsubo, M | 1 |
| Miyazono, N | 3 |
| Kanetsuki, I | 4 |
| Tanaka, D | 1 |
| Fukukura, Y | 1 |
| Tsuchimochi, S | 1 |
| Hokotate, H | 1 |
| Ida, K | 1 |
| Miyake, S | 1 |
| Satake, M | 2 |
| Nishida, H | 3 |
| Nakajo, M | 5 |
| Kantoh, T | 1 |
| Abo, H | 1 |
| Katsumori, T | 1 |
| Satoh, O | 1 |
| Kohda, Y | 1 |
| Akimoto, K | 1 |
| Ohno, K | 2 |
| Mäkelä, J | 2 |
| Tikkakoski, T | 2 |
| Leinonen, A | 2 |
| Siniluoto, T | 3 |
| Karttunen, A | 1 |
| Kairaluoma, MI | 2 |
| Itano, S | 1 |
| Kajiwara, M | 1 |
| Ijuin, H | 1 |
| Ban, S | 1 |
| Sakata, K | 2 |
| Ono, N | 2 |
| Noguchi, H | 5 |
| Sakai, T | 7 |
| Tani, T | 2 |
| Kawaguchi, A | 2 |
| Eguchi, Y | 1 |
| Sano, H | 2 |
| Kurumi, Y | 1 |
| Hanasawa, K | 1 |
| Terata, N | 1 |
| Shibata, J | 1 |
| Kono, H | 1 |
| Minami, K | 1 |
| Yamamoto, T | 1 |
| Nagata, N | 1 |
| Grau, JJ | 1 |
| Estapé, J | 1 |
| Alcobendas, F | 1 |
| Pera, C | 1 |
| Daniels, M | 1 |
| Terés, J | 1 |
| Kitamura, K | 3 |
| Noguchi, A | 2 |
| Honda, M | 3 |
| Otsuji, E | 2 |
| Maehara, Y | 4 |
| Takeuchi, H | 1 |
| Inutsuka, S | 1 |
| Kohnoe, S | 1 |
| Sugimachi, K | 7 |
| Kinoshita, K | 1 |
| Sawa, T | 5 |
| Yoshimitsu, S | 1 |
| Yonemura, Y | 7 |
| Matsui, H | 1 |
| Saiki, I | 1 |
| Yoneda, J | 1 |
| Igarashi, Y | 1 |
| Komazawa, H | 1 |
| Ishizaki, Y | 1 |
| Kato, I | 1 |
| Azuma, I | 1 |
| McKinnon, JG | 1 |
| Lalani, A | 1 |
| Sy, L | 1 |
| Bear, HD | 1 |
| Laget, M | 1 |
| Guiraud-Dauriac, H | 1 |
| de Méo, MP | 1 |
| di Giorgio, C | 1 |
| Roth, E | 1 |
| Duménil, G | 1 |
| Yamashita, F | 1 |
| Satomura, S | 1 |
| Yao, KS | 1 |
| Godwin, AK | 1 |
| Johnson, C | 1 |
| O'Dwyer, PJ | 1 |
| Tsuzuki, H | 1 |
| Niki, M | 1 |
| Ueda, H | 2 |
| Abe, H | 1 |
| Kurosu, Y | 1 |
| Miyaji, M | 1 |
| Ogoshi, K | 2 |
| Kajiura, Y | 1 |
| Kondo, Y | 1 |
| Tajima, T | 2 |
| Mitomi, T | 2 |
| Nishisaki, H | 1 |
| Yasutake, K | 1 |
| Oya, M | 1 |
| Nakashima, T | 1 |
| Hasegawa, H | 6 |
| Horita, K | 1 |
| Yoshida, R | 1 |
| Nakanishi, Y | 3 |
| Abo, K | 1 |
| Onda, M | 2 |
| Tokunaga, A | 1 |
| Yoshiyuki, T | 1 |
| Matsukura, N | 1 |
| Kim, DY | 1 |
| Yamashita, K | 10 |
| Hori, K | 1 |
| Takagaki, M | 1 |
| Koumoto, T | 1 |
| Andou, T | 1 |
| Cakmakli, S | 1 |
| Ersöz, S | 1 |
| Karaayvaz, M | 1 |
| Arat, AR | 1 |
| Soini, Y | 1 |
| Virkajärvi, N | 1 |
| Raunio, H | 1 |
| Pääkkö, P | 1 |
| Sutanto-Ward, E | 1 |
| Arisawa, Y | 3 |
| Tremiterra, S | 1 |
| Sigurdson, ER | 1 |
| Kubo, R | 2 |
| Katayama, K | 5 |
| Taguchi, S | 2 |
| Niimoto, S | 2 |
| Hirose, K | 2 |
| Yamaguchi, A | 2 |
| Nakagawara, G | 2 |
| Botvinik-Helling, S | 2 |
| Biederbick, W | 2 |
| Schierholz, JM | 1 |
| Stemmler, M | 1 |
| Pillasch, J | 4 |
| Weindel, M | 1 |
| Leder, G | 4 |
| Beger, HG | 6 |
| Iwasaki, T | 2 |
| Maeda, I | 1 |
| Sugimoto, T | 1 |
| Kanamaru, T | 2 |
| Kuroda, Y | 3 |
| Tanada, M | 1 |
| Saeki, T | 3 |
| Mogami, H | 1 |
| Hyoudou, I | 1 |
| Jinno, K | 1 |
| Matsumoto, J | 3 |
| Takami, M | 2 |
| Takanishi, K | 2 |
| Matsumine, T | 2 |
| Fujimura, T | 4 |
| Minami, M | 1 |
| Sato, T | 4 |
| Kawamura, T | 1 |
| Nojima, N | 1 |
| Kinami, S | 1 |
| Hirono, Y | 1 |
| Fushida, S | 3 |
| Nishimura, G | 1 |
| Miwa, K | 3 |
| Shiobara, S | 1 |
| Shishido, T | 1 |
| Yasoshima, T | 1 |
| Denno, R | 1 |
| Sato, N | 2 |
| Marinelli, A | 3 |
| de Brauw, LM | 1 |
| Beerman, H | 1 |
| Keizer, HJ | 1 |
| van Bockel, JH | 1 |
| Tjaden, UR | 1 |
| van de Velde, CJ | 3 |
| Boku, N | 1 |
| Ohtsu, A | 1 |
| Muro, K | 1 |
| Kaneko, K | 1 |
| Muto, M | 1 |
| Ohkuwa, M | 1 |
| Tajiri, H | 1 |
| Yoshida, S | 1 |
| Kusada, O | 1 |
| Ueda, N | 1 |
| Yoshimitsu, Y | 1 |
| Ohta, N | 1 |
| Kadoya, N | 2 |
| Hirosawa, H | 3 |
| Konishi, I | 1 |
| Hirono, T | 1 |
| Saito, K | 1 |
| Kawahara, N | 1 |
| Yokomizo, A | 1 |
| Nanri, H | 1 |
| Takenaka, K | 1 |
| Kuwano, M | 1 |
| Magistretti, G | 1 |
| Puricelli, GP | 1 |
| Damiani, G | 1 |
| Colombo, E | 1 |
| Cornalba, GP | 1 |
| Rafique, M | 1 |
| Adachi, W | 4 |
| Koike, S | 7 |
| Kajikawa, S | 4 |
| Yazawa, K | 2 |
| Sugenoya, A | 1 |
| Amano, J | 2 |
| Joseph, G | 1 |
| Bäcker, A | 1 |
| Takeuchi, Y | 1 |
| Taniguch, K | 1 |
| Taton, G | 1 |
| Kantola, R | 1 |
| Leinonen, S | 1 |
| Kiviniemi, H | 2 |
| Laitinen, S | 1 |
| Kairaluoma, M | 1 |
| Miura, M | 1 |
| Terashima, Y | 1 |
| Yamazaki, S | 1 |
| Ikeyama, S | 1 |
| Taki, S | 1 |
| Fukuda, Y | 1 |
| Ishikawa, M | 1 |
| Yogita, S | 1 |
| Tashiro, S | 1 |
| Sanz-Altamira, PM | 1 |
| Spence, LD | 1 |
| Huberman, MS | 1 |
| Posner, MR | 1 |
| Steele, G | 1 |
| Perry, LJ | 2 |
| Stuart, KE | 2 |
| Yang, EB | 1 |
| Tang, WY | 1 |
| Zhang, K | 1 |
| Cheng, LY | 1 |
| Mack, PO | 1 |
| Aitini, E | 1 |
| Rabbi, C | 1 |
| Cavazzini, G | 1 |
| Bertani, M | 1 |
| Pulica, C | 1 |
| Campo, S | 1 |
| Pari, F | 1 |
| Mambrini, A | 1 |
| Bezzi, A | 1 |
| Zamagni, D | 1 |
| Amadori, M | 1 |
| Smerieri, F | 1 |
| Kusenda, Z | 1 |
| Kerger, J | 1 |
| Awada, A | 1 |
| Geurs, F | 1 |
| Van Vreckem, A | 1 |
| Habboubi, N | 1 |
| Piccart, MJ | 1 |
| Suresh Kumar, G | 1 |
| Lipman, R | 1 |
| Cummings, J | 1 |
| Tomasz, M | 1 |
| Kogawa, T | 1 |
| Maeda, S | 2 |
| Yoshii, T | 1 |
| Kokawa, A | 1 |
| Yamamura, H | 1 |
| Ikeuchi, T | 1 |
| Tanaka, K | 5 |
| Morimoto, O | 1 |
| Shiozaki, K | 1 |
| Miya, A | 1 |
| Tomita, I | 1 |
| Kon, H | 1 |
| Sasaki, R | 1 |
| Onogawa, S | 1 |
| Nishimura, K | 1 |
| Umeda, Y | 1 |
| Imai, R | 1 |
| Nakagami, K | 1 |
| Tohyama, K | 1 |
| Suzuki, M | 2 |
| Muro, H | 1 |
| Minamimura, T | 1 |
| Katsuyama, S | 1 |
| Ookami, H | 1 |
| Okamoto, M | 1 |
| Masuyama, K | 1 |
| Takemori, S | 1 |
| Arai, H | 1 |
| Sakamoto, T | 1 |
| Tazawa, K | 1 |
| Fujimaki, M | 1 |
| Wu, Y | 3 |
| Zhou, D | 1 |
| Akasu, T | 1 |
| Moriya, Y | 7 |
| Takayama, T | 1 |
| O'Hagan, S | 1 |
| Diamond, T | 1 |
| Kusano, S | 2 |
| Katayama, M | 1 |
| Uematsu, M | 1 |
| Kaji, T | 1 |
| Kosuda, S | 1 |
| Ishii, K | 3 |
| Bornscheuer, A | 1 |
| Mahr, KH | 1 |
| Oldhafer, KJ | 1 |
| Höltje, M | 1 |
| Szabo, M | 1 |
| Kirchhoff, SK | 1 |
| Seitz, W | 1 |
| Kirchner, E | 1 |
| Roversi, R | 1 |
| Roversi, M | 1 |
| Cavallo, G | 1 |
| Tsushima, K | 2 |
| Kobayashi, I | 1 |
| Yokomori, T | 1 |
| Iesato, H | 1 |
| Ouya, T | 1 |
| Ohwada, S | 1 |
| Morishita, Y | 1 |
| Watanabe, H | 4 |
| Koide, N | 2 |
| Mihara, M | 1 |
| Nakata, S | 1 |
| Kuroda, T | 2 |
| Lale, AM | 1 |
| Jani, PJ | 1 |
| Ellis, PD | 1 |
| Vahrmeijer, AL | 1 |
| An, M | 1 |
| Terakado, H | 1 |
| Murata, M | 2 |
| Takagi, S | 2 |
| Ikawa, M | 1 |
| Nakasato, S | 1 |
| Tsugawa, T | 1 |
| Nashimoto, A | 3 |
| Sasaki, J | 3 |
| Sano, M | 2 |
| Tanaka, O | 1 |
| Tsutsui, M | 2 |
| Makino, H | 1 |
| Imamoto, H | 1 |
| Kan, K | 1 |
| Hirao, T | 1 |
| Fukunaga, M | 3 |
| Ohzato, H | 2 |
| Maruyama, H | 1 |
| Hasegawa, S | 2 |
| Kondou, M | 1 |
| Kim, Y | 1 |
| Maruo, H | 1 |
| Kirihara, M | 1 |
| Kawai, S | 1 |
| Tominaga, S | 1 |
| Ichikawa, T | 1 |
| Kume, S | 1 |
| Kasperk, R | 1 |
| Nabeya, Y | 1 |
| Okazaki, Y | 1 |
| Yamazaki, M | 1 |
| Iizuka, H | 2 |
| Akutsu, N | 1 |
| Kono, T | 1 |
| Sato, H | 2 |
| Kubosawa, H | 1 |
| Ihnat, MA | 1 |
| Lariviere, JP | 1 |
| Warren, AJ | 1 |
| La Ronde, N | 1 |
| Blaxall, JR | 1 |
| Pierre, KM | 1 |
| Turpie, BW | 1 |
| Hamilton, JW | 1 |
| Hoffman, RM | 1 |
| Kornmann, M | 4 |
| Leder, GH | 1 |
| Butzer, U | 2 |
| Staib, L | 2 |
| Gansauge, F | 2 |
| Kokudo, N | 1 |
| Seki, M | 2 |
| Azekura, K | 1 |
| Moroguchi, A | 1 |
| Matsubara, T | 1 |
| Castañeda, F | 1 |
| Kinne, RK | 1 |
| Pillasch, AF | 1 |
| Sunelaitis, E | 3 |
| Schatz, M | 2 |
| Pressmar, J | 1 |
| Sohara, N | 1 |
| Abe, T | 3 |
| Hashimoto, Y | 2 |
| Kojima, A | 1 |
| Takahashi, H | 3 |
| Nagamine, T | 2 |
| Sunamura, M | 1 |
| Egawa, S | 1 |
| Shibuya, K | 1 |
| Shimamura, H | 1 |
| Kobari, M | 1 |
| Matsuno, S | 1 |
| Solomon, B | 1 |
| Haskal, ZJ | 2 |
| Shlansky-Goldberg, RD | 2 |
| Cope, C | 1 |
| Kaneda, K | 1 |
| Rudroff, C | 1 |
| Altendorf-Hoffmann, A | 1 |
| Stangl, R | 2 |
| Scheele, J | 2 |
| Ambiru, S | 2 |
| Shimizu, H | 2 |
| Leichman, CG | 1 |
| Jacobson, JR | 1 |
| Modiano, M | 1 |
| Daniels, JR | 1 |
| Zalupski, MM | 1 |
| Doroshow, JH | 1 |
| Fletcher, WS | 1 |
| Macdonald, JS | 1 |
| Seno, H | 1 |
| Chiba, T | 1 |
| Kashima, Y | 1 |
| Kaiho, T | 2 |
| Furuya, S | 1 |
| Itoh, K | 1 |
| Takayasu, Y | 5 |
| Tajima, K | 1 |
| Rikitoku, T | 1 |
| Tamoto, A | 1 |
| Honda, T | 1 |
| Ukei, T | 2 |
| Touno, T | 1 |
| Oozato, H | 1 |
| Fukuda, K | 1 |
| Yoshioka, S | 1 |
| Azama, T | 2 |
| Katsumoto, Y | 2 |
| Nakaguchi, K | 2 |
| Furukawa, J | 2 |
| Okajima, S | 2 |
| Sue, F | 2 |
| Yamamura, T | 2 |
| Akaishi, O | 1 |
| Tsukikawa, S | 1 |
| Yabe, K | 1 |
| Higashi, S | 2 |
| Kato, C | 1 |
| Sakumoto, H | 1 |
| Sumiyoshi, K | 1 |
| Takahahsi, T | 1 |
| Matsumoto, K | 1 |
| Kane, T | 1 |
| Sakoda, M | 1 |
| Hosono, Y | 1 |
| Asano, M | 1 |
| Yamamoto, A | 1 |
| Takagi, Y | 1 |
| Kasuya, K | 2 |
| Ohashi, M | 1 |
| Balestreri, L | 1 |
| Morassut, S | 1 |
| Acunaş, B | 2 |
| Rozanes, I | 2 |
| Musha, N | 1 |
| Nihei, T | 1 |
| Sunami, E | 1 |
| Sasaki, M | 2 |
| Sando, N | 1 |
| Oka, K | 1 |
| Huang, YH | 1 |
| Wu, JC | 1 |
| Lui, WY | 2 |
| Chau, GY | 1 |
| Tsay, SH | 1 |
| Chiang, JH | 2 |
| King, KL | 1 |
| Huo, TI | 1 |
| Chang, FY | 1 |
| Lee, SD | 3 |
| Kakumu, S | 1 |
| Ito, S | 1 |
| Ishikawa, T | 2 |
| Mita, Y | 1 |
| Tagaya, T | 1 |
| Fukuzawa, Y | 1 |
| Yoshioka, K | 2 |
| Propper, DJ | 1 |
| Levitt, NC | 1 |
| O'Byrne, K | 1 |
| Braybrooke, JP | 1 |
| Talbot, DC | 1 |
| Ganesan, TS | 1 |
| Thompson, CH | 1 |
| Rajagopalan, B | 1 |
| Littlewood, TJ | 1 |
| Dixon, RM | 1 |
| Harris, AL | 1 |
| Pizzutilli, A | 1 |
| Mancini, E | 1 |
| Varrone, A | 1 |
| Palumbo, G | 1 |
| Amicucci, G | 1 |
| Perri, S | 1 |
| Deraco, M | 1 |
| Kok, LD | 1 |
| Wong, YP | 1 |
| Wu, TW | 1 |
| Chan, HC | 1 |
| Kwok, TT | 1 |
| Fung, KP | 1 |
| Salonga, D | 1 |
| Danenberg, KD | 1 |
| Danenberg, PV | 1 |
| Zhu, K | 1 |
| Hu, G | 1 |
| Liang, W | 1 |
| Abramson, RG | 1 |
| Rosen, MP | 1 |
| Brophy, DP | 1 |
| Raeburn, SL | 1 |
| Ikeda, J | 1 |
| Kikunaga, H | 1 |
| Sotome, K | 1 |
| Morisue, A | 1 |
| Matsudo, A | 1 |
| Nakai, H | 1 |
| Takao, M | 1 |
| Osakabe, Y | 1 |
| Miura, H | 1 |
| Toshima, T | 1 |
| Teshima, T | 1 |
| Hejna, M | 1 |
| Köstler, WJ | 1 |
| Raderer, M | 1 |
| Tomek, S | 1 |
| Brodowicz, T | 1 |
| Wiltschke, C | 1 |
| Zielinski, CC | 1 |
| Ikeda, H | 1 |
| Takamatsu, M | 1 |
| Sendou, H | 1 |
| Kanoh, Y | 1 |
| Yasue, A | 1 |
| Okada, K | 3 |
| Hata, T | 1 |
| Iwazawa, T | 1 |
| Matsui, S | 1 |
| Yano, H | 1 |
| Kinuta, M | 1 |
| Monden, T | 2 |
| Tamamori, Y | 2 |
| Shimizu, S | 1 |
| Oosawa, T | 1 |
| Sakimoto, T | 1 |
| Niinobu, T | 1 |
| Shibata, T | 2 |
| Fukushima, Y | 1 |
| Kitada, M | 1 |
| Tukahara, Y | 1 |
| Hata, S | 1 |
| Hayashida, H | 1 |
| Fuzita, J | 1 |
| Takahashi, Y | 5 |
| Suzuki, R | 1 |
| Shimano, T | 3 |
| Ishida, T | 1 |
| Yukawa, M | 1 |
| Takekuni, K | 1 |
| Desai, DC | 1 |
| O'Dorisio, TM | 1 |
| Schirmer, WJ | 1 |
| Jung, SS | 1 |
| Khabiri, H | 1 |
| Villanueva, V | 1 |
| Martin, EW | 1 |
| Goda, F | 1 |
| Wakabayashi, H | 1 |
| Maeba, T | 1 |
| Mori, S | 1 |
| Okano, K | 1 |
| Usuki, H | 1 |
| Mihara, T | 1 |
| Okada, H | 1 |
| Uchida, Y | 1 |
| Maeta, H | 1 |
| Senda, S | 1 |
| Yamasaki, Y | 1 |
| Noda, M | 2 |
| Kusunoki, M | 1 |
| Yanagi, H | 1 |
| Yoshikawa, R | 1 |
| Matsuoka, K | 1 |
| Hisamatsu, T | 1 |
| Aoyagi, S | 1 |
| Motohashi, Y | 1 |
| Ikezawa, T | 1 |
| Tatsuno, S | 1 |
| Mizuno, Y | 1 |
| Ishizaki, M | 1 |
| Akiyama, N | 1 |
| Motegi, M | 1 |
| Sasamoto, H | 1 |
| Osawa, H | 1 |
| Wada, W | 1 |
| Nakajima, M | 1 |
| Rajan, DK | 1 |
| Freiman, DB | 1 |
| Nishio, Y | 1 |
| Ueno, N | 1 |
| Kawaguchi, K | 1 |
| Khoubehi, B | 1 |
| Schofield, A | 1 |
| Leslie, M | 1 |
| Talbot, IC | 1 |
| Northover, JM | 1 |
| Baba, M | 1 |
| Kamiya, K | 1 |
| Oba, K | 1 |
| Kaneko, T | 1 |
| Syouji, T | 1 |
| Igarashi, A | 1 |
| Brountzos, EN | 1 |
| Panagiotou, IE | 1 |
| Bafaloukos, D | 1 |
| Magoulas, D | 1 |
| Kelekis, DA | 1 |
| Chia-Hsien Cheng, J | 1 |
| Cheng, SH | 1 |
| Lin, YM | 1 |
| Cheng, TI | 1 |
| Yang, PS | 1 |
| Jian, JJ | 1 |
| You, DL | 1 |
| Horng, CF | 1 |
| Huang, AT | 1 |
| Hishikawa, Y | 1 |
| Kimoto, T | 2 |
| Dhar, DK | 2 |
| Tachibana, M | 2 |
| Gores, GJ | 1 |
| Nozu, S | 1 |
| Saitou, AY | 1 |
| Okayasu, K | 1 |
| Majima, T | 1 |
| Yagi, A | 1 |
| Asami, S | 1 |
| Saito, Y | 3 |
| Daikoku, Y | 1 |
| Nakazawa, K | 1 |
| Shibata, S | 1 |
| Suzuki, H | 2 |
| Murata, N | 1 |
| Tokura, H | 2 |
| Ikeda, T | 2 |
| Masamura, S | 1 |
| Matsui, A | 1 |
| Hojo, T | 1 |
| Kawaguchi, M | 1 |
| Takayama, S | 1 |
| Mitsui, Y | 1 |
| Miyabe, R | 1 |
| Gille, T | 1 |
| Engelmann, K | 1 |
| Woitaschek, D | 1 |
| Poyanli, A | 1 |
| Sencer, S | 1 |
| Formentini, A | 1 |
| Kim, YC | 1 |
| Koh, JT | 1 |
| Shin, BA | 1 |
| Ahn, KY | 1 |
| Choi, BK | 1 |
| Kim, CG | 1 |
| Kim, KK | 1 |
| Xu, C | 1 |
| Zheng, S | 1 |
| Cai, Y | 1 |
| Huang, Z | 1 |
| Yashimura, H | 1 |
| Ohno, S | 1 |
| Kiss, I | 1 |
| Marková, J | 1 |
| Tomásek, J | 1 |
| Vyzula, R | 1 |
| Válek, V | 1 |
| Boudný, J | 1 |
| Kala, Z | 1 |
| Hanke, I | 1 |
| Ostrízek, T | 1 |
| Leypold, J | 1 |
| Achenbach, T | 1 |
| Seifert, JK | 1 |
| Schunk, K | 1 |
| Niitsu, Y | 1 |
| Watanabe, O | 1 |
| Haga, S | 1 |
| Kato, H | 2 |
| Ooishi, T | 1 |
| Kobayashi, S | 1 |
| Okabe, T | 1 |
| Yoshimatsu, K | 1 |
| Yokomizo, H | 1 |
| Kumazawa, K | 1 |
| Murayama, M | 1 |
| Kajiwara, T | 1 |
| Murakami, M | 1 |
| Morikawa, A | 1 |
| Okabe, R | 1 |
| Miyazawa, K | 1 |
| Iijima, S | 2 |
| Ozaki, K | 1 |
| Suzuki, A | 1 |
| Sugiyama, A | 1 |
| Popov, I | 1 |
| Lavrnić, S | 1 |
| Jelić, S | 1 |
| Jezdić, S | 1 |
| Jasović, A | 1 |
| Minami, S | 1 |
| Mai, M | 3 |
| Yang, S | 1 |
| Zhu, H | 1 |
| Cao, J | 1 |
| Matsuki, S | 1 |
| Matama, S | 1 |
| Shibata, H | 2 |
| Matsumoto, M | 2 |
| Nakayama, M | 2 |
| Kitagami, K | 1 |
| Fukui, H | 1 |
| Tsujii, T | 2 |
| Okamoto, Y | 1 |
| Schilling, A | 1 |
| Gewiese, B | 1 |
| Berger, G | 1 |
| Boese-Landgraf, J | 1 |
| Fobbe, F | 1 |
| Stiller, D | 1 |
| Gallkowski, U | 1 |
| Wolf, KJ | 1 |
| Damascelli, B | 2 |
| Garbagnati, F | 1 |
| Marchianò, A | 2 |
| Salvetti, M | 1 |
| Di Tolla, G | 1 |
| Lanocita, R | 1 |
| Kitamura, T | 1 |
| Maruyama, T | 2 |
| Iwaki, Y | 1 |
| Kawano, T | 1 |
| Eto, T | 1 |
| Tamaki, N | 1 |
| Komura, K | 1 |
| Ishinoda, Y | 1 |
| Oiyong, G | 1 |
| Ohue, S | 2 |
| Phornphutkul, K | 1 |
| Handagoon, P | 1 |
| Sirivanichai, C | 1 |
| Senarat, S | 1 |
| Yamagata, M | 3 |
| Kanematsu, T | 4 |
| Matsumata, T | 3 |
| Utsunomiya, T | 3 |
| Ikeda, Y | 1 |
| Abe, K | 2 |
| Sugata, F | 2 |
| Takizawa, K | 2 |
| Yoshiba, M | 2 |
| Takagi, T | 2 |
| Kuniyasu, Y | 2 |
| Iwao, Y | 2 |
| Iwasa, K | 1 |
| Masutani, H | 1 |
| Nakazaki, H | 2 |
| Kuramoto, S | 1 |
| Hanawa, S | 2 |
| Hasebe, Y | 1 |
| Yanagita, K | 1 |
| Yoshio, T | 1 |
| Komada, H | 1 |
| Yamamura, M | 1 |
| Kawaguchi, Y | 1 |
| Kwon, M | 1 |
| Uetsuji, S | 1 |
| Kamiyama, Y | 1 |
| Harima, K | 1 |
| Akaza, K | 2 |
| Mitani, T | 1 |
| Murakami, T | 1 |
| Nakanishi, K | 1 |
| Maeshima, S | 1 |
| Tomoda, K | 1 |
| Kozuka, T | 1 |
| Morioka, N | 1 |
| Tanigawa, N | 1 |
| Okuda, Y | 1 |
| Yano, T | 2 |
| Tsukui, M | 2 |
| Goto, K | 1 |
| Makuuchi, H | 1 |
| Chen, X | 1 |
| Zhong, D | 1 |
| Tan, T | 1 |
| Yan, C | 1 |
| Yamada, Y | 2 |
| Kakizaki, K | 2 |
| Yamauchi, H | 2 |
| Atiq, OT | 1 |
| Niedzwiecki, D | 3 |
| Botet, J | 1 |
| Gotoh, M | 2 |
| Umeshita, K | 3 |
| Dono, K | 1 |
| Mori, T | 4 |
| Matuki, N | 2 |
| Ohyama, S | 2 |
| Muraoka, K | 1 |
| Kaji, M | 1 |
| Tsugawa, K | 2 |
| Segawa, M | 2 |
| Yabushita, K | 2 |
| Fukushima, W | 1 |
| Sahara, H | 1 |
| Saitoh, F | 1 |
| Taniya, T | 1 |
| Tsuji, M | 1 |
| Hara, T | 1 |
| Taniguchi, T | 1 |
| Ding, JW | 1 |
| Wu, ZD | 1 |
| Andersson, R | 1 |
| Bengmark, S | 1 |
| Katou, M | 1 |
| Kanno, A | 1 |
| Kaneda, N | 1 |
| Yamawaki, Y | 1 |
| Tabuchi, M | 1 |
| Takeda, T | 1 |
| Yakushiji, H | 1 |
| Hiroyoshi, M | 1 |
| Matsumoto, S | 1 |
| Fukawa, M | 1 |
| Imaizumi, N | 1 |
| Okushima, K | 1 |
| Koike, T | 1 |
| Honda, H | 1 |
| Fuchinoue, S | 2 |
| Teraoka, S | 2 |
| Agishi, T | 2 |
| Ota, K | 3 |
| Awano, T | 2 |
| Matsubara, H | 2 |
| Nakaichi, H | 1 |
| Funami, Y | 1 |
| Matsushita, K | 1 |
| Amano, H | 1 |
| Horigome, N | 2 |
| Hanasaki, K | 2 |
| Shiohara, E | 1 |
| Haba, Y | 1 |
| Kaneko, G | 1 |
| Makino, Y | 1 |
| Taniura, H | 1 |
| Ohiwa, K | 1 |
| Takemoto, Y | 1 |
| O'Connell, MJ | 1 |
| Sella, A | 1 |
| Logothetis, CJ | 1 |
| Fitz, K | 1 |
| Dexeus, FH | 1 |
| Amato, R | 1 |
| Kilbourn, R | 1 |
| Clement, O | 1 |
| Frija, G | 1 |
| Chambon, C | 1 |
| Schouman-Clayes, E | 1 |
| Nabeyama, A | 1 |
| Nakashima, A | 1 |
| Kanzaki, T | 1 |
| Matsuo, S | 1 |
| Ohta, K | 1 |
| Endoh, A | 1 |
| Kai, K | 1 |
| Sasahashi, N | 1 |
| Richter, EI | 2 |
| Schultheis, KH | 2 |
| Gebhardt, C | 2 |
| Wurzer, W | 1 |
| Bécouarn, Y | 1 |
| Brunet, R | 1 |
| Ravaud, A | 1 |
| Bussières, E | 1 |
| Lagarde, P | 1 |
| Satoh, J | 1 |
| Hatayama, H | 1 |
| Kitamura, H | 1 |
| Shibata, N | 1 |
| Noguchi, S | 1 |
| Kawamura, M | 1 |
| Ishihara, T | 1 |
| Mouri, M | 1 |
| Mizutani, J | 1 |
| Hiraoka, T | 1 |
| Miyauchi, Y | 1 |
| Goldberg, JA | 2 |
| Anderson, JR | 1 |
| Wilmott, N | 1 |
| Whatelely, AT | 1 |
| Mckillop, J | 1 |
| Mura, T | 1 |
| Bandou, H | 1 |
| Nomura, T | 1 |
| Takeda, M | 1 |
| Mizuguchi, N | 1 |
| Ohyama, Y | 1 |
| Suzuki, S | 1 |
| Itoh, M | 1 |
| Mukojima, T | 1 |
| Kumagai, T | 1 |
| Iwasaki, H | 1 |
| Tada, I | 2 |
| Mori, K | 1 |
| Takeyama, M | 1 |
| Kamiyama, T | 2 |
| Une, Y | 3 |
| Matsuoka, S | 2 |
| Nagabuchi, E | 2 |
| Gotoda, A | 1 |
| Katsumata, T | 1 |
| Fukai, S | 1 |
| Li, GQ | 1 |
| Sawada, Y | 2 |
| Iwamoto, S | 2 |
| Yurino, N | 1 |
| Fujii, S | 1 |
| Murai, N | 1 |
| Okuno, F | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Takashima, T | 1 |
| Shizumi, Y | 3 |
| Nishigaki, H | 1 |
| Horiike, S | 1 |
| Taniwaki, M | 1 |
| Misawa, S | 1 |
| Kashima, K | 1 |
| Hironaka, T | 1 |
| Fujimoto, K | 1 |
| Takada, K | 1 |
| Mitsuhashi, T | 1 |
| Ichikawa, W | 1 |
| Nihei, Z | 1 |
| Sawai, S | 1 |
| Uetake, H | 1 |
| Yamashita, T | 1 |
| Kawamura, N | 1 |
| Shiraishi, T | 1 |
| Mishima, Y | 1 |
| Chiba, Y | 1 |
| Fukushi, G | 1 |
| Matsukawa, M | 1 |
| Wada, K | 1 |
| Aoyama, H | 1 |
| Fukushi, M | 1 |
| Nakagawa, A | 1 |
| Hiramatsu, Y | 1 |
| Kitade, H | 1 |
| Ogura, T | 1 |
| Takada, H | 1 |
| Hioki, K | 1 |
| Franchi, F | 1 |
| Seminara, P | 1 |
| Giannarelli, D | 1 |
| Konovalova, N | 1 |
| Mukaiyama, T | 2 |
| Mizunuma, N | 1 |
| Itami, S | 1 |
| Hirano, A | 1 |
| Matsuoka, A | 1 |
| Matsumura, T | 1 |
| Yoshinaka, K | 3 |
| Ohtagaki, S | 1 |
| Toi, M | 1 |
| Toge, T | 4 |
| Altendorf-Hofmann, A | 1 |
| Gall, FP | 1 |
| Shirabe, K | 2 |
| Akazawa, K | 1 |
| Furui, S | 1 |
| Nakoa, N | 1 |
| Kamino, K | 1 |
| Ohnishi, M | 1 |
| Okamoto, E | 1 |
| Matsuda, H | 1 |
| Yoshimatsu, A | 2 |
| Yasuda, D | 2 |
| Blackie, R | 1 |
| Whately, TL | 1 |
| Pettit, L | 1 |
| Oyamada, H | 3 |
| Ichikawa, H | 2 |
| Kokura, S | 1 |
| Tainaka, K | 5 |
| Sugino, S | 5 |
| Urade, M | 2 |
| Takegawa, S | 2 |
| Kamata, T | 2 |
| Matumoto, H | 1 |
| Chang, YC | 1 |
| Yukaya, H | 1 |
| Dijkstra, FR | 1 |
| van Dierendonck, JH | 1 |
| Kuppen, PJ | 1 |
| Cornelisse, CJ | 1 |
| Weder, W | 2 |
| Röthlin, M | 1 |
| Largiadèr, F | 2 |
| Czejka, M | 1 |
| Jäger, W | 2 |
| Schüller, J | 2 |
| Schernthaner, G | 1 |
| Oka, H | 1 |
| Ishida, Y | 1 |
| Kojima, N | 1 |
| Kusumoto, S | 1 |
| Nakayoshi, A | 1 |
| Kumaki, T | 1 |
| Katoh, M | 1 |
| Gotohda, H | 1 |
| Saitoh, H | 1 |
| Kurosawa, H | 1 |
| Ohki, S | 2 |
| Joh, T | 2 |
| Imai, S | 2 |
| Matsuo, K | 2 |
| Fukano, M | 2 |
| Tokitoh, T | 1 |
| Masui, H | 1 |
| Morimoto, H | 1 |
| Ishikawa, H | 1 |
| Shimizu, T | 5 |
| Nakagoe, T | 1 |
| Kusano, H | 1 |
| Kajiwara, K | 1 |
| Nakamura, Y | 3 |
| Ifuku, M | 1 |
| Shiraishi, E | 1 |
| Tanemura, H | 1 |
| Kawai, M | 1 |
| Hasegawa, Y | 1 |
| Honnma, S | 1 |
| Yajima, K | 1 |
| Nakashima, Y | 1 |
| Sugihara, K | 3 |
| Tsujitani, S | 1 |
| Watanabe, A | 3 |
| Kakeji, Y | 1 |
| Tomoda, H | 1 |
| Furusawa, M | 1 |
| Shirayama, Y | 1 |
| Hirohata, T | 1 |
| Ozaki, M | 2 |
| Kambhu, SA | 1 |
| Kelsen, DP | 1 |
| Fiore, J | 1 |
| Chapman, D | 2 |
| Vinciguerra, V | 1 |
| Rosenbluth, R | 1 |
| Goshima, H | 1 |
| Yamazaki, Y | 1 |
| Kokehara, N | 1 |
| Oota, M | 1 |
| Ishida, N | 1 |
| Itou, F | 1 |
| Yamasaki, S | 1 |
| Moriya, N | 1 |
| Yasui, K | 1 |
| Hirai, T | 1 |
| Fukuzumi, S | 1 |
| Terui, S | 1 |
| Kakuta, T | 3 |
| Sakurai, H | 1 |
| Suga, T | 1 |
| Ohta, T | 2 |
| Sawaguchi, K | 1 |
| Ogino, T | 2 |
| Fukunaga, J | 1 |
| Kitahama, H | 1 |
| Okuyama, A | 1 |
| Seki, T | 1 |
| Tsurui, K | 1 |
| Saka, M | 1 |
| Sasagawa, M | 1 |
| Hishinuma, S | 1 |
| Kotake, K | 1 |
| Yasuda, S | 1 |
| Noto, T | 1 |
| Ikeda, M | 1 |
| Mukai, M | 1 |
| Mizutani, K | 1 |
| Gotoh, K | 1 |
| Ohtani, Y | 1 |
| Kawano, N | 1 |
| Houjo, K | 1 |
| Iijima, K | 1 |
| Nakajima, S | 1 |
| Hamahata, Y | 1 |
| Kimura, H | 1 |
| Matsuki, N | 2 |
| Kawahara, T | 1 |
| Nomura, M | 1 |
| Kudou, J | 1 |
| Ishibashi, O | 1 |
| Niho, Y | 1 |
| Schwemmle, K | 3 |
| Schumacher, F | 1 |
| Jinushi, K | 2 |
| Hirabayashi, N | 1 |
| Kirihara, Y | 1 |
| Takagami, S | 1 |
| Ryuji, K | 1 |
| Yorishima, T | 1 |
| Nishiyama, M | 2 |
| Noso, Y | 1 |
| Safi, F | 1 |
| Schumacher, K | 1 |
| Roscher, R | 1 |
| Bittner, R | 1 |
| Watanabe, T | 3 |
| Funahashi, H | 1 |
| Imai, T | 1 |
| Kato, N | 1 |
| Oike, E | 1 |
| Odaka, K | 1 |
| Narita, T | 1 |
| Chuganji, Y | 1 |
| Matsuzaki, Y | 1 |
| Ebihara, T | 1 |
| Shoda, J | 1 |
| Nishi, M | 1 |
| Koyama, S | 1 |
| Fukutomi, H | 1 |
| Osuga, T | 2 |
| Audisio, RA | 1 |
| Doci, R | 1 |
| Mazzaferro, V | 1 |
| Bellegotti, L | 1 |
| Tommasini, M | 1 |
| Montalto, F | 1 |
| Piva, A | 1 |
| DeFazio, C | 1 |
| Ikeya, S | 1 |
| Muramatsu, Y | 1 |
| Moriyama, N | 1 |
| Jones, WB | 1 |
| Wagner-Reiss, KM | 1 |
| Lewis, JL | 1 |
| Kiyozaki, H | 1 |
| Teranaka, M | 1 |
| Niwa, M | 1 |
| Kato, K | 2 |
| Akai, S | 2 |
| Isshiki, K | 2 |
| Kishimoto, W | 3 |
| Yokoyama, H | 2 |
| Takehara, M | 2 |
| Kotake, M | 2 |
| Aoki, Y | 7 |
| Hiratuka, H | 1 |
| Majima, Y | 5 |
| Ohashi, I | 1 |
| Oohigashi, H | 1 |
| Fukuda, I | 1 |
| Fukushima, H | 1 |
| Shimada, M | 1 |
| Iwai, I | 1 |
| Nakashima, O | 1 |
| Ohsawa, K | 1 |
| Goto, T | 1 |
| Chiba, S | 1 |
| Kondoh, K | 1 |
| Sasaki, S | 1 |
| Sekine, K | 1 |
| Katayama, S | 1 |
| Moriai, O | 1 |
| Kuwahara, A | 1 |
| Hirao, E | 1 |
| Shimoda, K | 1 |
| Miyahara, M | 1 |
| Hatta, Y | 1 |
| Sassa, T | 1 |
| Yoshikawa, N | 1 |
| Hirose, N | 1 |
| Funatomi, H | 1 |
| Morimoto, Y | 2 |
| Nimura, Y | 1 |
| Hayakawa, N | 1 |
| Kamiya, J | 1 |
| Shionoya, S | 1 |
| Kikuno, M | 1 |
| Hiraki, Y | 2 |
| Toyohira, K | 1 |
| Wada, T | 3 |
| Iwanaga, T | 2 |
| Koyama, H | 1 |
| Akita, N | 1 |
| Wada, A | 1 |
| Molzahn, E | 1 |
| Gruenagel, HH | 1 |
| Freund, U | 1 |
| Gross, D | 1 |
| Sawada, H | 2 |
| Nakatani, K | 1 |
| Miyagi, N | 1 |
| Ezaki, T | 1 |
| Sugisaki, T | 1 |
| Nishiwada, T | 1 |
| Okumura, T | 2 |
| Shiratori, T | 1 |
| Konishi, Y | 1 |
| Sakabe, T | 2 |
| Kamata, R | 1 |
| Okayasu, I | 1 |
| Hatakeyama, S | 1 |
| Yoshimatsu, S | 1 |
| Tsuruta, K | 1 |
| Kimula, Y | 1 |
| Lele, SB | 1 |
| Piver, MS | 1 |
| Muraoka, A | 1 |
| Tokiwa, T | 1 |
| Sato, J | 1 |
| Horishi, M | 2 |
| Yashige, H | 1 |
| Sue, K | 1 |
| Ukida, M | 1 |
| Nouso, K | 1 |
| Sasaki, F | 1 |
| Hata, Y | 1 |
| Tamura, M | 2 |
| Bissat, A | 2 |
| Koella, C | 1 |
| Seybold, K | 1 |
| Andersson, M | 1 |
| Aronsen, KF | 1 |
| Balch, C | 1 |
| Domellöf, L | 1 |
| Eksborg, S | 1 |
| Hafström, LO | 1 |
| Kåresen, R | 1 |
| Midander, J | 1 |
| Teder, H | 1 |
| Henne-Bruns, D | 1 |
| Marks, HG | 1 |
| Marks, V | 1 |
| Weh, HJ | 1 |
| Kremer, B | 1 |
| Ikubo, A | 1 |
| Miyazaki, K | 1 |
| Takano, N | 1 |
| Uogishi, M | 1 |
| Hottenrott, C | 4 |
| Guhji, M | 3 |
| Kokubun, M | 2 |
| Kiuchi, S | 2 |
| Konno, C | 1 |
| Teshima, Y | 1 |
| Fujiyoshi, M | 1 |
| Ogata, Y | 1 |
| Kimitsuki, H | 1 |
| Hiraki, M | 1 |
| Sawada, T | 4 |
| Takano, H | 1 |
| Gunji, Y | 1 |
| Kosaki, G | 2 |
| Matsuda, T | 1 |
| Maruyama, J | 1 |
| Morikawa, E | 1 |
| Hida, J | 1 |
| Ko, K | 1 |
| Ishimura, M | 1 |
| Gondo, H | 1 |
| Misawa, K | 1 |
| Ishiguro, M | 1 |
| Wakatsuki, T | 1 |
| Hamazoe, R | 1 |
| Shimizu, N | 1 |
| Komi, N | 1 |
| Abe, O | 3 |
| Mori, N | 1 |
| Tanaka, A | 1 |
| Czejka, MJ | 1 |
| Barras, J | 1 |
| Bär, HU | 1 |
| Schweizer, W | 1 |
| Schneider, A | 1 |
| Oderman, P | 1 |
| Yang, CF | 2 |
| Ho, YZ | 2 |
| Chang, JM | 2 |
| Chiang, RH | 1 |
| Tsai, YT | 2 |
| Liu, TJ | 1 |
| Chen, GH | 2 |
| Yoshimura, H | 1 |
| Matsui, T | 1 |
| Takaya, A | 1 |
| Cheirsilpa, A | 1 |
| Leelasethakul, S | 1 |
| Auethaveekiat, V | 1 |
| Maoleekulpriroj, S | 1 |
| Kangsumrit, N | 1 |
| Thanakaravit, P | 1 |
| Phanthumjida, P | 1 |
| Hasumura, S | 1 |
| Nagamori, S | 1 |
| Fujise, K | 1 |
| Homma, S | 1 |
| Sujino, H | 1 |
| Matsuura, T | 1 |
| Niiya, M | 1 |
| Kameda, H | 1 |
| Udagawa, I | 1 |
| Koshikawa, H | 1 |
| Kanno, Y | 1 |
| Teramoto, O | 1 |
| Otsuka, S | 1 |
| Tsubuku, Y | 1 |
| Kenmizaki, H | 1 |
| Tatekawa, I | 1 |
| Miyazono, K | 2 |
| Kubo, Y | 3 |
| Saitsu, H | 1 |
| Koura, Y | 1 |
| Kurisu, Y | 1 |
| Kuroi, K | 1 |
| Shiga, T | 1 |
| Noguchi, T | 1 |
| Nishimaki, K | 1 |
| Kinosita, T | 1 |
| Sodeyama, H | 1 |
| Iida, F | 1 |
| Ishibashi, T | 1 |
| Okajima, K | 1 |
| Isozaki, H | 1 |
| Nakata, E | 1 |
| Nishimura, J | 1 |
| Iga, C | 1 |
| Amioka, K | 1 |
| Tanimura, M | 1 |
| Hara, H | 1 |
| Haida, K | 2 |
| Mitarai, Y | 1 |
| Horichi, H | 1 |
| Kitabayashi, K | 1 |
| Yasumori, K | 1 |
| Masuda, K | 1 |
| Haba, T | 2 |
| Mizoguchi, M | 1 |
| Eguchi, H | 1 |
| Mitsugi, O | 1 |
| Iimura, Y | 1 |
| Sugahara, K | 1 |
| Hattori, F | 1 |
| Takagi, A | 1 |
| Iseki, J | 1 |
| Taniguchi, H | 3 |
| Sawai, K | 3 |
| Karube, H | 1 |
| Okabe, H | 1 |
| Okudaira, M | 1 |
| Araki, I | 1 |
| Shinagawa, T | 1 |
| Sekikawa, H | 1 |
| Soga, K | 2 |
| Turuya, T | 1 |
| Toshima, M | 1 |
| Shibasaki, K | 1 |
| Matugi, H | 1 |
| Kawai, C | 1 |
| Asakura, H | 1 |
| Miyamoto, K | 1 |
| Miyairi, M | 1 |
| Saitoh, S | 2 |
| Itoh, T | 1 |
| Sasaki, D | 1 |
| Yoshida, Y | 2 |
| Miyake, Y | 3 |
| Sakamoto, K | 2 |
| Akamatsu, H | 1 |
| Takabayashi, T | 2 |
| Sugita, S | 2 |
| Iida, S | 1 |
| Tanabe, Y | 2 |
| Ooi, T | 2 |
| Horie, Y | 1 |
| Inoue, J | 1 |
| Hara, Y | 1 |
| Okumura, M | 1 |
| Hirayama, C | 1 |
| Uehara, M | 1 |
| Takayama, H | 1 |
| Ojima, T | 1 |
| Katakai, S | 1 |
| Takezawa, J | 1 |
| Mavor, AI | 1 |
| Parkin, A | 1 |
| Riley, A | 1 |
| Smye, S | 1 |
| O'Brien, T | 1 |
| Robinson, PJ | 1 |
| Giles, GR | 1 |
| Ohtsuka, N | 1 |
| Nomoto, M | 1 |
| Ichida, T | 1 |
| Aoyagi, Y | 1 |
| Ichida, F | 1 |
| Sako, M | 3 |
| Hirota, S | 3 |
| Hasegawa, M | 2 |
| Hase, M | 2 |
| Kono, M | 1 |
| Shimotsuma, M | 2 |
| Kagawa, K | 1 |
| Kamachi, M | 1 |
| Ashihara, T | 1 |
| Shimamura, Y | 2 |
| Itoh, Y | 1 |
| Kuroe, K | 1 |
| Shioaki, Y | 1 |
| Itoh, A | 1 |
| Seiki, K | 1 |
| Kitai, S | 1 |
| Kuninobu, H | 1 |
| Kodama, H | 2 |
| Niimoto, M | 2 |
| Saitu, H | 1 |
| Nakayama, K | 1 |
| Tsuda, M | 1 |
| Nishioka, S | 1 |
| Yataka, I | 1 |
| Seto, O | 2 |
| Miyazone, K | 1 |
| Chang, T | 1 |
| Liu, WY | 1 |
| Kusumoto, T | 1 |
| Adachi, S | 1 |
| Todoroki, T | 1 |
| Nosue, M | 1 |
| Fukao, K | 1 |
| Saida, Y | 1 |
| Doi, M | 1 |
| Ebisui, S | 1 |
| Maekawa, T | 1 |
| Mitoshi, M | 1 |
| Tarusawa, K | 1 |
| Midorikawa, H | 1 |
| Kanehira, J | 1 |
| Ikami, I | 1 |
| Yodono, H | 1 |
| Takekawa, SD | 1 |
| Yamashita, M | 1 |
| Kushima, K | 1 |
| Matsuno, H | 1 |
| Hashiba, M | 1 |
| Miyamoto, Y | 1 |
| Nasu, H | 1 |
| Arakawa, H | 1 |
| Masamune, O | 1 |
| Vaughn, CB | 1 |
| Chapman, J | 1 |
| Zaks, J | 1 |
| Young, S | 1 |
| Chinn, B | 1 |
| Enochs, K | 1 |
| Maniscalco, E | 1 |
| Duffin, H | 1 |
| Groshko, G | 1 |
| Reznik, S | 1 |
| McBride, CM | 1 |
| Ames, FC | 1 |
| Claghorn, LJ | 1 |
| Cleary, KR | 1 |
| Boddie, AW | 1 |
| Charnsangavej, C | 2 |
| Faintuch, J | 1 |
| Levin, B | 1 |
| Carrasco, C | 1 |
| Suzuyama, H | 1 |
| Kotanagi, H | 1 |
| Balletto, N | 1 |
| Scopinaro, G | 1 |
| Simoni, G | 1 |
| Claudiani, F | 1 |
| De Paoli, M | 1 |
| Fratino, G | 1 |
| Margreiter, R | 1 |
| Schmid, T | 1 |
| Steiner, E | 1 |
| Aigner, F | 1 |
| Then, P | 1 |
| Pernthaler, H | 1 |
| Ficorella, C | 1 |
| Cagnazzo, P | 1 |
| Cardi, G | 1 |
| Ricciuti, FP | 1 |
| Marchetti, P | 1 |
| Frati, L | 1 |
| Marchei, P | 1 |
| Maeda, H | 1 |
| Al-Idrissi, HY | 1 |
| Ibrahim, EM | 1 |
| Abdel Satir, A | 1 |
| Satti, MB | 1 |
| Al-Kasem, S | 1 |
| Al-Qurain, A | 1 |
| Yoshioka, H | 1 |
| Wakasa, K | 1 |
| Iwai, M | 2 |
| Obata, H | 1 |
| Tomimatsu, M | 1 |
| Okazaki, N | 1 |
| Kurioka, N | 1 |
| Ohyama, M | 1 |
| Ohtsuki, S | 1 |
| Naitoh, A | 1 |
| Tarumi, T | 1 |
| Nakase, A | 1 |
| Yagita, A | 1 |
| Tachikawa, I | 1 |
| Onodera, H | 1 |
| Oikawa, M | 1 |
| Chida, N | 1 |
| Goto, Y | 1 |
| Kondoh, H | 1 |
| Chin, JH | 1 |
| Oon, CJ | 1 |
| Tan, L | 1 |
| Yong, YM | 1 |
| Iwamura, F | 1 |
| Yamashita, Y | 1 |
| Shinzato, J | 1 |
| Saito, R | 1 |
| Korogi, Y | 1 |
| Sakai, M | 1 |
| Fujio, N | 1 |
| Hirohashi, K | 1 |
| Kubo, S | 1 |
| Iwasa, R | 1 |
| Naito, Y | 1 |
| Hotta, T | 1 |
| Ohmura, K | 1 |
| Matsuo, SK | 1 |
| Ohtsuka, Y | 1 |
| Hayasaka, A | 1 |
| Tsunoda, T | 1 |
| Chin, N | 1 |
| Tada, A | 1 |
| Yamazaki, H | 1 |
| Schaeffer, N | 1 |
| Higgins, J | 1 |
| Pandya, KJ | 1 |
| Chang, AY | 1 |
| Qazi, R | 1 |
| Rubins, J | 1 |
| Asbury, R | 1 |
| Kurokawa, H | 1 |
| Kamita, N | 1 |
| Nagahori, J | 1 |
| Kijima, Y | 1 |
| Ritsuno, H | 1 |
| Inaniwa, K | 1 |
| Nakazawa, H | 1 |
| Akimoto, S | 1 |
| Hamano, K | 1 |
| Watase, M | 1 |
| Okuda, H | 1 |
| Aigner, K | 1 |
| Overbosch, EH | 1 |
| Kuijpers, TJ | 1 |
| Murata, T | 1 |
| Kawa, S | 1 |
| Wollner, IS | 1 |
| Walker-Andrews, SC | 1 |
| Smith, JE | 1 |
| Jain, S | 1 |
| Seymour, AE | 1 |
| Mermillod, B | 1 |
| Gloor, F | 1 |
| Mueller, W | 1 |
| Rieck, B | 1 |
| Follezou, JY | 1 |
| Baumelou, A | 1 |
| Audebert, A | 1 |
| Beaufils, H | 1 |
| Karkouche, B | 1 |
| Yamada, H | 1 |
| Starkhammar, H | 1 |
| Morales, O | 1 |
| Svedberg, J | 1 |
| Niemelä, R | 1 |
| Ståhlberg, M | 1 |
| Kin, R | 1 |
| Iwamori, S | 1 |
| Saeki, S | 1 |
| Nishimawari, K | 1 |
| Nagusa, Y | 1 |
| Sasao, T | 1 |
| Roethlin, M | 1 |
| Voigt, H | 1 |
| Gerard, A | 2 |
| Bleiberg, H | 1 |
| Oyamada, Y | 1 |
| Yamada, T | 1 |
| Matsuo, R | 1 |
| Usuki, N | 1 |
| Kaminou, T | 1 |
| Tsubakimoto, M | 1 |
| Manabe, T | 1 |
| Ota, J | 1 |
| Nehashi, Y | 1 |
| Reimann-Kirkowa, M | 1 |
| Guo, JY | 1 |
| Housholder, DF | 1 |
| Hynes, HE | 1 |
| Dakhil, SR | 1 |
| Marymont, JV | 1 |
| Sterchi, JM | 1 |
| Wells, JJ | 1 |
| Nostrant, TT | 1 |
| Wilson, JA | 1 |
| Sakurai, Y | 1 |
| Kuzuoka, M | 1 |
| Ishii, T | 1 |
| Terao, K | 1 |
| Suyama, K | 1 |
| Kitsukawa, Y | 1 |
| Higuchi, M | 1 |
| Masuda, T | 1 |
| Narisawa, T | 1 |
| Koyama, K | 1 |
| Shigemitsu, M | 1 |
| Joya, K | 1 |
| Hara, S | 1 |
| Katsumi, S | 1 |
| Murai, T | 1 |
| Kawaguchi, T | 1 |
| Idezuki, Y | 1 |
| Arizuka, S | 1 |
| Ashida, Y | 1 |
| Midoh, Y | 1 |
| Hanmyo, K | 1 |
| Harakawa, S | 1 |
| Daido, K | 1 |
| Hayashi, M | 1 |
| Fujiwara, T | 1 |
| Juan, IK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hepatic Arterial Infusion Chemotherapy as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma(HCC): A Prospective Randomized Controlled Clinical Trial[NCT02767375] | Phase 2/Phase 3 | 192 participants (Anticipated) | Interventional | 2015-02-28 | Recruiting | ||
| A Prospective, Observational, Single-center Post-marketing Surveillance Study of Telbivudine in Chronic Hepatitis B Adults With HBeAg Positive/Negative.[NCT00970216] | 160 participants (Actual) | Observational | 2009-02-28 | Completed | |||
| Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0[NCT01621217] | Phase 1 | 21 participants (Anticipated) | Interventional | 2012-06-30 | Completed | ||
| Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer[NCT00201747] | Phase 2 | 80 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
| Transarterial Chemoembolisation With Doxorubicin in Combination With Systemic Administration of Sorafenib for Patients With Hepatocellular Carcinoma[NCT00478374] | Phase 1 | 21 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| TACE Combined With Iodine-125 Seeds Implantation Versus TACE Alone for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective, Multicenter, Randomized, Controlled Study[NCT03322280] | 270 participants (Anticipated) | Interventional | 2018-07-01 | Active, not recruiting | |||
| A Phase II Trial of Induction Gemcitabine, Cisplatin and Nab-Paclitaxel Triplet Chemotherapy Followed by Gemcitabine, Cisplatin and Radioembolization for the Treatment of Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma[NCT05422690] | Phase 2 | 16 participants (Anticipated) | Interventional | 2024-01-30 | Not yet recruiting | ||
| Systemic Chemotherapy VersusTranscatheter Arterial Chemoembolization As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma(HCC)[NCT02585479] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2015-10-31 | Withdrawn (stopped due to It doesn't meet the requirements of randomized trials) | ||
| The Clinical Randomized Trial of Adjuvant Transarterial Chemo Embolization (TACE) to Reduce the Recurrence in Hepatocellular Carcinoma (HCC) Patients at High Risk After Resection[NCT02788526] | Phase 3 | 180 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| A Humanitarian Device Exemption Use Protocol of Therasphere® for Treatment of Unresectable Hepatocellular and Metastatic Liver Tumors - HDE #980006[NCT00701168] | 0 participants | Expanded Access | No longer available | ||||
| Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy (CVD-Protocol) in the Second-Line Therapy of Distant Metastasized Malignant Melanoma[NCT00226473] | Phase 4 | 200 participants | Interventional | 2001-09-30 | Recruiting | ||
| A Randomized Phase II Trial of Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma or Who Are Unfit for Standard Therapy[NCT01097083] | Phase 2 | 20 participants | Interventional | 2010-04-30 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00970216)
Timeframe: 48 weeks
| Intervention | participants (Number) |
|---|---|
| Chronic Hepatitis B | 79 |
39 reviews available for mitomycin and Cancer of Liver
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoembolization, Th | 2014 |
Catheter-based transarterial therapies for hepatocellular cancer.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorub | 2015 |
Regional chemotherapy for liver-limited metastatic colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neo | 2008 |
Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Fluorouracil; Hu | 2012 |
[The role of the regional (intra-arterial) chemotherapy in the treatment of hepatic metastases of colorectal cancer].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic | 2003 |
Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Combine | 2003 |
[Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cholangitis, Sclerosing | 2003 |
[The chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cis | 2003 |
[Hepatic arterial infusion chemotherapy for colorectal liver metastases].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Ad | 2004 |
Pharmacokinetics of the antineoplastic drug mitomycin C in regional chemotherapy using the aortic stop flow technique in advanced pancreatic carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Area Under Curve; Biological Availability; Chemotherapy, C | 2005 |
Transcatheter arterial embolization for the treatment of liver metastases in a patient with malignant pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Angiography; Antibiotics, Antineoplastic; Blo | 2006 |
[Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gelatin Sponge, Ab | 2007 |
[Liver tumor targeting of drugs: Spherex, a vascular occlusive agent].
Topics: Chemoembolization, Therapeutic; Doxorubicin; Hepatic Artery; Humans; Injections, Intra-Arterial; Liv | 1995 |
[Targeting therapy of gastric and colorectal cancer].
Topics: Colorectal Neoplasms; Drug Delivery Systems; Fat Emulsions, Intravenous; Fluorouracil; Humans; Infus | 1994 |
Hepatic arterial chemotherapy for metastatic colorectal carcinoma.
Topics: Colorectal Neoplasms; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; | 1994 |
[Diagnosis and therapy for metastatic liver cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Basement Membrane; Colorectal Neoplasms; Co | 1996 |
Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Reg | 1996 |
Intraarterial infusion chemotherapy for unresectable hepatic metastases from colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Hepatic Artery; | 1996 |
Regional chemotherapy with blood filtration for non resectable liver metastases.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Combined Modality Therapy; Filtration; Hepatecto | 1997 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cis | 1998 |
Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases.
Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topi | 1998 |
[Multidisciplinary treatment for colorectal liver metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Flu | 1998 |
Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Drug | 1999 |
[Therapeutic strategy for the recurrence of pancreatic cancer following pancreatectomy].
Topics: Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Pancreatectomy; P | 1999 |
Regional IL-2-based immunochemotherapy of colorectal liver metastases.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cance | 1999 |
[Clinical effectiveness of degradable starch microspheres (DSM) in patients with liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1999 |
[Is portal infusion chemotherapy uneffective for hepatic recurrence after resection for colorectal cancer?].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration | 1999 |
[Hepatic chemoembolization in a patient allergic to iodinated contrast media: the use of Gd-DTPA].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoembolization, Therapeutic; | 1999 |
Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1999 |
[Multidisciplinary treatment for liver metastasis using cytokines].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality | 2001 |
[A case of gastric cancer with multiple liver metastases that were completely responsive to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirub | 2001 |
[Intra-arterial infusion chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Drug Admin | 2002 |
[A new regional arterial infusion chemotherapy for patients with advanced pancreatic cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Embolization, Therapeutic; Fluorouracil; | 2002 |
Is hepatic infusion of chemotherapy effective treatment for liver metastases? No!
Topics: Antineoplastic Agents; Colorectal Neoplasms; Floxuridine; Fluorouracil; Forecasting; Humans; Infusio | 1992 |
[Systemic chemotherapy in metastatic colorectal adenocarcinomas].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Fem | 1992 |
Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma.
Topics: Aclarubicin; Adolescent; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Carcinoma, Hepatoce | 1991 |
Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Emboli | 1988 |
Hepatic artery infusion for metastatic neoplastic disease.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Collateral Circul | 1985 |
126 trials available for mitomycin and Cancer of Liver
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Chemoembolization, Therapeutic; Colorect | 2013 |
Objective assessment of transcatheter arterial chemoembolization angiographic endpoints: preliminary study of quantitative digital subtraction angiography.
Topics: Adult; Aged; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellula | 2013 |
[Effectiveness of combined systemic and regional chemotherapy in treating patients with metastatic colorectal cancer after extrahepatic progression of the disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Cancer, Reg | 2013 |
Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoc | 2014 |
Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepat | 2015 |
Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Cetu | 2015 |
Radiofrequency Ablation Combined with Hepatic Arterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Liver Metastasis from Colorectal Cancer: A Prospective Multicenter Study.
Topics: Aged; Aged, 80 and over; Catheter Ablation; Chemoembolization, Therapeutic; Colorectal Neoplasms; Co | 2017 |
Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined C | 2008 |
Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine | 2009 |
Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2010 |
Clinical studies of laser ablation in treatment of primary liver carcinoma-associated portal vein tumor thrombus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Mod | 2010 |
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring | 2010 |
Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carcin | 2010 |
Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study.
Topics: Antineoplastic Agents; Antineoplastic Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Cathe | 2010 |
Selective and sequential transarterial chemoembolization: survival in patients with hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Ethiodized Oil; Fe | 2012 |
Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 2011 |
Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bile | 2012 |
Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hep | 2012 |
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherap | 2012 |
Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 2013 |
Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 2013 |
Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; | 2002 |
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2003 |
Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
Topics: Adult; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antin | 2003 |
Combined electro-acupuncture with liver artery intubation in treatment of massive liver cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherap | 2002 |
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Bo | 2004 |
Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2004 |
Mitomycin C, 5-fluorouracil and folinic acid (Mi-Fu-Fo) as salvage chemotherapy in breast cancer patients with liver metastases and impaired hepatic function: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; | 2004 |
[Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin | 2004 |
[Clinical observation on the treatment of middle-late stage liver carcinoma by combined therapy of hepato-arterial chemo-embolising and Chinese drugs for strengthening pi and regulating qi].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2004 |
[Capecitabine combined with TACE for advanced liver cancer].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemoembolization, | 2004 |
[External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcin | 2005 |
Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Filtration; Humans | 2004 |
[TACE: therapy of the HCC before liver transplantation--experiences].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Femal | 2005 |
Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dexamethasone; Dose- | 2005 |
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-F | 2005 |
Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; He | 2006 |
Hypoxic stop-flow perfusion with mitomycin-C in the treatment of multifocal liver metastases. Usefulness of a vascular arterial stent to prevent iatrogenic lesions of the hepatic arterial wall.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Balloon Occlusion; Chemotherapy, Cancer, Regional Perfusio | 2003 |
Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Com | 2006 |
Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: a randomized study with 131 cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2006 |
Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.
Topics: Adult; Aged; Chemoembolization, Therapeutic; Female; Follow-Up Studies; Humans; Injections, Intra-Ar | 2007 |
A comparison of transcatheter arterial embolization with one shot therapy for the patients with hepatic cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carbazilquinone; Carcinoma, Hepatocellular; Catheterization; Dox | 1982 |
Targeted chemotherapy for unresectable primary and metastatic liver cancer.
Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; | 1994 |
[Primary hepatic carcinoma treated by chemoembolization--a clinical analysis of 20 cases with survival period longer than 3 years].
Topics: Adult; Aged; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Fe | 1994 |
Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, He | 1995 |
[Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuv | 1995 |
[Study of hepatic arterial infusion chemotherapy for prophylaxis of liver metastases of colorectal cancer after hepatic resection].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neop | 1995 |
[The study of chemotherapy via the reservoir to colo-rectal cancer patients with liver metastases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms | 1995 |
[Efficacy of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy for unresectable tumors of the liver].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubi | 1995 |
[A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Th | 1995 |
[Clinical evaluation of anticancer effect of methionine-depleting total parenteral nutrition with 5-fluorouracil and/or mitomycin C].
Topics: Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Adminis | 1995 |
[Cooperative study of surgical adjuvant chemotherapy for colorectal cancer. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Admi | 1995 |
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biotransformation; Bone Marrow Diseases; Carcino | 1995 |
[Effect of prophylactic intra-arterial infusion of anticancer drugs on post hepatic resection for hepatic metastasis of colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administrati | 1994 |
[Effects and problems of intraarterial noradrenaline-induced hypertensive chemotherapy for liver metastasis of gastric cancer].
Topics: Aged; Blood Pressure; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusion Pumps, | 1994 |
[The value of hepatic arterial infusion chemotherapy for liver metastases--discussion from viewpoints of prevention of hepatic death and QOL].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Fl | 1994 |
[Evaluation of prophylactic intra-hepatic-arterial infusion chemotherapy after resection of hepatic metastases from colorectal primaries].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Do | 1994 |
[Adjuvant chemo-endocrine chemotherapy with gastrin antagonist after resection of liver metastasis in colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 1994 |
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; He | 1994 |
[Evaluation of local treatment for unresectable primary liver tumor].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Epirubi | 1994 |
[Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 1994 |
[A study of various complications in arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Catheters, Indwelling; | 1994 |
[The treatment of hepatocellular carcinoma by chemoembolization].
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoe | 1994 |
Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1994 |
Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Gelatin Spong | 1994 |
[Status of portal perfusion in colorectal cancer. Swiss Study Group for Clinical Cancer Research].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal N | 1994 |
Hepatic arterial infusion chemotherapy for liver metastases from breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Fluoro | 1994 |
[Multi-center cooperative phase II study of combined infusion of PJ-203 (degradable starch microspheres) into hepatic artery in metastatic liver cancer].
Topics: Adult; Aged; Embolization, Therapeutic; Female; Follow-Up Studies; Hepatic Artery; Humans; Injection | 1993 |
[Comparative clinical study in metastatic liver cancer between intra-arterial infusion of mitomycin C alone and intra-arterial infusion of mitomycin C combined with PJ-203 (degradable starch microspheres)].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Embolization, Therapeutic; Female; Follow | 1993 |
[A randomized trial of intrahepatic infusion chemotherapy for unresectable colorectal liver metastases. Sendai Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubicin; Epir | 1993 |
[The efficacy of intra-arterial infusion chemotherapy in patients with non-resectable liver metastasis from colorectal cancer--a randomized study comparing FAM versus FEM].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Ad | 1993 |
Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Leukopenia; Liver Ne | 1993 |
Pharmacokinetics of intraarterial mitomycin C in the chemoembolisation treatment of liver metastases.
Topics: Antibiotics, Antineoplastic; Area Under Curve; Chemoembolization, Therapeutic; Colorectal Neoplasms; | 1996 |
[The effect of high-dose intraarterial chemotherapy with percutaneous hepatic venous isolation and charcoal hemoperfusion (HVI.CHP) for unresectable multiple hepatocellular carcinoma--comparison with other therapeutic modalities].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Charcoal; Doxorubicin; Em | 1996 |
[Intrahepatic arterial infusion chemotherapy for the colon cancer patients with liver metastases--a comparison of arterial embolization chemotherapy versus continuous arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Admi | 1996 |
Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neopl | 1996 |
Disposition of mitomycin C after local intraarterial application.
Topics: Antibiotics, Antineoplastic; Biological Availability; Chemoembolization, Therapeutic; Colorectal Neo | 1997 |
Superselective intra-arterial chemotherapy with mitomycin C in hepatic metastases from colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Colorectal Neoplasms; Female; Follow-Up | 1997 |
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial.
Topics: Abdominal Pain; Adult; Aged; Alkaline Phosphatase; Angiography; Antimetabolites, Antineoplastic; Ant | 1997 |
Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC).
Topics: Adult; Aged; Amifostine; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplas | 1997 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fema | 1997 |
[Evaluation of hepatic arterial infusion chemotherapy using reservoir for liver metastases from gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubic | 1998 |
Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial.
Topics: Adult; Aged; Antidotes; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 1996 |
Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neop | 1999 |
Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplat | 1999 |
Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 1999 |
[Evaluation of intermittent hepatic arterial infusion chemotherapy for multiple liver metastasis of colorectal cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Colonic Neoplasms; Drug Administration Schedule; Femal | 1999 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neopla | 1999 |
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Che | 2000 |
Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
Topics: Adult; Aged; Benzaldehydes; Cell Hypoxia; Colorectal Neoplasms; Drug Synergism; Drug Therapy, Combin | 2000 |
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorour | 2000 |
[Percutaneous transfemoral arterial implantation of drug delivery system for arterial infusion therapy of advanced primary hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Drug Delive | 1998 |
Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothec | 2000 |
[Phase I study of super high-dose chemotherapy for liver cancer with percutaneous isolated hepatic perfusion (PIHP) and peripheral blood stem cell transplantation (PBSCT)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2000 |
[Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Combined Moda | 2000 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastases and lymph node metastases from gastric cancer--comparative analysis for intra-arterial group and non-intra-arterial group].
Topics: Angiotensin II; Antibiotics, Antineoplastic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lym | 2001 |
Palliative treatment of hepatocellular carcinoma by chemoembolization.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Cathet | 2001 |
Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluoroura | 2001 |
[Clinical study on effect of Chinese herbal medicine on liver damage caused by hepatic artery chemoembolization].
Topics: Adult; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Female; Hepatic Artery; Humans; Liver | 1999 |
Chemoembolization for liver metastases from colorectal carcinoma: risk or a benefit.
Topics: Aged; Chemoembolization, Therapeutic; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free | 2002 |
Embolization and chemoembolization for hepatocellular carcinoma.
Topics: Capsules; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Hepa | 1992 |
Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; F | 1992 |
Is hepatic infusion of chemotherapy effective treatment for liver metastases? No!
Topics: Antineoplastic Agents; Colorectal Neoplasms; Floxuridine; Fluorouracil; Forecasting; Humans; Infusio | 1992 |
Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Dr | 1992 |
[Histologic assessment on resected hepatocellular carcinoma specimens with preoperative transcatheter hepatic arterial chemo-embolizations].
Topics: Adult; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Arteri | 1991 |
[Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Proto | 1992 |
[Oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in repeated arterial bolus chemotherapy in metastatic liver cancer of humans--preliminary randomized trial].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorub | 1991 |
Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neopl | 1991 |
[Chemoembolization of colorectal liver metastases].
Topics: Adult; Aged; Colorectal Neoplasms; Combined Modality Therapy; Diatrizoate; Drug Combinations; Emboli | 1990 |
[Concepts in the prevention and treatment of liver metastases of colorectal cancer by regional chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Colonic Ne | 1988 |
[Intra-portal chemoprevention and therapy of liver metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Comb | 1989 |
Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancer.
Topics: Adult; Aged; Female; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Male; Microspheres; | 1989 |
[Effect of PMU hepatic arterial chemotherapy for liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug A | 1989 |
[Effects of prophylactic intraportal chemotherapy on liver function, blood profile and survival in patients with colo-rectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therap | 1989 |
[Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): a preliminary report. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug A | 1989 |
[Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Fem | 1989 |
[Studies on drug release from anti-cancer drug suspended Lipiodol].
Topics: Antineoplastic Agents; Cisplatin; Delayed-Action Preparations; Diatrizoate Meglumine; Doxorubicin; H | 1989 |
[European topic: liver surgery II--regional chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Flo | 1989 |
Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Clinical Trials as Top | 1989 |
[Clinical value of OK-432 immunotherapy after one-shot arterial infusion of anti-cancer agents in the treatment of hepatocellular carcinoma--a randomized study].
Topics: Administration, Oral; Biological Products; Carcinoma, Hepatocellular; Clinical Trials as Topic; Huma | 1988 |
[The role of antineoplastic solution in transcatheter hepatic arterial embolization--in terms of survival rates affecting anticancer agents together with gelatin sponge].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Embolization | 1988 |
Gastroduodenal mucosal injury during hepatic arterial infusion of chemotherapeutic agents. Lack of cytoprotection by prostaglandin E1 analogue.
Topics: Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Double-Blind | 1987 |
Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; C | 1987 |
Superselective intra-arterial chemotherapy with mitomycin C in liver and gallbladder cancer.
Topics: Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Gallbladder Neoplasms; Humans; I | 1988 |
Pilot study on the regional treatment of colorectal liver metastases by intermittent arterial ischaemia with degradable starch microspheres and arterial and portal infusion with mitomycin C plus 5-fluorouracil--a clinical trial led by the Gastrointestinal
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Emboliz | 1988 |
732 other studies available for mitomycin and Cancer of Liver
| Article | Year |
|---|---|
Germacrane-Type Sesquiterpenoids with Antiproliferative Activities from Eupatorium chinense.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Ce | 2018 |
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Female; Huma | 2023 |
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Female; Huma | 2023 |
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Female; Huma | 2023 |
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Female; Huma | 2023 |
Sequential intra-arterial infusion of 90Y-resin microspheres and mitomycin C in chemo refractory liver metastatic breast cancer patients: a single centre pilot study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Body Surface Area; Breast Neoplasms; Combined Modality The | 2020 |
Transarterial chemoembolization for pulmonary or mediastinal metastases from hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2020 |
Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tum | 2021 |
Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorouracil; | 2017 |
Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone | 2017 |
5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorouracil; H | 2018 |
Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 2018 |
Outpatient Transarterial Chemoembolization of Hepatocellular Carcinoma: Review of a Same-Day Discharge Strategy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubic | 2018 |
Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
Topics: Ablation Techniques; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; | 2018 |
Gastrointestinal Elimination of a Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Humans; Live | 2018 |
Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carrier Proteins; | 2018 |
Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2018 |
[Regional chemotherapy in treatment of patients with unresectable liver metastases of uveal melanoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoembolization, Therape | 2016 |
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chol | 2019 |
Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Resistance, Neop | 2019 |
Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2019 |
Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 2013 |
Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization.
Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; | 2013 |
A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma; Cell Line; Coculture Techniques; Collagen; Doxorubi | 2013 |
Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
Topics: Adult; alpha-Fetoproteins; Angiography; Angioplasty; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 2013 |
Extensive hepatic necrosis after transarterial chemoembolization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Chemoembolization, Therapeutic; Cis | 2014 |
Aggressive strategy for the treatment of synchronous metastatic anal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplat | 2013 |
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; F | 2014 |
Long-term outcomes and prognostic factors with reductive hepatectomy and sequential percutaneous isolated hepatic perfusion for multiple bilobar hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Cance | 2014 |
Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepato | 2014 |
Anticancer effects of deproteinized asparagus polysaccharide on hepatocellular carcinoma in vitro and in vivo.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Asparagus Plant; Carcinoma, Hepatocellular; Caspase 3; | 2014 |
[Morphology and microRNA expression profiles of drug-resistant cells in hepatocellular carcinoma].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug R | 2013 |
Combination chemotherapy for metastatic extramammary Paget disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Neopla | 2014 |
[Analysis of the safety and efficacy of percutaneous isolated hepatic perfusion after particle therapy for advanced hepatocellular carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Cance | 2013 |
Immediate radical therapy or conservative treatments when meeting the Milan criteria for advanced HCC patients after successful TACE.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; | 2014 |
Mitomycin-based hepatic arterial infusion chemotherapy for solitary ampullary cancer liver metastasis: an unusual treatment for an uncommon disease.
Topics: Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Common Bile Duct Neoplasms; | 2015 |
Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer.
Topics: Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Ad | 2016 |
Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2014 |
Cutaneous necrosis associated with transcatheter arterial chemoembolization of the intercostal artery.
Topics: Adult; Angiography, Digital Subtraction; Antineoplastic Agents; Carcinoma, Hepatocellular; Collatera | 2014 |
A natural antisense transcript regulates acetylcholinesterase gene expression via epigenetic modification in Hepatocellular Carcinoma.
Topics: Acetylcholinesterase; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular | 2014 |
Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic | 2014 |
Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2015 |
Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor | 2015 |
Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwellin | 2016 |
Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 2016 |
Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Abl | 2016 |
Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol.
Topics: Animals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Ethio | 2016 |
Digital Glissonectomy: A Safe Perihepatic Peritonectomy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cispla | 2016 |
Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
Topics: Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Chemoembolization, Therapeutic; Cisplatin; D | 2016 |
Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Catheter Ablation; Colo | 2016 |
Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicated?
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Hepatocellular; Cholangitis; Cisplatin; Dose-Response Relati | 2009 |
Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Topics: Absorbable Implants; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carci | 2008 |
Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Hepatocellular; | 2008 |
Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoe | 2009 |
[Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2008 |
[Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
Topics: Adolescent; Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Diffusion M | 2008 |
Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplat | 2009 |
Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases.
Topics: Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Infusions, P | 2009 |
[Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Topics: Adult; Aged; Chemoembolization, Therapeutic; Cisplatin; Colonic Neoplasms; Diffusion Magnetic Resona | 2009 |
The augmented anti-tumor effects of Antrodia camphorata co-fermented with Chinese medicinal herb in human hepatoma cells.
Topics: Antineoplastic Agents; Antrodia; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2009 |
[Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer].
Topics: Adult; Aged; Camptothecin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modal | 2009 |
Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined C | 2009 |
Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models.
Topics: Bystander Effect; Carcinoma, Hepatocellular; Cell Count; Cell Death; Cell Line, Tumor; Cell Membrane | 2009 |
Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
Topics: Acrylic Resins; Adolescent; Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antine | 2009 |
[A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplast | 2009 |
[Therapeutic effects of vinorelbine-based chemotherapy--retrospective study of 65 patients with metastatic or relapsed breast cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2010 |
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; | 2010 |
Beneficial effects of 5-Fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cis | 2010 |
[Evaluation of transhepatic artery chemotherapy for highly advanced hepatocellular carcinoma].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 2010 |
Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin C treatment through the inactivation of bad-mediated apoptosis.
Topics: Apoptosis; Caspase 8; Ethanol; Flow Cytometry; Humans; Liver Neoplasms; Mitochondria; Mitomycin; Sti | 2010 |
Chemoembolic lobectomy: imaging findings of hepatic lobar volume reduction after transcatheter arterial chemoembolization.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Th | 2011 |
Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, | 2010 |
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplatin; Colorecta | 2011 |
Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings.
Topics: Antibiotics, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Female; Follow-Up Stud | 2011 |
Hazardous chemical splatter during liver chemoembolization.
Topics: Accidents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolizat | 2010 |
Successful remission of extensive liver metastases in a breast cancer patient with acute liver failure using a combined chemotherapy regimen with mitomycin, folinate, and 5-fluorouracil (Mi/Fo/FU).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Fluorouracil; H | 2010 |
Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ch | 2011 |
[A case of Vp4 portal vein tumor thrombosis--a complete remission achieved with dual treatment of surgery plus percutaneous isolated hepatic perfusion].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusi | 2010 |
[Successful treatment of multiple pulmonary and peritoneal recurrence of hepatocellular carcinoma with bronchial artery infusion therapy and PEIT followed by surgery--a case report].
Topics: Aged, 80 and over; Antineoplastic Agents; Bronchial Arteries; Carcinoma, Hepatocellular; Ethanol; He | 2010 |
Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin | 2011 |
Chemoembolization via branches from the splenic artery in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Chemoembolization, Therape | 2012 |
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile | 2011 |
Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studie | 2011 |
Intracellular delivery of mitomycin C with targeted polysaccharide conjugates against multidrug resistance.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Resistance, Multiple; Drug Res | 2011 |
Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Ethiodized O | 2011 |
Mitomycin C and doxorubicin elicit conflicting signals by causing accumulation of cyclin E prior to p21WAF1/CIP1 elevation in human hepatocellular carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Su | 2012 |
Hypoxic liver perfusion with mitomycin-C for treating multifocal metastases and unresectable primary tumours: a single-centre series of 42 patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cell Hypoxia; Disease-Free Survival; Feasibility Studies; | 2011 |
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplast | 2012 |
Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterizat | 2011 |
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Diseases; Causality; Cohort Studies; Colorectal Neopla | 2012 |
Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplatin; Deoxycyti | 2012 |
Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carci | 2012 |
Retrospective study on the use of different protocols for repeated transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 2012 |
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2012 |
Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI.
Topics: Aged; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Cisplatin; Contras | 2012 |
Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization | 2012 |
Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Epirubicin; Ethiodized O | 2012 |
Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2012 |
Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?
Topics: Antibiotic Prophylaxis; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therape | 2012 |
Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Enbucrila | 2012 |
Dual-phase CT angiography through the port-catheter system for hepatic arterial infusion chemotherapy using multislice CT: assessment of system dysfunction and impact on predicting clinical problems.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antineoplastic Agents; Carcinoma, Hepatoc | 2012 |
Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality | 2013 |
Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemoemboliz | 2012 |
[Evaluation of the efficacy and prognostic factors for colorectal liver metastases treated with transcatheter arterial chemoembolization].
Topics: Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Carcinoembryonic Antigen; | 2012 |
Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studie | 2013 |
Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Down-Reg | 2013 |
Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluoroura | 2002 |
A patient with advanced gastric cancer, underwent curative gastrectomy and partial resection of metachronous hepatic metastases, is surviving for 13 years to date.
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Disease-Free Survival; Gastrectomy; Humans; | 2002 |
[Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combine | 2002 |
Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2002 |
Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres.
Topics: Aged; Antibiotics, Antineoplastic; Area Under Curve; Biological Availability; Chemoembolization, The | 2002 |
[A case of intrahepatic bile duct necrosis following hepatic arterial infusion chemotherapy].
Topics: Alkaline Phosphatase; Antibiotics, Antineoplastic; Bile Ducts, Intrahepatic; gamma-Glutamyltransfera | 2002 |
[A case report of intra-hepatic arterial infusion of mitomycin C with degradable starch microspheres for liver metastases of sigmoid colon carcinoma].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Biodegradation, Enviro | 2002 |
[Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer FEM--combination therapy of 5 FU, Epirubicin and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Hepatectomy; Humans; Infus | 2002 |
[Effect of hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin | 2002 |
[Three cases of multiple liver metastases of carcinoid tumor responding to hepatic arterial infusion chemotherapy using degradable starch microspheres].
Topics: Aged; Antibiotics, Antineoplastic; Biodegradation, Environmental; Carcinoid Tumor; Female; Hepatic A | 2002 |
[Audit of the safety of hepatic arterial infusion of degradable starch microspheres (DSM). Adriamycin (ADM).mitomycin C (MMC) on aged patients with liver metastases of colorectal cancer].
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Biodegradation, Environmental; Colorectal Neop | 2002 |
[A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Iodized Oil; Li | 2002 |
In vitro stability of tris-acryl gelatin microspheres in a multipharmaceutical chemoembolization solution.
Topics: Centrifugation, Density Gradient; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Drug Stabi | 2003 |
Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 2001 |
[Early effect of intra-arterial chemotherapy combined with degradable starch microspheres for malignant hepatic tumors].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Doxorubicin; E | 2003 |
[Synergistic antitumor effect of sodium caffeate and mitomycin].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Caffeic Acids; Calcium; Carcinoma, Hepa | 2002 |
Synergistic effects of geldanamycin and antitumor drugs.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; | 2001 |
Pharmacokinetics of intraarterial mitomycin C in hypoxic hepatic infusion with embolization in the treatment of liver metastases.
Topics: Adult; Aged; Area Under Curve; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Hypo | 2002 |
Liver metastasis of pancreatic cancer managed by intra-arterial infusion chemotherapy combined with degradable starch microspheres.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Carcinoma, Hepatocellular; Chemo | 2003 |
[A case of gastric cancer with liver metastasis in which obstruction of the bile duct and choledocholithiasis was caused by intra-hepatic arterial infusion chemotherapy].
Topics: Angiotensin II; Cholestasis; Drug Administration Schedule; Drug Therapy, Combination; Gallstones; Ga | 2003 |
Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; | 2003 |
[A case of liver metastasis of colon cancer demonstrating complete remission with combination chemotherapy of 5'-DFUR and MMC].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modalit | 2003 |
[A case report of complete remission of liver metastases from colorectal cancer treated with continuous hepatic arterial infusion].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modal | 2003 |
STUDIES ON REGIONAL PERFUSION AND INTRA-ARTERIAL INFUSION FOR CANCER CHEMOTHERAPY.
Topics: Antineoplastic Agents; Breast Neoplasms; Celiac Artery; Chemotherapy, Cancer, Regional Perfusion; Co | 1964 |
[CHEMOTHERAPY OF PRIMARY AND METASTATIC HEPATIC CANCER BY HEPATIC ARTERY INFUSION].
Topics: Blood; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Function Tests; Liver Neoplasms; Mi | 1964 |
ADMINISTRATION METHOD OF MITOMYCIN C.
Topics: Carcinoma, Hepatocellular; Liver Neoplasms; Methylcholanthrene; Mitomycin; Mitomycins; Neoplasms; Ne | 1964 |
PAPER ELECTROPHORETIC STUDIES ON SERUM PROTEINS IN THE DISEASES OF THE DIGESTIVE SYSTEM, WITH PARTICULAR REFERENCE TO THE CHANGES IN SERUM PROTEINS IN THE PATIENTS WITH CANCER.
Topics: Antineoplastic Agents; Blood Protein Electrophoresis; Blood Proteins; Carcinoma, Hepatocellular; Dig | 1963 |
[EXPERIMENTAL STUDIES ON THE PREVENTION OF HEMATOGENIC METASTASIS OF CANCER WITH ANTICANCER DRUGS].
Topics: Ascites; Blood Circulation; Injections, Intravenous; Liver Neoplasms; Mitomycin; Mitomycins; Neoplas | 1964 |
INHIBITORY EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS ON LIVER METASTASIS OF INTRAPORTALLY INOCULATED MOUSE ASCITES HEPATOMA.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; Injection | 1964 |
THE USE OF RAT ASCITES TUMORS HETEROGRAFTED IN MICE FOR SCREENING OF ANTICANCEROUS AGENTS.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ascites; Carcinoma, Ehrlich Tumor; Carcinoma, | 1963 |
[EXPERIMENTAL STUDIES ON THE EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS TO LIVER METASTASIS FOLLOWING PORTAL INJECTION OF MOUSE ASCITES HEPATOMA].
Topics: Animals; Ascites; Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Mice; Mitomycin; Mitom | 1963 |
[DEVELOPMENT OF FREE-CELL SUBLINES OF THE ASCITES HEPATOMA AH-130 AND THEIR BIOLOGICAL PROPERTIES].
Topics: Ascites; Carcinoma, Hepatocellular; Chromosomes; Electrons; Liver Neoplasms; Mechlorethamine; Micros | 1964 |
[EXPERIMENTAL ANTICANCER STUDIES. 23. FURTHER EXPERIMENTS ON THE ANTITUMOR ACTIVITY OF 4-AMINO-6-OCTYLRESORCINOL HYDROCHLORIDE].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Leukemia; Leuke | 1964 |
Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Pe | 2003 |
Multimodality management of hepatocellular carcinoma larger than 10 cm.
Topics: Acetic Acid; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2003 |
Five years and 4 months of recurrence-free survival in hepatic angiosarcoma.
Topics: Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Contrast Media; Disease-Free Survival; | 2003 |
[Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Fl | 2003 |
[Evaluation of arterial infusion chemotherapy for liver metastasis from gastric cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administrat | 2003 |
[Relationship between effectiveness of hepatic artery injection chemotherapy and serum VEGF].
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Carcinoembryonic Antigen; Chemoembo | 2003 |
[Validity of two-hour continuous hepatic arterial infusion chemotherapy with low-dose 5-FU for unresectable liver metastasis from colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; | 2003 |
[Evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin, mitomycin C as seen in changes in CEA at early stage of therapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoe | 2003 |
[A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Brain Neoplasm | 2003 |
[A case of unresectable liver metastases from rectosigmoid colon cancer with survival for over 3 years after multidisciplinary treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug Admini | 2003 |
Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplatin; Doxorubic | 2003 |
Chemoembolization of liver metastasis from breast carcinoma.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcin | 2004 |
[Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2004 |
[A case of effective treatment of oral TS-1 and intravenous MMC administration for multiple metastases of gastric cancer].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Che | 2004 |
Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis.
Topics: Adrenal Glands; Aged; Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Catheters, I | 2004 |
2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; | 2004 |
Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
Topics: Albumins; Antibiotics, Antineoplastic; Antineoplastic Agents; Bilirubin; Carcinoma, Hepatocellular; | 2004 |
[Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion].
Topics: Administration, Oral; Adult; Aged; Agmatine; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 2004 |
[Usefulness of F-18-fluorodeoxyglucose positron emission tomography for evaluating the efficacy of transient hepatic arterial chemoembolization for liver metastases of rectal cancer--a case report].
Topics: Chemoembolization, Therapeutic; Cholecystectomy; Doxorubicin; Fluorodeoxyglucose F18; Hepatectomy; H | 2004 |
[Hepatic arterial infusion and occlusion technique for the evaluation of the hepatic resection to control the local liver tumor].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepato | 2004 |
[Efficacy of hepatic arterial infusion of adriamycin and mitomycin C mixed with degradable starch microspheres for liver metastasis of colorectal cancer--correlation with the mRNA expression of DNA topoisomerase-IIalpha and glutathione-S transferase-pi in
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; | 2004 |
[Histological examination of the effect of hepatic arterial infusion of degradable starch microspheres mixed with adriamycin and mitomycin C for liver metastases of colorectal cancer--second report].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biodegradation, Environmental; Colorect | 2004 |
[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined | 2004 |
[The value of Roferon-A combined with hepatic artery chemoembolization and portal vein chemotherapy after radical resection in hepatocellular carcinoma for preventing recurrence].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combi | 2004 |
[Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; | 2004 |
Endoscopic stenting of the common bile duct allows successful treatment of a breast cancer patient with excessive liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Common | 2004 |
[A case of diffuse type of hepatocellular carcinoma with tumor thrombosis of inferior vena cava (Vv3) and main trunk of portal vein (Vp4), showing marked response to transcatheter arterial chemoembolization with degradable starch microspheres (DSM-TACE)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2004 |
[Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; | 2005 |
Intraarterial chemotherapy: another choice for unresectable advanced hepatocellular carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2004 |
Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Adm | 2004 |
[A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-u
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 2005 |
[Low-output radiofrequency ablation combined with transcatheter arterial oily-chemoembolization for hepatocellular carcinoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheter Ablation; Chemoemboliz | 2005 |
A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis.
Topics: Animals; Body Weight; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Drug; | 2005 |
[Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combi | 2005 |
Science to practice: can combination therapy for colorectal liver metastases improve results over chemoembolization or ablation alone?
Topics: Animals; Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Colorectal Neoplasms; Combined | 2005 |
Liver metastases in rats: chemoembolization combined with interstitial laser ablation for treatment.
Topics: Analysis of Variance; Animals; Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Colorect | 2005 |
[A case of advanced gastric cancer with liver and lung metastases markedly responded to TS-1-based sequential chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplasti | 2005 |
Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2006 |
[A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2005 |
[Observation on efficiency of shelian capsule as adjuvant of embolismic chemotherapy on primary hepatic carcinoma].
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoco | 2005 |
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ch | 2005 |
[Investigation of bile duct injury after transcatheter arterial chemoembolization].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Carcinom | 2005 |
Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineo | 2006 |
[A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemoembo | 2006 |
Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.
Topics: Antineoplastic Agents; Chemoembolization, Therapeutic; Cisplatin; Female; Fluorouracil; Humans; Iodi | 2006 |
Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT).
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, H | 2007 |
Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Drug Carriers; Enbucrilate; Female; Heart; I | 2006 |
[A case of effective multidisciplinary treatment with hepatic resection for synchronous multiple liver metastases from rectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubic | 2006 |
[Case report of a liver metastasis from rectal cancer achieving complete response (CR) by a combination of intra-hepatic arterial infusion of irinotecan (CPT-11) with degradable starch microspheres (DSM) and weekly high-dose intra-hepatic arterial chemoth
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat | 2006 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, | 2007 |
Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Duodenal Ulcer; Duodenum; Embolization, | 2007 |
MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Topics: Butadienes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; | 2007 |
Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.
Topics: Animals; Antineoplastic Agents; Azacitidine; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor | 2007 |
Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Disease | 2007 |
Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendo | 2007 |
Feasibility of transcatheter arterial chemoembolization for hepatic adenoma.
Topics: Adenoma; Adolescent; Adult; Chemoembolization, Therapeutic; Contrast Media; Feasibility Studies; Fem | 2007 |
[Effect of constitutive androstane receptor on the cytotoxicity of mitomycin C and 5-(aziridin-1-yl)-3-hydroxymethyl-1-methylindole-4,7-dione].
Topics: Antibiotics, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Aziridines; Carcinoma, Hepatocellular; C | 2007 |
[A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Epi | 2007 |
FANCD2 depletion sensitizes cancer cells repopulation ability in vitro.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Damage; Dos | 2007 |
Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Baltimore; Breast Ne | 2007 |
RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Topics: Adult; Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor | 2008 |
[Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cause of Death; Chemoembolization, The | 2007 |
Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Breast Neoplasms; Female; Humans; | 2008 |
Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antine | 2008 |
Conjunctival intraepithelial neoplasia in a patient treated with tacrolimus after liver transplantation.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neopla | 2007 |
[Expression of survivin mRNA and protein in mitomycin-treated hepatoma carcinoma Hepa1-6 cells].
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Inhibit | 2008 |
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Contrast Media; Doxorubi | 2008 |
Repetitive transarterial chemoembolization (TACE) of liver metastases from renal cell carcinoma: local control and survival results.
Topics: Adult; Aged; Carcinoma, Renal Cell; Chemoembolization, Therapeutic; Contrast Media; Deoxycytidine; F | 2008 |
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoemboliz | 2008 |
MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2008 |
Hepatitis B virus X protein disrupts DNA interstrand crosslinking agent mitomycin C induced ATR dependent intra-S-phase checkpoint.
Topics: Carcinoma, Hepatocellular; Checkpoint Kinase 1; DNA Damage; Hepatitis B, Chronic; Humans; Liver Neop | 2008 |
[MMC-oil suspension (MOS) as a new chemoembolic agent].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hum | 1984 |
[Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; C | 1984 |
[Effects of arterial chemotherapy in patients with hepatocellular carcinoma--alternate administration of mitomycin C and adriamycin].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Female; Hepatic Artery; Humans; | 1984 |
Evaluation of conservative therapeutic modalities for hepatocellular carcinoma--analysis of 206 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Mod | 1984 |
Hepatic artery infusion with 5-fluorouracil and mitomycin-C in metastatic colorectal carcinoma phase II study.
Topics: Adult; Aged; Catheterization; Colonic Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; | 1982 |
Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1983 |
[Effect of continuous intra-arterial infusion therapy with BLM-MMC-lentinan (B-M-L) in treating patients with hepatic metastases of esophageal cancer].
Topics: Aged; Bleomycin; Drug Therapy, Combination; Esophageal Neoplasms; Female; Humans; Infusions, Intra-A | 1982 |
[Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C].
Topics: Adult; Aged; alpha-Fetoproteins; Angiography; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular | 1982 |
[Clinical evaluation of chemotherapeutic agents in the treatment of primary liver cancer].
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluor | 1982 |
Ligation and catheterization of the hepatic artery for palliative treatment of malignant hepatic tumors.
Topics: Aged; Carcinoma, Hepatocellular; Catheterization; Doxorubicin; Hepatic Artery; Humans; Ligation; Liv | 1983 |
Continuous intra-arterial infusion chemotherapy of hepatoma.
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Fema | 1983 |
[Chemo-embolization with mitomycin C microcapsules for hepatoma].
Topics: alpha-Fetoproteins; Capsules; Carcinoma, Hepatocellular; Catheterization; Embolization, Therapeutic; | 1984 |
[Balloon occluded arterial infusion therapy for malignant hepatic tumors].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Doxorub | 1984 |
Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules.
Topics: Adult; Aged; alpha-Fetoproteins; Angiography; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular | 1984 |
[The clinical effect of hyperthermia combined with induced hypertension chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Pressure; Cisplatin | 1984 |
Regional hepatic chemotherapy using an implantable drug infusion pump.
Topics: Antineoplastic Agents; Carmustine; Drug Therapy, Combination; Floxuridine; Hepatic Artery; Humans; I | 1983 |
Effective retreatment of patients with colorectal cancer and liver metastases.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Colonic Neoplasms; Drug Resistan | 1983 |
Regional chemotherapy of colorectal cancer metastatic to the liver.
Topics: Antineoplastic Agents; Catheters, Indwelling; Colonic Neoplasms; Drug Evaluation; Female; Floxuridin | 1984 |
[Transcatheter hepatic artery embolization in 60 patients with hepatocellular carcinoma studies on angiographic features (author's transl)].
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Child; Child, Preschool; Doxorubicin; Embolizati | 1981 |
[Liver diseases. C 1. Treatment of liver cancer].
Topics: Carcinoma, Hepatocellular; Humans; Injections, Intra-Arterial; Liver Neoplasms; Mitomycin; Mitomycin | 1982 |
[Clinical efficacy of transcatheter arterial embolization in hepatocellular carcinoma--evaluation in comparison with hepatic artery infusion chemotherapy].
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neopl | 1983 |
[Treatment of unresectable hepatocellular carcinoma by arterial infusion of mitomycin C microcapsules (MMCmc)].
Topics: Aged; Capsules; Carcinoma, Hepatocellular; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasm | 1983 |
[Comparison between continuous arterial infusion chemotherapy and mitomycin C microcapsule administration in primary and metastatic liver cancer].
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Capsules; Carcinoma, Hepatocellular; Hepatic Artery; | 1983 |
[Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil].
Topics: Aged; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Therapy, Combination; Female; Fl | 1982 |
[Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumors of the liver].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Drug Therapy, Combination; Female; Hepatic Arte | 1982 |
[Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Colonic Neoplasms; Drug Synergism; Dru | 1983 |
Total tumor cell count and hematopoietic system of ah 109A-bearing rats treated with mitomycin C and carboquone.
Topics: Animals; Antineoplastic Agents; Azirines; Carbazilquinone; Carcinoma, Hepatocellular; Cell Transform | 1982 |
[Preoperative chemo-embolization for liver cell cancer].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Embolization, Therap | 1983 |
Enhancement of the cytocidal effect of mitomycin C by means of simultaneous administration of prostaglandin E1.
Topics: Alprostadil; Animals; Colonic Neoplasms; Drug Synergism; Humans; Injections, Intra-Arterial; Injecti | 1983 |
Pharmacokinetics of intraarterial mitomycin C in humans.
Topics: Aged; Antibiotics, Antineoplastic; Female; Humans; Infusions, Intra-Arterial; Kinetics; Liver Neopla | 1983 |
Improved regional selectivity of hepatic arterial mitomycin by starch microspheres.
Topics: Adult; Aged; Catheterization; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; M | 1983 |
[Chemotherapy of gastric cancer patients with hepatic metastases].
Topics: Administration, Oral; Antibiotics, Antineoplastic; Fluorouracil; Humans; Liver Neoplasms; Mitomycin; | 1983 |
[Alteration of blood coagulation and fibrinolysis after intra-arterial one-shot chemotherapy in liver cancer].
Topics: Antineoplastic Agents; Blood Coagulation; Doxorubicin; Fibrinolysis; Humans; Injections, Intra-Arter | 1983 |
[Intra-arterial infusion chemotherapy for metastatic hepatic tumor of colo-rectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil | 1983 |
[Analysis of the mechanism of cancer metastasis by using anticancer agents].
Topics: Animals; Antineoplastic Agents; Cell Division; Cisplatin; Killer Cells, Natural; Liver Neoplasms; Ma | 1984 |
[Enhancing effect of mitomycin C on hematogenous metastases of ascites hepatoma in rat].
Topics: Animals; Antibiotics, Antineoplastic; Female; Liver Neoplasms; Liver Neoplasms, Experimental; Male; | 1983 |
Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 1984 |
[Basic and clinical studies on metastatic cancer--with special reference of multidisciplinary treatment of gastric and colorectal cancer patients with hepatic metastasis].
Topics: Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Ar | 1983 |
Combination of hepatic arterial infusion and systemic chemotherapy for gastric cancer with synchronous hepatic metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatic Artery; H | 1984 |
Liver calcifications following hepatic artery infusion with 5-fluorouracil, adriamycin and mitomycin C (FAM).
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcinosis; Chemical and Drug Induced Liver Injury; | 1984 |
[Experimental studies on hepatic cancer chemo-embolization].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Embolization, Therapeutic; Hepatic Arter | 1984 |
[Constant intra-aortic infusion chemotherapy for advanced abdominal cancer--a technic and the effect in patients with peritoneal metastases].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Coloni | 1984 |
[Intra-hepato-arterial administration of cis-diammine-dichloroplatinum II (CDDP) for primary or metastatic hepatic cancer].
Topics: Adult; Aged; Carcinoembryonic Antigen; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; F | 1984 |
Intravenous and hepatic arterial infusion of high dose mitomycin C with autologous bone marrow transplantation in patients with tumour metastatic to the liver.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Hepatic Artery; Humans; Injections, I | 1984 |
[A clinicopathological study on hematogenous recurrence of colo-rectal cancer--with special reference to prediction and prevention of the recurrence].
Topics: Antineoplastic Agents; Colonic Neoplasms; Combined Modality Therapy; Follow-Up Studies; Humans; Live | 1984 |
Hepatic artery ligation and portal vein infusion for liver metastases from colon cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Hepat | 1984 |
[Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anorexia; Antibiotics, Antineoplastic; Aspartate Amin | 1984 |
FAM2 regimen in disseminated gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; | 1984 |
Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Doxorubicin; D | 1984 |
Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Fluorouracil; | 1984 |
Efficacy of dacarbazine imidazole carboxamide and mitomycin C combination therapy in patients with adenocarcinoma of the colon refractory to 5-fluorouracil therapy.
Topics: Adenocarcinoma; Colonic Neoplasms; Dacarbazine; Drug Resistance; Drug Therapy, Combination; Female; | 1981 |
Intrahepatic artery 5-fluorouracil and mitomycin-C in previously untreated patients with hepatic metastases from colorectal carcinoma.
Topics: Adult; Colonic Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitomyci | 1982 |
[Mytomycin C nephrotoxicity. 3 new cases and review of the literature].
Topics: Adenocarcinoma; Carcinoid Tumor; Creatinine; Female; Gastrointestinal Neoplasms; Humans; Kidney Dise | 1982 |
[Effect of cancer chemotherapy for unresectable cancer of the pancreas].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Mal | 1982 |
[Antitumor treatment for synchronous hepatic metastasis from stomach cancer].
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver N | 1982 |
[Treatment of unresectable liver cancer with intrahepatic arterial infusion chemotherapy].
Topics: Adult; Aged; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middl | 1982 |
[A case of pancreatic cancer surviving for 7 years 11 months following intra-arterial and portal infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Disease-Free Survival; Female; Humans; Infusions, Intra-Arterial; Infusions, I | 1995 |
[Regional therapy breast cancer liver metastases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 1995 |
Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined C | 1994 |
Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Carcinoma, Hepatocellular; Catheterization, Peripheral; | 1994 |
Combination chemotherapy with mitomycin C and cisplatin for advanced gastric cancer with multiple liver metastases.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1994 |
Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Cell Division; Colonic Neoplasms; Cyclohexanes; H | 1995 |
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplat | 1995 |
[A case of intrahepatic infusion chemotherapy with angiotensin II human for liver metastasis from early gastric cancer].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure | 1995 |
[A case report of far advanced gastric cancer with multiple liver metastasis (H3) treated with transarterial intermittent chemotherapy and intradermal administration of low molecular lipopolysaccharide (LPSp) extracted from Pantoea agglomerans].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Enterobacteriaceae; Epirubicin; Fluorouracil; | 1995 |
A 10-year survivor with unresectable hepatic metastases from sigmoid colon carcinoma treated with regional chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hepatic Artery; Humans | 1995 |
Effect of lovastatin alone and as an adjuvant chemotherapeutic agent on hepatoma tissue culture-4 cell growth.
Topics: Animals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Division; Chemotherapy, Adjuvant; Cholestero | 1995 |
[Hepatic artery chemotherapy-embolization and biological response modifiers for late hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Combine | 1995 |
Pancreatic tissue damage by transcatheter arterial embolization for hepatoma.
Topics: Adult; Aged; Amylases; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Gelatin Sponge, | 1993 |
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Ethanol; Femal | 1993 |
[Palliative therapy of primary liver tumors].
Topics: Adenoma, Bile Duct; Adolescent; Adult; Aged; alpha-Fetoproteins; Angiography; Antineoplastic Combine | 1993 |
[Hepatic arterial infusion chemotherapy and embolization in the treatment of hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Doxorub | 1994 |
Antibiotic C3368-A, a fungus-derived nucleoside transport inhibitor, potentiates the activity of antitumor drugs.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzofurans; Biological Transport; Carc | 1995 |
Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterizat | 1995 |
[Home therapy approach in cancer patients-chemotherapy (case 2-1)].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorourac | 1994 |
[Home therapy approach in cancer patients-chemotherapy (case 2-3)--intra-arterial infusion cancer chemotherapy for hepatic metastasis of colorectal cancer--case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic | 1994 |
The significance of anatomical variations of hepatic artery and multiple arterial supplies in embolization of liver tumors.
Topics: Adult; Aged; Chemoembolization, Therapeutic; Female; Fluorouracil; Hepatic Artery; Humans; Liver Cir | 1994 |
[Surgical therapy of liver metastases. Therapeutic procedures, results and prognostic factors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Chem | 1994 |
[Noradrenaline-assisted selective chemoembolization of hepatocellular carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Femal | 1994 |
[A case of gastric cancer with multiple liver metastasis responding to combined therapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined | 1995 |
[Targeting treatment of human HCC xenografts implanted in nude mice using bifunctional antibody HC-1 combined with mitomycin C].
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Humans; Immunoto | 1994 |
[Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 1994 |
[Survival in 46 patients with hepatocarcinoma treated by chemoembolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Humans; Liv | 1994 |
[A long-survival case of unresectable liver metastasis of colon cancer by hepatic arterial intermittent multidrug infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxoru | 1994 |
[Two cases of hepatic metastasis of colorectal cancer treated effectively by intrahepatic arterial infusion immunotherapy using OK-432, rIL-2, MMC and 5-FU].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Sch | 1994 |
[A case of liver metastasis from bile duct cancer effectively treated with hepatic artery infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Drug Administration Schedule; E | 1994 |
Treatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheres.
Topics: Adult; Aged; Chemoembolization, Therapeutic; Colonic Neoplasms; Female; Fluorouracil; Humans; Liver | 1994 |
Multiple intrahepatic aneurysms following transcatheter arterial embolization. Work in progress.
Topics: Aneurysm; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Gelatin Sponge, Absorba | 1994 |
[A case of poorly differentiated hepatic cell carcinoma which showed 90% decrease in size after chemotherapy with intraarterial infusion of mitomycin C and oral administration of tegafur].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1994 |
Management of advanced colorectal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal N | 1994 |
Studies of effects of anticancer agents in combination with/without hyperthermia on metastasized human bladder cancer cells in chick embryos using the polymerase chain reaction technique.
Topics: Animals; Antineoplastic Agents; Base Sequence; Carboplatin; Cell Division; Cell Transplantation; Chi | 1994 |
Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion.
Topics: Aclarubicin; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle | 1993 |
[A case of advanced gastric cancer with multiple liver metastases showing marked response to new combination chemotherapy using 5-FU, THP and MMC (FTM)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administrati | 1994 |
Complete remission of liver metastases from colorectal cancer by treatment with a hepatic artery infusion (HAI) of interleukin-2-based immunochemotherapy: reports of three cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Flu | 1994 |
[Hypervascular liver metastases of gastric cancer completely responding to transcatheter oily chemoembolization using epirubicin hydrochloride, mitomycin C and lipiodol].
Topics: Adenocarcinoma; Aged; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver | 1994 |
[Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for nodular type of hepatocellular carcinoma non-occluding the main portal vein--in comparison with transcatheter arterial embolization].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; Emboli | 1994 |
[Antitumor activity of LY 188011, a new deoxycytidine analog, against human cancers xenografted into nude mice].
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Colonic Neoplasms; Deoxycytidine; Drug Admini | 1994 |
Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 1994 |
Effects of hepatic arterial infusion chemotherapy on unresectable or recurrent hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1994 |
Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, | 1994 |
[Application of crossed assay design in test of drug sensitivity in vitro in combined chemotherapy of liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; D | 1993 |
Splenic arterial portal infusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Do | 1994 |
[A case of icteric type hepatoma responding to MMC infusion therapy via cannulation into the hepatic artery].
Topics: Aged; Carcinoma, Hepatocellular; Cholestasis; Female; Humans; Infusions, Intra-Arterial; Liver Neopl | 1993 |
[Prophylactic effects of mitomycin C (MMC) on the liver recurrence in a rabbit gastric VX2 cancer model with high frequency of the recurrence].
Topics: Animals; Disease Models, Animal; Female; Injections, Intravenous; Liver Neoplasms; Mitomycin; Neopla | 1993 |
Diagnosis and therapy for primary hepatic carcinoma: transcatheter inferior phrenic arteriography and chemoembolization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1993 |
[A case of advanced gastric cancer with liver and lung metastasis effectively treated by combined chemo-immunotherapy of MMC, 5'-DFUR, OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 1993 |
[Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytokines; Doxorubicin; Fluorouracil; Humans; Immuno | 1993 |
[Clinical study on the effect of continuous transarterial infusion chemotherapy of CDDP for metastatic liver tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Admi | 1993 |
[Efficacy of hepatic arterial and intraportal infusion chemotherapy for liver metastasis of colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Colorectal | 1993 |
[Importance of systemic administration of pyrimidine after thermochemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Fluorouracil; Gas | 1993 |
[Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluoroura | 1993 |
[Advanced breast cancer with onset of multi-organ metastases successfully treated with combined loco-regional therapies: a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Ch | 1993 |
[The present status of chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcino | 1993 |
[Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1993 |
Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; F | 1993 |
[Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization (TAE)--significance of repetitive therapies and responses to them within 6 months after the first intervention].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubic | 1993 |
[Treatment of hepatocellular carcinoma by transarterial approach].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1993 |
[Transcatheter hepatic segmental chemo-Lipiodol-embolization against hepatocellular carcinoma accompanied by tumor thrombosis in the portal vein].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized | 1993 |
Superselective intra-arterial chemotherapy with mitomycin C in hepatic neoplasms.
Topics: Aged; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Gallbladder Neoplasms; Hepatic Artery | 1993 |
[Clinical evaluation of postoperative adjuvant arterial infusion chemotherapy in resected hepatoma patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; C | 1993 |
[Complication of gastro-duodenum with intra-hepatic arterial infusion chemotherapy using implantable reservoir system for hepatic tumors].
Topics: Carcinoma, Hepatocellular; Cisplatin; Drug Administration Schedule; Duodenal Diseases; Female; Fluor | 1993 |
[Prevention of postoperative recurrence after hepatic resection for metastatic colorectal cancer by adjuvant locoregional chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Chemotherapy, | 1993 |
[A case of gastric cancer with multiple liver metastases responding significantly to intra-arterial infusion of epirubicin/mitomycin C-lipiodol suspension].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; C | 1993 |
Follow-up study of patients treated with monoclonal antibody-drug conjugate: report of 77 cases with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protoco | 1993 |
[Experimental and clinical study in vitro chemosensitivity test for succinate dehydrogenase inhibition test].
Topics: Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neopla | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 1993 |
Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs.
Topics: Amino Acid Sequence; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Dose-Re | 1993 |
Generation of cytotoxic T lymphocytes from peripheral blood.
Topics: Animals; Cell Division; Female; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Act | 1993 |
[A new mode of expression for the assessment of capacities of DNA repair by flow cytometry].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Division; Depression, Chemical; DNA Rep | 1995 |
Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
Topics: Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Case-Control Studi | 1995 |
Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
Topics: Alternative Splicing; Antibiotics, Antineoplastic; Base Sequence; Carcinoma, Hepatocellular; Cell Li | 1996 |
[Successful combination chemotherapy for a post-operative gastric cancer patient with multiple liver metastases and elevated CEA].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Combined Modality Th | 1996 |
[A case of advanced gastric cancer with liver metastasis with no recurrence and long survival].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; C | 1996 |
[Combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16) and 5'-DFUR, (MACVD therapy) as a second-line chemotherapy for metastatic gastric cancer: three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridi | 1996 |
[Mitomycin C-DNA adduct detection in rat organs and human liver].
Topics: Adult; Animals; Carcinoma, Hepatocellular; DNA Adducts; Female; Humans; Liver; Liver Cirrhosis; Live | 1996 |
[A case of effective chemotherapy by combination of 5'-DFUR and MMC for recurrent colon cancer with multiple liver metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Drug A | 1996 |
A prospective evaluation of the treatment of primary or metastatic liver carcinoma with hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; An | 1996 |
Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Carcinoma, Hepatocellula | 1996 |
Regional chemotherapy for colorectal hepatic metastases: evidence for improved survival with new drug combinations.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemo | 1996 |
[Liver resection in a case of multiple liver metastases of gastric cancer following hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1996 |
[A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Femal | 1996 |
[Induced hypertensive chemotherapy with angiotensin-II for liver metastases from gastric cancer].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Female; Fluoro | 1996 |
[Chemohyperthermic peritoneal perfusion and high-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced colon cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Combined | 1996 |
Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cyclohexanes; Female; Humans; Liver Neoplasms; | 1996 |
[Effective transcatheter arterial embolization for hepatic metastasis in a case of AFP producing gastric cancer].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Embolization, Therapeutic; Gastr | 1996 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseas | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adm | 1996 |
Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.
Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Carrier Proteins; Cisplatin; Doxorubicin; D | 1996 |
Arteritis following intra-arterial chemotherapy for liver tumors.
Topics: Aged; Antibiotics, Antineoplastic; Arteritis; Carcinoma, Hepatocellular; Chemoembolization, Therapeu | 1997 |
Adverse effects of intraportal chemotherapy on natural killer cell activity in colorectal cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Chemotherapy, Adjuvant; Colorect | 1997 |
Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Chemotherapy, Ad | 1997 |
[Secondary hepatic resections in a case of sigmoid colon cancer with multiple liver metastasis (H3) after successful continuous hepatic artery infusion chemotherapy oriented by in vitro chemosensitivity test].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug | 1997 |
Radiofrequency capacitive hyperthermia for unresectable hepatic cancers.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Doxorubicin; Embolization, Ther | 1997 |
Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival.
Topics: Animals; Antineoplastic Agents; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hep | 1997 |
[Combined intra-arterial locoregional and systemic treatment of nonresectable hepatic metastases of colorectal carcinoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic | 1997 |
Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C.
Topics: Alkylation; Animals; Antibiotics, Antineoplastic; Carcinoma; DNA Adducts; DNA, Bacterial; Hydrogen-I | 1997 |
[Percutaneous transcatheter thermotherapy (PTCT): use of hotwire for local tumor control].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1997 |
[Hepatic arterial chemotherapy for liver cancer over a period of 8 years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; | 1997 |
[Evaluation of hepatic resection and hepatic arterial infusion chemotherapy for multiple liver metastases from colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; | 1997 |
[Liver metastases from breast cancer 14 years after radical mastectomy; successful treatment with hepatic arterial infusion chemotherapy and systemic endocrine therapy--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Fadrozole; Femal | 1997 |
[Extra-arterial dislocation of indwelling catheter in hepatic arterial infusion chemotherapy--special reference to tissue destruction by 5-fluorouracil].
Topics: Aged; Aneurysm, False; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protoco | 1997 |
[Effects of OK-432 intraportal administration on cell-mediated immune responses].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Humans; Immunity, Cellular; Im | 1997 |
[Antibody-targeted radio-chemotherapy of human primary liver cancer with radio-iodinated AFP monoclonal antibodies conjugated with mitomycin C: a preliminary clinical observation].
Topics: Adult; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Carcinoma, Hepatocel | 1996 |
A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modal | 1997 |
Cutaneous metastasis as a complication of hepatic intra-arterial chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorourac | 1997 |
Intraarterial infusion of dibutyryl cyclic adenosine monophosphate plus mitomycin C for unresectable hepatocellular carcinoma: long-term survival and response to tumor growth inhibition.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, | 1995 |
[Anesthesiologic characteristics of isolated hyperthermic liver perfusion with mitomycin C].
Topics: Adult; Aged; Anesthesia, General; Antibiotics, Antineoplastic; Female; Hemodynamics; Humans; Hyperth | 1997 |
[Locoregional therapy with hypoxic liver perfusion in malignant neoplasms of the gallbladder. Preliminary experience].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Carcinoid Tumor; Chemotherapy, Cancer, Regional P | 1997 |
[A case of multiple liver metastasis of gastric cancer responding to hepatic arterial infusion chronotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Circadian Rhythm; Cisplatin; Drug Ad | 1998 |
[Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedul | 1998 |
An unusual complication of chemotherapy: an abscess in the pterygopalatine fossa.
Topics: Abscess; Anti-Bacterial Agents; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Immunos | 1998 |
[Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1998 |
[Adjuvant intra-arterial chemotherapy with gastrin receptor antagonist after hepatic resection in colorectal cancer metastasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Doxoru | 1998 |
[Intrahepatic arterial infusion chemotherapy with angiotensin II for liver metastasis from gastric cancer].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administr | 1998 |
[Long-term survival in a case of multiple liver metastasis from postoperative gastric cancer effectively treated by hepatic intraarterial infusion chemotherapy using MMC and pirarubicin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Gastrectomy; Hepatic Artery; Humans; In | 1998 |
[Appearance of extrahepatic lesions in the superior lip and orbit of a patient with liver metastases of gastric cancer following partial response by hepatic arterial infusion chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fluo | 1998 |
[Adjuvant regional arterial port chemotherapy after resection of colorectal liver metastases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwellin | 1998 |
Metastatic malignant meningioma of the liver with hypoglycemia: report of a case.
Topics: Aged; Chemoembolization, Therapeutic; Fatal Outcome; Hepatectomy; Humans; Hypoglycemia; Liver; Liver | 1998 |
Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, | 1997 |
Clinical applications of the histoculture drug response assay.
Topics: Antineoplastic Agents; Cell Culture Techniques; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorecta | 1995 |
Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 1998 |
Effects of doxorubicin, mitomycin C, and ethanol on Hep-G2 cells in vitro.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Cell Count; | 1999 |
Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antiemetics; Antineoplastic Agents; Car | 1999 |
Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population.
Topics: alpha-Fetoproteins; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chem | 1999 |
[A case of liver metastases from gastric cancer responding to induced hypertensive chemotherapy with angiotensin II].
Topics: Aged; Angiotensin II; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic C | 1999 |
Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Co | 1999 |
Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellu | 1999 |
Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein.
Topics: Aclarubicin; Aged; Antibiotics, Antineoplastic; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Che | 1999 |
[Intraarterial infusion therapy for unresectable liver metastasis of colorectal cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Drug Administration Schedule; Fe | 1999 |
[Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms | 1999 |
[Percutaneous ethanol injection therapy with hepatic arterial infusion chemotherapy for liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Ethanol; Fluorouracil; Hepatic Art | 1999 |
[Efficacy and problems of hepatic arterial chemotherapy with angiotensin II for liver metastasis from gastric cancer].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administr | 1999 |
[Complete remission in a case of sigmoid colon cancer with multiple liver metastases-treatment with arterial chemotherapy and percutaneous microwave coagulation therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Admi | 2000 |
Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepat | 2000 |
Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Dendritic Ce | 2000 |
Significance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Blood Flow Velocity; Case-Control Studies; Colorectal Neop | 2000 |
Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Cell Survival; Cytoprotection; Doxorubicin; Endoth | 2000 |
Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benchmarking; C | 2000 |
[Hepatic arterial infusion chemotherapy using totally implantable port system].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; D | 2000 |
[A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 2000 |
[A case of colonic cancer with multiple liver metastases effectively treated by intra-arterial chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Femal | 2000 |
[Intra-arterial infusion chemotherapy in combination with microwave hyperthermia for cancer of head of pancreas and liver metastasis--a case of 16 years survival].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; | 2000 |
[Hepatic arterial infusion chemotherapy for unresectable liver metastasis of gastrointestinal cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Fluorouracil; Hepati | 2000 |
[Hepatic arterial injection of degradable starch microspheres (DSM) combined with adriamycin (ADM) and mitomycin C (MMC) in patients with liver metastasis of colorectal cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxor | 2000 |
[Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
Topics: Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatoc | 2000 |
[Repetitive chemo-embolization with degradable starch microspheres (DSM) to each left and replaced right hepatic artery in a patient with multiple liver metastases of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colonic Neoplasms; E | 2000 |
Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Chemoembolization, Therape | 2001 |
[Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Fluorouracil; He | 2000 |
Advanced gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion of 5-FU, MMC and peroral administration of 5-FU: a case report.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hepatic Artery; | 2000 |
[Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 2001 |
[A case of gastric cancer with liver metastases successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineopla | 2001 |
[Long-term survival of a patient with postoperative liver metastasis of stage IVa gallbladder cancer responding to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; C | 2001 |
Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization.
Topics: Chemoembolization, Therapeutic; Cisplatin; Disease Progression; Doxorubicin; Ethiodized Oil; Female; | 2001 |
[A case of multiple liver metastasis of gastric cancer which was effectively treated by arterial infusion chemotherapy with hyperthermia and 10 years survival].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Embolization, Therapeutic; | 2001 |
Metastatic in-situ perianal Paget's disease.
Topics: Abdomen; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Cisplatin; Fluorourac | 2001 |
Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; C | 2001 |
Malignant fibrous histiocytoma of the trunk metastatic to the liver: treatment with transcatheter intrahepatic chemoembolization.
Topics: Carboplatin; Chemoembolization, Therapeutic; Epirubicin; Histiocytoma, Benign Fibrous; Humans; Iodiz | 2001 |
Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Car | 2001 |
Expression of metallothionein in colorectal cancers and synchronous liver metastases.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cispla | 2001 |
Chemoembolization as a bridge to transplantation for hepatocellular carcinoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Th | 2001 |
[Clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and prediction of effectiveness by diagnostic imaging].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colorectal Neoplasms | 2001 |
[Hepatic resection for synchronous liver metastases of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatectomy; Hepatic Art | 2001 |
[Histological evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin/mitomycin C].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubicin; Female; Hum | 2001 |
[Clinical experience of intra-arterial chemotherapy for liver metastases of breast cancer patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catheters, Indwelling; Doxo | 2001 |
[Transarterial chemoembolization in hepatocellular carcinomas: technique, indications, results].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diagnosti | 2001 |
An antisense construct of full-length human RAD50 cDNA confers sensitivity to ionizing radiation and alkylating agents on human cell lines.
Topics: Acid Anhydride Hydrolases; Alkylating Agents; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; C | 2002 |
[Intervention treatment of hepatocellular carcinoma with 125I-lipiodol plus chemotherapeutic drugs and self body hairs: a report of 56 cases].
Topics: Adult; Aged; Agmatine; alpha-Fetoproteins; Arteries; Carcinoma, Hepatocellular; Chemoembolization, T | 2000 |
Selective approaches to gastric cancer patients with liver metastases: role of liver-directed chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Doxorubicin; Fluorouracil; Humans; Infusi | 2001 |
[Personal experience with intra-arterial locoregional chemotherapy of liver metastases from colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Doxorubicin; Female | 2001 |
Chemoembolization for primary liver cancer.
Topics: Aged; Aged, 80 and over; alpha-Fetoproteins; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; | 2002 |
Case of liver metastasis from colon cancer successfully treated by regional chemotherapy with mitomycin C alone.
Topics: Antibiotics, Antineoplastic; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mal | 2002 |
[Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2002 |
Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Car | 2002 |
[Gastroduodenal ulcer, perforation after chemo-embolization in 4 cases of advanced hepatocellular carcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1999 |
[Chemoembolization of primary hepatic carcinoma with portal vein tumor thrombus].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Doxorubicin; | 1999 |
Is necrosis induction therapy relevant to hepatocellular carcinoma? Prognostic evaluation viewed from necrosing feature in HCC occluding the main portal vein after treatment with DBcAMP and MMC.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; | 1992 |
[Effect of dibutyryl cyclic AMP in the treatment of hepatocellular carcinoma--intraarterial infusion therapy combined with anticancer agent for hepatocellular carcinoma with portal vein thrombosis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; Doxoru | 1992 |
Liver tumors: follow-up with P-31 MR spectroscopy after local chemotherapy and chemoembolization.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Colorectal Neoplasms; Female; Fluorouraci | 1992 |
[Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS)].
Topics: Adenoma, Bile Duct; Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubi | 1992 |
[A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Hepatic Arter | 1992 |
[Usefulness of segmental Lp-TAE using lipiodol mixed with anticancer agent for inoperable hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Evaluation Studies as | 1992 |
Hepatocellular carcinoma and transcatheter oily chemoembolization in Thailand.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Gelatin | 1992 |
The difference in chemosensitivity to antineoplastic agents of human hepatocellular carcinoma cells under normo-oxygenated or hypoxic conditions.
Topics: Antineoplastic Agents; Carbazilquinone; Carcinoma, Hepatocellular; Cell Hypoxia; Cisplatin; Doxorubi | 1992 |
[Effects of intra-arterial infusion chemotherapy with radiation therapy for advanced hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy | 1992 |
[Prophylactic chemotherapy by regional arterial infusion in resected hepatoma patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; F | 1992 |
[Prevention of postoperative recurrence of hepatocellular carcinoma by adjuvant locoregional chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1992 |
[Intermittent intra-arterial chemotherapy using subcutaneously implanted reservoir for hepatocellular carcinoma and liver metastasis of colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; C | 1992 |
[Disappearance of lung metastases from hepatocellular carcinoma following bronchial arterial infusion of CDDP and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Hepatocellular; Cispl | 1992 |
[Two cases of esophageal varices complication after hepatic arterial infusion chemotherapy (HAI) for metastatic liver tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Esophageal and Gastric Varices; Female; | 1992 |
[Stage III, IV hepatocellular carcinoma patients surviving more than five years after transcatheter chemoembolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Humans; Iodized Oil; L | 1992 |
[Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using implantable drug delivery system].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubic | 1992 |
[Clinical evaluation of operative and non-operative treatment in hepatocellular carcinoma with main portal vein tumor thrombus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; C | 1992 |
[Hepatic carcinoma treated by hepatic arterial embolization using 131I and chemotherapeutic agent gelatin microspheres: report of 9 cases].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Gelatin; Hepatic Artery; Hum | 1992 |
[Portal blood levels of mitomycin C after intraperitoneal administration].
Topics: Humans; Infusions, Parenteral; Intraoperative Care; Liver Neoplasms; Mitomycin; Neoplastic Cells, Ci | 1992 |
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Hepati | 1992 |
[The efficacy of transcatheter arterial infusion chemotherapy in patients with hepatocellular carcinoma].
Topics: Administration, Oral; Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Doxorubicin; Femal | 1992 |
Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administrati | 1992 |
[Comparative changes in hepatic function induced by transhepatic arterial chemoimmunoembolization among liver cancer patients].
Topics: Chemoembolization, Therapeutic; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Cirr | 1992 |
Pharmacokinetics of mitomycin C following hepatic arterial chemoembolization with gelfoam.
Topics: Animals; Chemoembolization, Therapeutic; Dogs; Femoral Vein; Gelatin Sponge, Absorbable; Hepatic Art | 1992 |
[Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration | 1992 |
[Intermittent intra-arterial infusion chemotherapy using implantable reservoir for the treatment of hepatic metastasis].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Do | 1992 |
[Evaluation of implantation of a cancer chemotherapeutic vascular access device: report of 91 cases].
Topics: Catheters, Indwelling; Cisplatin; Evaluation Studies as Topic; Femoral Artery; Fluorouracil; Humans; | 1992 |
[Signification of liver metastases of colorectal cancer with special reference to recurrence in the residual liver after hepatic resection].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubi | 1992 |
[Treatment of liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 1992 |
[A pharmacokinetic study of intra-arterial chemotherapy for prophylactic treatment of liver metastasis after hepatectomy for liver cancer].
Topics: Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Hepatectomy; Hepatic Artery; Humans; Infusions, Int | 1992 |
[Effective treatment of liver metastasis and peritoneal dissemination of gastric cancer using intra-arterial therapy--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administration Schedule; Fluoro | 1992 |
[Evaluation of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy of unresectable primary or secondary cancer of the liver].
Topics: Catheterization; Catheters, Indwelling; Combined Modality Therapy; Doxorubicin; Epirubicin; Female; | 1992 |
Superparamagnetic iron oxide-enhanced magnetic resonance imaging of experimental liver tumors after mitomycin C administration.
Topics: Animals; Contrast Media; Dextrans; Ferrosoferric Oxide; Iron; Liver Neoplasms; Magnetic Resonance Im | 1992 |
[A case of recurrent liver tumor from gastric cancer responding remarkably to hepatic arterial infusion of large doses of mitomycin C and 5-fluorouracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Gastrectomy; Hepatic Artery; Hum | 1992 |
[Indication for chemoembolization of liver tumors. An interdisciplinary concept and initial results].
Topics: Adult; Chemoembolization, Therapeutic; Colonic Neoplasms; Female; Fluorouracil; Germany, West; Human | 1992 |
[A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neopla | 1992 |
[A case report of complete remission of liver metastasis from rectal carcinoma treated with intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusion | 1992 |
[Intra-arterial infusion chemotherapy using implantable reservoir for liver metastasis of the lung cancer--an effective case].
Topics: Adenocarcinoma; Aged; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial | 1992 |
[Portal blood levels of mitomycin C after intraperitoneal administration].
Topics: Humans; Infusions, Parenteral; Liver Neoplasms; Mitomycin; Pancreatic Neoplasms; Portal Vein | 1992 |
Promotion of hepatic metastases by liver resection in the rat.
Topics: Animals; Fluorouracil; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Liver Regeneration; Mi | 1992 |
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs.
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Colonic Neoplasms; D | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sche | 1992 |
[A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; D | 1991 |
[Efficacy of anticancer agent-lipiodol emulsion for hepatic arterial infusion and regional hyperthermia in patients with nonresectable hepatoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modal | 1991 |
[Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; D | 1991 |
[Effects of intraarterial infusion chemotherapy on liver function in patients with hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cytarabine; | 1991 |
[Effectiveness and timing of one shot transarterial infusion and/or transcatheter arterial embolization therapy for recurrence of postoperative hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeuti | 1991 |
[Transcatheter hepatic artery infusion chemotherapy and embolization for 60 patients with primary hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 1991 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1991 |
[Histopathologic study on resected hepatocellular carcinoma after transcatheter hepatic arterial chemo-embolization].
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Hepatic Artery; Humans; In | 1991 |
[Balloon occluded arterial infusion therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Doxorubi | 1991 |
Hepatocellular carcinoma associated with polyarteritis nodosa with symptoms appearing after intra-arterial chemotherapy.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Hepatic Artery; Humans; Injections, I | 1991 |
[The changes in tumor marker levels after chemolipiodolization in early phase].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryo | 1991 |
[Nutritional support for cancer bearing patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Home Nursing; Humans | 1991 |
[Complete response in a case of rectal carcinoma with multiple liver metastasis treated by infuse-a-port].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatic Artery; Humans | 1991 |
Fractional incorporation of radionucleotides, a marker of in vitro tumor cell chemosensitivity in colorectal cancer.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Daunorubicin; DNA, Neoplasm; Doxorubicin; Humans; In Vi | 1991 |
Evaluation of prognostic factors for 233 patients with recurrent advanced breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclopho | 1991 |
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; | 1991 |
[Regional chemotherapy of diffuse liver metastases of colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality | 1991 |
Human hepatocellular carcinoma sensitivity to antitumor drugs assayed using the succinate dehydrogenase inhibition test.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Drug Screening Assays, Antitumo | 1991 |
Prevention of gastric complications in hepatic arterial chemoembolization. Balloon catheter occlusion technique.
Topics: Carcinoma, Hepatocellular; Catheterization; Doxorubicin; Embolization, Therapeutic; Gelatin Sponge, | 1991 |
Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Ge | 1991 |
[Serial changes in serum levels of laminin and type III procollagen N-terminal peptide after transarterial embolization (TAE) in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1991 |
[Study of intermittent intra-arterial infusion chemotherapy in liver metastases from squamous cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubic | 1991 |
Mitomycin C-loaded microcapsules in the treatment of colorectal liver metastases. Pharmacokinetics of regionally administered particulate chemotherapy.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Drug Compounding; Half-Life; Hepatic Artery; Humans; In | 1991 |
[Chemoembolization with degradable starch microspheres for liver metastases of colorectal cancer].
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; | 1991 |
[Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Moda | 1991 |
[Targeting cancer chemotherapy for metastatic liver cancer--effects of DSM on hepatic hemodynamics and on clinical outcome].
Topics: Aged; Antineoplastic Agents; Drug Evaluation; Female; Hemodynamics; Humans; Infusions, Intra-Arteria | 1991 |
Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.
Topics: Animals; Antineoplastic Agents; Cell Count; Cell Division; Cell Line; Colonic Neoplasms; DNA, Neopla | 1991 |
[Pharmacokinetics and local availability of mitomycin. The influence of vasoconstriction and chemoembolization].
Topics: Biological Availability; Chemistry, Pharmaceutical; Diffusion; Embolization, Therapeutic; Half-Life; | 1991 |
[Effect of intraarterial noradrenaline-induced hypertensive chemotherapy of hepatic metastasis in gastric cancer].
Topics: Aged; Blood Pressure; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver | 1991 |
[Continuous infusion chemotherapy using an infusional port in colorectal cancer with liver metastases].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colo | 1991 |
[Intra-arterial infusion chemotherapy using an implantable reservoir in the treatment of hepatic metastases in colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cisplatin; Colorectal Neop | 1991 |
[Effects and complications of continuous hepatic arterial infusion chemotherapy using implantable reservoir for liver metastases from colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Catheterization; Colorectal Neoplasms; Drug Administ | 1991 |
[The efficacy of intra-arterial infusion chemotherapy in patients with metastatic liver tumors].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Catheters, Indwelling; Colonic Neoplasms; Combi | 1991 |
[A study on hepatic arterial infusion for metastatic liver tumor].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; | 1991 |
[Therapeutic effect of transarterial infusion immunochemotherapy for metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1991 |
Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neop | 1991 |
Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neop | 1991 |
[Splenic or hepatic arterial injections of interleukin-2 with chemotherapeutic agents for hepatic metastases].
Topics: Aged; Cyclophosphamide; Female; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; In | 1991 |
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Hu | 1990 |
[A case of unresectable liver metastasis from leiomyosarcoma of the stomach successfully treated by intra hepato-arterial chemotherapy with Infuse-A-Port].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Hepatic Artery; Humans; I | 1990 |
[Combined treatment by hepatectomy and postoperative chemotherapy via a catheter in the hepatic artery of metastatic liver tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Fluorouracil | 1990 |
[Treatment of liver metastases from colorectal cancer--major hepatic resection and continuous hepatic arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubicin; Fluorouracil; Hep | 1990 |
Serious chemical sclerosing cholangitis associated with hepatic arterial 5FU and MMC chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cholangiopancreatography, Endoscopic Retrogra | 1990 |
[Evaluation of the liver and peritoneal metastasis in the treatment of gastric carcinoma with intra-arterial injection in terms of survival period].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Int | 1990 |
[A study of low-dose intermittent intra-arterial infusion chemotherapy for liver metastasis in colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; | 1990 |
[Study of intraarteric infusion chemotherapy with drug delivery system].
Topics: Aged; Angiotensin II; Antineoplastic Agents; Blood Pressure; Cisplatin; Doxorubicin; Drug Administra | 1990 |
[Warm drug solution injected into tumor vessel may enhance antitumor effect].
Topics: Animals; Body Temperature; Carcinoma 256, Walker; Combined Modality Therapy; Female; Glucose; Humans | 1990 |
[Clinical evaluation and problem of intra-arterial infusion chemotherapy of liver metastasis from digestive organ cancer].
Topics: Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Infusion Pumps, Implantabl | 1990 |
[Hepatic arterial infusion chemotherapy using implantable reservoir in colorectal liver metastasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Doxorubicin; Fluoro | 1990 |
[Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorour | 1990 |
[Continuous hepatic arterial infusion chemotherapy using implantable reservoir in liver metastases from colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colorectal Neoplasms; Drug | 1990 |
[Multivariate analysis of gastric cancer patients with liver metastases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 1990 |
[Hepatic resection plus hepatic artery infusion with implantable port for colorectal metastases].
Topics: Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Doxorubicin; Female; Hepatec | 1990 |
[Successful treatment of advanced gastric cancer with multiple liver metastasis by combination chemotherapy using mitomycin C, 5-fluorouracil, and high-dose leucovorin: a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; | 1990 |
[Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer].
Topics: Adenosine Triphosphate; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Scree | 1990 |
[Missile therapy of colorectal and pancreatic cancers--clinical trial of monoclonal antibody, A7-NCS, in 73 patients with colorectal and pancreatic cancers].
Topics: Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Colorectal Neoplasms; Doxorubicin; Drug A | 1990 |
Regional chemotherapy in liver metastases of colorectal carcinoma: monitoring with arterial computed tomography.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorub | 1990 |
[Intra-hepato-arterial infusion chemotherapy using catheter inserted and placed in hepatic artery via the left radial artery on liver malignancy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1990 |
[Clinical efficacy of ifosfamide for liver metastasis of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Breast Neoplasms; Doxorubicin; Drug Ad | 1990 |
[Combined therapy for unresectable hepatocellular carcinoma with hepatic arterial infusion of lymphokine-activated killer cells from autologous splenocytes and of lipiodolized antitumor agent].
Topics: Carcinoma, Hepatocellular; Hepatic Artery; Humans; Immunization, Passive; Infusions, Intra-Arterial; | 1990 |
Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis.
Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Delayed-Action Preparations; Embolizatio | 1990 |
[Evaluation of the efficacy of oil chemoembolization for hepatocellular carcinoma by computed tomography: a proposal for altering the criteria to indicate the efficacy].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Embolization, Therapeutic; Female; H | 1990 |
Intracerebral choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; | 1990 |
[A case of recurrent liver tumor from gastric cancer responding remarkably to intra-hepato-arterial infusion of CDDP, MMC and Lipiodol].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Hepatic Art | 1990 |
[Evaluation of quality of life in arterial infusion chemotherapy of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Hepatic Artery; Hospitalization; | 1990 |
[Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy | 1990 |
[Intermittent arterial chemoembolization in liver tumor using degradable starch microspheres].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Humans; Infu | 1990 |
[Therapeutic effects by implantable infusion pump for hepatic malignant tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorub | 1990 |
[Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer].
Topics: Adenoma, Bile Duct; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile | 1990 |
[Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy].
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Ne | 1990 |
[A case of hepatocellular carcinoma treated by intrahepatic arterial administration of anticancer agents: serial determination of the concentration of the chemotherapeutic agents in serum and dialysate during hemodialysis].
Topics: Adult; Carcinoma, Hepatocellular; Doxorubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; In | 1990 |
[A case of nonresectable gastric cancer completely responding to combined chemotherapy according to the mode of progression].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 1990 |
[Hyperthermia: microwave hyperthermia in combination with intra-arterial infusion chemotherapy of cancer of the pancreas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Hepatocellular; Combined | 1985 |
Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil.
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biodegradation, Env | 1985 |
[Palliative treatment for unresectable cases of pancreatic carcinoma].
Topics: Adult; Aged; Gastroenterostomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Age | 1985 |
[A case of hepatocellular carcinoma treated by irradiation after ADMOS (adriamycin/mitomycin C-oil suspension) arterial infusion therapy].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular | 1986 |
[A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Live | 1988 |
[The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice].
Topics: Adenocarcinoma; alpha-Fetoproteins; Animals; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Mitomy | 1988 |
[Transcatheter hepatic arterial chemoembolization using microencapsulated mitomycin C (MMCmc)].
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Drug Compounding; Embolization, Therapeu | 1988 |
Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Electron Probe Microanalysis; Embolization, Therapeut | 1988 |
Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1989 |
Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cisp | 1989 |
[The clinical course of nodular type hepatocellular carcinomas after transcatheter arterial embolization (TAE) therapy].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1989 |
Immunotherapy using Freund's adjuvant and recombinant interleukin-2 combined with transarterial chemoembolization for hepatocellular carcinoma.
Topics: Aclarubicin; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1989 |
[Clinical study of intrahepatic arterial infusion of unresectable hepatoblastoma and hepatocarcinoma in children].
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 1989 |
Treatment of hepatic cancer by hepatic arterial infusion chemotherapy.
Topics: Embolization, Therapeutic; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Ne | 1989 |
Non-homogeneous intrahepatic drug distribution in intraportal infusional chemotherapy demonstrated by Tc-99m-MAA perfusion SPECT.
Topics: Aged; Catheterization, Central Venous; Chemotherapy, Cancer, Regional Perfusion; Combined Modality T | 1989 |
[Chemotherapeutic effect on metastatic tumors].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxorubicin; Fluorou | 1989 |
[Locoregional chemotherapy of liver tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality | 1989 |
[A case report of bilateral liver metastasis from rectal cancer effectively treated with continuous infusion of anti-cancer drugs through hepatic artery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Carcinoma, Transitional Cell; Cisplat | 1989 |
Temporary chemoembolization of liver malignancies--technique.
Topics: Antineoplastic Agents; Cisplatin; Doxorubicin; Embolization, Therapeutic; Humans; Immunotoxins; Live | 1989 |
[Preventive hepatic arterial infusion in high risk cases of liver metastasis from gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Evaluation; Fluorour | 1989 |
[Effect of degradable starch microspheres (DSM) on hepatic hemodynamics].
Topics: Hemodynamics; Humans; Infusions, Intra-Arterial; Liver Circulation; Liver Neoplasms; Microspheres; M | 1989 |
[Preventive effects of intra-arterial infusion chemotherapy of liver metastasis in non-resectable pancreatic cancer].
Topics: Alprostadil; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Humans; Infusions, Intr | 1989 |
[Availability of intermittent chemotherapy by reservoir in liver metastasis of colo-rectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Evaluation Studie | 1989 |
[Intra-arterial infusion chemotherapy of liver metastases in colorectal cancer].
Topics: Adult; Aged; Catheterization; Colorectal Neoplasms; Female; Hepatic Artery; Humans; Infusion Pumps; | 1989 |
[Results of intra-arterial infusion chemotherapy of colorectal cancer in patients with metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Catheterization; Colorectal Neoplasms; Combined Moda | 1989 |
[Chemoembolization with degradable starch microspheres for liver metastases in colorectal cancer].
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Evaluation Studies as Topic; Hepatic Artery; Humans | 1989 |
[Over two years survival of intra-arterial infusion chemotherapy in gastric cancer with liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Fluoro | 1989 |
[Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Aorta; Doxorubicin; Fluorouracil; He | 1989 |
[Study of long-survival cases with liver metastasis of colorectal cancer by hepatic arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colorectal Neoplasms; Doxo | 1989 |
[Reservoir implanted arterial infusion therapy in liver cancer with replaced right hepatic artery].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubi | 1989 |
[Intra-arterial infusion port system for intermittent degradable starch microsphere chemoembolization and implantation method].
Topics: Adult; Aged; Catheterization; Doxorubicin; Embolization, Therapeutic; Female; Humans; Infusion Pumps | 1989 |
[Complications of intra-arterial infusion chemotherapy in patients with colorectal cancer with liver metastasis, with special reference to IA-5-FU induced sclerosing cholangitis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cholangitis, Sclerosin | 1989 |
[Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatic Artery; Humans; | 1989 |
Mitomycin C determination using loop-column extraction: a rapid and sensitive high-performance liquid chromatographic assay for pharmacokinetic studies with Spherex starch particles.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Liver Neoplasms; Mitomycin; Mit | 1989 |
Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma.
Topics: Colorectal Neoplasms; Female; Floxuridine; Humans; Leukocyte Count; Liver Neoplasms; Male; Mitomycin | 1989 |
Transcatheter arterial chemoembolization for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheterization, Peripheral; Doxorubicin; Embolization, Ther | 1989 |
Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Catheterization, Peripheral; Doxorubicin; Embolization, Therapeutic; Hepa | 1989 |
Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Catheterization, Peripheral; Doxorubicin; Embolization, Therapeutic; Hepa | 1989 |
High-dose mitomycin C: activity in hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Evaluation; Female; Human | 1989 |
[Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Combined Modality Therapy; Doxorubicin; | 1989 |
[Influence of hepatic ischemia on liver regeneration following hepatectomy, with special reference to the therapeutic choice for ruptured hepatoma].
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatectomy; Humans; Isc | 1989 |
[Metastatic liver cancer from the stomach successfully treated by combined immunochemotherapy and transarterial embolization].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabin | 1989 |
[An assessment of therapeutic effects by transcatheter arterial embolization (TAE) with degradable starch microspheres (DSM) for hepatic malignant tumors].
Topics: Adenoma, Bile Duct; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1989 |
[Intra-arterial infusion chemotherapy in non-resectable pancreatic cancer using angiotensin-II and implantable drug delivery system].
Topics: Adenoma, Bile Duct; Adult; Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemothe | 1989 |
[New approach for unresectable primary liver cancer--intra-arterial combination chemotherapy during and after operation with local injection of ethanol].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality T | 1989 |
[Usefulness of subcutaneously implanted reservoir for postoperative therapy in hepatocellular carcinoma and liver metastases of colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Colorectal Neoplasms; Com | 1989 |
[Hepatic arterial infusion chemotherapy of hepatocellular carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Drug E | 1989 |
[Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Combin | 1989 |
[A case of recurrent hepatocellular carcinoma successfully treated by arterial chemoembolization in combination with local hyperthermia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality | 1989 |
[Analysis of prognostic factors in patients with hepatocellular cancer treated by hepatic arterial infusion chemotherapy].
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1989 |
[Assessment of three-year survival cases with unresectable hepatocellular carcinoma treated by arterial chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Mod | 1989 |
[Eight cases of non-resectable hepatocellular carcinoma surviving for more than 3 years after Lipiodol administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Female; Hepa | 1989 |
[The study of transcatheter arterial chemo-lipiodol administration in liver metastasis of colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality | 1989 |
[Prognosis of intra-arterial chemo-embolization in metastatic liver cancer].
Topics: Cisplatin; Embolization, Therapeutic; Emulsions; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; | 1989 |
Intraarterial infusion chemotherapy for metastatic liver tumors using multiple anti-cancer agents suspended in a lipid contrast medium.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Diatrizoate M | 1989 |
Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for hepatocellular carcinoma occluding main portal vein: case studies.
Topics: Adult; Aged; Bucladesine; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Humans; Infu | 1989 |
Chemoembolization of liver malignancies--the experience at the university-hospital in Frankfurt/M. (West-Germany).
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; | 1989 |
[A resected case of hepatocellular carcinoma effectively treated by hepatic artery embolization and systemic chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modal | 1989 |
[Two cases of digestive cancer demonstrated remarkable regression by hyperthermia with systemic chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Colonic N | 1989 |
[Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic | 1989 |
[A 5-FU, ADR, MMC combined hepatic arterial infusion therapy in non-resectable liver metastases from colon and gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Flu | 1989 |
[Hepatic arterial infusion chemotherapy using totally implantable reservoir in liver metastases in colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Carcinoemb | 1989 |
[Arterial infusion cancer chemotherapy in liver tumor using implantable reservoir].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 1989 |
Arterial chemoembolization with mitomycin C microcapsules followed by transcatheter hepatic artery embolization for hepatocellular carcinoma.
Topics: Aged; Capsules; Carcinoma, Hepatocellular; Catheterization; Embolization, Therapeutic; Female; Hepat | 1987 |
[Combination intra-arterial chemotherapy with degradable starch microspheres and mitomycin C against inoperable hepatic metastases].
Topics: Carcinoma, Hepatocellular; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microsp | 1988 |
[Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis].
Topics: Aged; Capsules; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Emulsions; Humans | 1988 |
Initial clinical experience with degradable starch microspheres.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Female | 1987 |
[Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Furans; Hepatecto | 1988 |
Clinical evaluation of transcatheter arterial embolization and one-shot chemotherapy in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; | 1988 |
[Clinical evaluation of advanced hepatocellular carcinomas with intraarterial infusion therapy using polysaccharide solution as a carrier of anticancer drugs].
Topics: Carcinoma, Hepatocellular; Doxorubicin; Evaluation Studies as Topic; Humans; Infusions, Intra-Arteri | 1988 |
[Cytofluorometric and histopathological studies on non-cancerous liver lesions after lipiodol-transcatheter arterial embolization].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; DNA; Doxorubicin; Embolization, Therapeut | 1988 |
[Accumulating patterns of lipiodol and therapeutic effect of combination therapy with ADMOS and CDDP two-route infusion in hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; D | 1988 |
[Arterial infusion of anticancer agent and lipiodol using a totally implanted drug delivery system].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Combinations; Emulsions; Fluoroura | 1988 |
[Trans-arterial embolization or transarterial infusion of anti-cancer drugs suspended in a lipid contrast medium against unresectable metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Embolization, Therapeutic; Fluorouracil | 1988 |
[Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Combin | 1988 |
[Multidisciplinary treatment of unresectable liver cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Mod | 1988 |
[Treatment with degradable starch microspheres (DSM) in malignant hepatic tumors-clinical experience of implantable drug delivery system (Port-A-Cath)].
Topics: Adenoma, Bile Duct; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carci | 1988 |
[Chemoembolization and regional hyperthermia with degradable starch microspheres in the treatment of malignant hepatic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy | 1988 |
[Assessment of therapeutic effects by transcatheter arterial embolization (TAE) in hepatic malignant tumors with degradable starch microspheres (DSM)].
Topics: Adenoma, Bile Duct; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Doxorubicin; Embolization, | 1988 |
[Chemo-embolization of primary hepatocellular carcinoma].
Topics: Adult; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Hepatic Artery; Hu | 1987 |
Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
Topics: Aclarubicin; Antineoplastic Agents; Carbazilquinone; Carcinoma, Hepatocellular; Cisplatin; Doxorubic | 1988 |
Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis.
Topics: Animals; Carcinoma, Hepatocellular; DNA; DNA Damage; DNA, Neoplasm; Humans; Leukocytes; Liver Neopla | 1988 |
[Transcatheter arterial infusion therapy using lipiodol and mitomycin C for hepatocellular carcinoma with liver cirrhosis].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Humans; Infusions, Intr | 1988 |
[A case of HCC with a tumor thrombus in the main portal vein surviving (Vp4) for over three years and six months].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubi | 1988 |
[Chemoembolization therapy of hepatocellular carcinoma-antitumor effect and side effect].
Topics: Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Embolization, Therapeutic; Humans; Iodized Oil; L | 1988 |
[Olive oil-lipiodol mixture and anticancer agents (5FU, MMC) emulsion as a chemoembolic agent].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Emboliza | 1988 |
[A case of hepatocellular carcinoma surviving more than five years by chemoembolization with mitomycin C microcapsules].
Topics: Aged; Capsules; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; | 1988 |
[Intra-arterial infusion therapy with polysaccharide solution as a carrier of anticancer agents--a new method of intra-arterial infusion therapy].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Delayed-Action P | 1988 |
Hepatic arterial and systemic chemotherapy for the treatment of primary and secondary malignancies of the liver.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Fl | 1985 |
Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colonic Neoplasms; Combined Modality Therapy; Female; Floxuri | 1987 |
Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma.
Topics: Adult; Aged; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Colonic Neoplasms; Drug E | 1988 |
[Redistribution of intrahepatic arterial blood flow after ligation of an aberrant lobar artery. Use of degradable starch microspheres].
Topics: Floxuridine; Hepatic Artery; Humans; Infusions, Intra-Arterial; Ligation; Liver Circulation; Liver N | 1988 |
[Our therapy concept in nonresectable liver metastases].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Com | 1988 |
[Rationale and current results of loco-regional chemotherapy in hepatic metastases of colorectal carcinoma].
Topics: Antineoplastic Agents; Carmustine; Cisplatin; Colorectal Neoplasms; Doxorubicin; Floxuridine; Fluoro | 1987 |
[Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Availability; Capillary Perm | 1985 |
Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1985 |
[Preoperative chemo-embolization for treatment of hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Humans; Iodized Oil; Liver | 1985 |
[Retrospective study of short survival cases in hepatocellular carcinoma after transcatheter arterial embolization therapy].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Gelatin Sponge, Absorbable; Human | 1985 |
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorouracil; | 1985 |
[Alteration of blood coagulation and fibrinolysis after transcatheter arterial embolization of hepatocellular carcinomas].
Topics: Antineoplastic Agents; Blood Coagulation; Blood Coagulation Factors; Carcinoma, Hepatocellular; Doxo | 1985 |
[Study of 45 patients with hepatocellular carcinoma complicating occlusion of the main portal vein].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; L | 1985 |
[Low-dose intermittent intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dox | 1985 |
[One-shot therapy and transcatheter arterial embolization (TAE) therapy of unresectable hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Embolization | 1985 |
[Transarterial chemoembolization therapy of hepatocellular carcinoma using anticancer agents (mitomycin C and/or adriamycin) suspended in lipiodol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1985 |
[Intraarterial infusion therapy with polysaccharide solution as a carrier of anticancer drugs].
Topics: Animals; Carcinoma, Hepatocellular; Delayed-Action Preparations; Dogs; Humans; Infusions, Intra-Arte | 1985 |
[Chemoembolization therapy of liver cancer combined with lipiodol and OK-432 intra-arterial administration].
Topics: Adult; Biological Products; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Femal | 1986 |
[Evaluation of intermittent hepatic arterial occlusion with infusion chemotherapy of unresectable hepatocellular carcinoma].
Topics: Aged; Animals; Carcinoma, Hepatocellular; Dogs; Embolization, Therapeutic; Female; Fluorouracil; Hep | 1986 |
[A long-term survivor of primary hepatoma--a case suggesting the superiority of a multi-drug (OK-432, SPG, PSK) over mono-drug immunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neopl | 1986 |
[Large amount of intra-arterial injection of iodized oil (Lipiodol) in the treatment of unresectable hepatoma].
Topics: Aged; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Hepatic Artery; Hum | 1986 |
Emphysematous cholecystitis: complication of hepatic artery embolization.
Topics: Aged; Carcinoma, Hepatocellular; Cholecystitis; Embolization, Therapeutic; Emphysema; Gelatin Sponge | 1986 |
Treatment of irresectible hepatocellular carcinoma with intrahepatic arterial lipoidal mixed with adriamycin and mitomycin C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1986 |
[A case of hepatoma effectively treated by TAE and intra-arterial and intraportal infusion chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality | 1986 |
[Ruptured hepatocellular carcinoma following transcatheter arterial embolization: a case report].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Gelatin Sponge, Absorbable; Hepatic Arte | 1986 |
[Chemotherapy of balloon-occluded arterial infusion in a patient with unresectable hepatocellular carcinoma and autoimmune hemolytic anemia].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepa | 1986 |
[Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization | 1987 |
[Chemoembolization with degradable starch microspheres in malignant hepatic tumors].
Topics: Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial | 1987 |
[Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Adminis | 1987 |
[Comparison of various therapeutic modalities with transcatheter arterial infusion of anticancer drugs in hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Embolization | 1986 |
[Intra-arterial chemoembolization with albumin microspheres including mitomycin C in inoperable hepatic cancer].
Topics: Adult; Aged; Albumins; Animals; Carcinoma, Hepatocellular; Female; Hepatic Artery; Humans; Infusions | 1987 |
[Arterial infusion of combination chemotherapy consisting of adriamycin and mitomycin C for liver metastases of breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Adm | 1986 |
Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colonic Neoplasms; Fluorouracil; Follow- | 1986 |
Combination chemotherapy for advanced colorectal cancer. A pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Female; F | 1986 |
[Intra-arterial embolization of microcapsulated mitomycin C in the treatment of advanced carcinoma].
Topics: Adult; Aged; Capsules; Embolization, Therapeutic; Female; Gallbladder Neoplasms; Humans; Injections, | 1986 |
[Intraarterial bolus infusion followed by rapid removal of anticancer agents with hemocarboperfusion under local hyperthermia in advanced hepatic cancer].
Topics: Adult; Aged; Charcoal; Combined Modality Therapy; Doxorubicin; Female; Humans; Hyperthermia, Induced | 1986 |
[A case of multiple liver metastases from sigmoid carcinoma treated successfully with arterial infusion chemotherapy].
Topics: Adenocarcinoma; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Dru | 1986 |
Requirements and results of liver perfusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Follow-Up Studies; Humans; Infusions, | 1986 |
[The features of liver metastasis of breast cancer on imaging and its response to arterial infusion chemotherapy].
Topics: Adult; Aged; Angiography; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubi | 1986 |
Hepatic artery bolus infusion chemotherapy with mitomycin C. Angiographic results and complications.
Topics: Angiography; Catheterization; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mi | 1986 |
[Enhancement of anti-tumor effects by arterial embolization combined with hyperthermia in the treatment of hepatic tumors].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Embolization, Thera | 1987 |
Phase II study of hepatic arterial degradable starch microspheres and mitomycin.
Topics: Adult; Aged; Drug Evaluation; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neopl | 1986 |
Mitomycin C associated hemolytic uremic syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Doxorubicin; Fluorouracil; Hemolyti | 1987 |
Rationale and indications for perfusion in liver tumors: current data.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusio | 1987 |
[Anatomo-clinical conference. Hôpital de la Pitié-Salpêtrière. Case n. 2-1987. Anemia, thrombopenia and renal insufficiency in a patient treated for cancer of the pancreas].
Topics: Hemolytic-Uremic Syndrome; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pancre | 1987 |
[A case of gastric cancer with marked response to intra-arterial infusion of cisplatinum, mitomycin C and 5-fluorouracil].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Infusions, | 1987 |
Liver metastasis of colon 26 cells implanted into the superior mesenteric vein in mice.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Disease Models, Animal; Injections, Intravenous; Liver N | 1987 |
Intra-arterial mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres.
Topics: Female; Humans; Injections, Intra-Arterial; Liver Circulation; Liver Neoplasms; Male; Microspheres; | 1987 |
[Clinical observations of hepatic artery infusion therapy combined with hepatic artery ligation in metastatic liver cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Adminis | 1988 |
[Intra-arterial chemotherapy of colorectal liver metastases with 5-fluorouracil (5-FU) and mitomycin C (MMC)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil | 1987 |
[Changes in CT findings in patients with liver metastases of breast cancer during effective intra-arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Humans; Infusion Pump | 1988 |
[Regional intra-arterial chemotherapy].
Topics: Cisplatin; Dacarbazine; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Melanoma; Mitomycin; Mit | 1988 |
[Results of intra-arterial infusion chemotherapy in colorectal cancer patients with metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Colonic Neoplasms; Combined Modality Th | 1988 |
[Intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in unresectable metastatic liver carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Papillary; Combined Modality Therapy; Embolization, Therapeu | 1988 |
[Repeated intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in inoperable metastatic hepatic cancer].
Topics: Combined Modality Therapy; Embolization, Therapeutic; Female; Hemodynamics; Hepatic Artery; Humans; | 1988 |
[Chemoembolization with degradable starch microspheres in metastatic liver cancer].
Topics: Embolization, Therapeutic; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male | 1988 |
[Experimental and clinical studies on degradable starch microspheres (DSM) in the treatment of hepatic neoplasms].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Embolization, Therapeutic; Hem | 1988 |
[Fundamental and clinical studies of intra-arterial chemotherapy combined with degradable starch microspheres (DSM)].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; | 1988 |
[Hepatic arterial infusion of degradable starch microspheres (DSM) with adriamycin or mitomycin C in liver cancer].
Topics: Adult; Aged; Doxorubicin; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Infusions, Intr | 1988 |
[Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusion | 1988 |
[Regional therapy of isolated liver metastases from breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catheters, Indwelling | 1988 |
[Hepatic artery chemoembolization in the treatment of primary liver cancer].
Topics: Adult; Combined Modality Therapy; Embolization, Therapeutic; Female; Fluorouracil; Gelatin Sponge, A | 1988 |
Hepatobiliary scintigraphy in patients receiving hepatic artery infusion chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cholecystitis; Colonic Neoplasms; Do | 1985 |
Gastroduodenal ulcerations in patients receiving selective hepatic artery infusion chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Female; Floxuridine; Gastroscopy; Humans; Infusions, Intra-Arterial; | 1985 |
[5-FU/ADR/MMC combined hepatic infusion in liver metastases from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Doxorubicin; Drug Evaluation; Fem | 1988 |
[Transcatheter arterial chemoembolization and selective hepatic arterial infusion using totally implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Embolization, Therap | 1988 |
[Preliminary results of a phase II study of 5-FU, adriamycin, and mitomycin C (FAM) in combined hepatic infusion in patients with non-resectable metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Dr | 1987 |
[The effect and CT imaging of FAM hepatic infusion chemotherapy in patients with liver metastasis from colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Female; Fluorouracil | 1987 |
Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Ev | 1986 |
Effects of intra-arterially infused biodegradable microspheres containing mitomycin C.
Topics: Animals; Antibiotics, Antineoplastic; Arterioles; Biodegradation, Environmental; Hepatic Artery; Inf | 1985 |
[Intra-arterial infusion chemotherapy using a subcutaneously implanted silicone reservoir--with reference to the chemotherapy protocol].
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cytarabi | 1985 |
[Experimental studies on effects of total-body and local hyperthermia on metastases in mice].
Topics: Animals; Antibiotics, Antineoplastic; Body Temperature; Cisplatin; Combined Modality Therapy; Hypert | 1985 |
Long-term survivors of colorectal cancer with unresectable hepatic metastases.
Topics: Administration, Oral; Aged; Carcinoembryonic Antigen; Colonic Neoplasms; Female; Fluorouracil; Human | 1985 |
[A long survival case of carcinoma of the colon with hepatic metastasis following intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Calcinosis; Colonic Neoplasms; Fluor | 1985 |
[A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 1985 |
[Intra-arterial infusion chemotherapy combine with noradrenalin administration (an improved antitumor effect using a cancerous blood vessel].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma 256, Walker; Doxorubicin; Humans; | 1985 |
[Intra-arterial infusion chemotherapy with mitomycin C containing albumin microspheres].
Topics: Albumins; Animals; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Li | 1985 |
[Intra-arterial infusion chemotherapy of hepatic carcinoma using a totally-implantable Infusaid pump].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Catheterization; Fluorouraci | 1985 |
[Intra-arterial continuous infusion in patients with advanced and recurrent cancer of the digestive system].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 1985 |
[Multimodality therapy of colorectal cancer].
Topics: Aged; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Administration Schedule; Emboliz | 1985 |
[Experimental and clinical study of reduction surgery combined with chemotherapy of primary liver cancer].
Topics: Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; Doxorubicin; Embolization, Therapeu | 1985 |
[A clinical use of a new embolus fibrin paste mixed with MMC].
Topics: Aged; Embolization, Therapeutic; Fibrin; Hepatic Artery; Humans; Liver Neoplasms; Male; Middle Aged; | 1985 |
Evaluation of treatment for gastric cancer with liver metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Evaluation Studies as Topic; Female; Fl | 1985 |